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ABSTRACT 
Electrochemically activated persulfate (EAP) is a potential point source treatment for wastewater 
effluents containing high pharmaceutical content. This dissertation explores the fundamental 
mechanisms of EAP to better understand this technology for practical application.  Ciprofloxacin, 
a fluoroquinolone antibiotic, was chosen as the model compound to assess parameters of EAP. 
Ciprofloxacin was selected for its high environmental risk factor and prevalence in hospital 
wastewater, a potential application for EAP.   During the evaluation of EAP as a point source 
treatment, degradation kinetics and pathways of ciprofloxacin were elucidated.   
In the first stage of this study, persulfate activation by solid iron with and without applied 
current was characterized and applied to the degradation of ciprofloxacin. It was found that 
persulfate activation increased with iron surface area and increased to a plateau with increasing 
current.  Ciprofloxacin degraded via first-order kinetics; however, applied current did not affect 
ciprofloxacin removal.   
In the second part of this study, electrochemical persulfate activation without iron, using 
boron-doped diamond (BDD) anodes and graphite or platinum cathodes, was examined. Sulfate 
radical formation at a BDD anode and persulfate activation at a graphite cathode were elucidated 
using different electrolytes and electrochemical set-ups. In this system, ciprofloxacin degraded via 
first order-kinetics, with persulfate electrolyte enhancing ciprofloxacin removal over sulfate or 
nitrate. 
In the final phase of this study, parameters such as reactor configuration, electrode surface 
area, persulfate concentrations and the presence of a complex matrix were examined to determine 
their impact on contaminant removal.  Due to mass transfer limitations and relative cathode sizes, 
 vi 
 
a flow-through reactor was least benefited by persulfate addition while a rotating-disk electrode 
reactor showed enhanced ciprofloxacin removal with persulfate electrolyte. Ciprofloxacin removal 
from synthetic hospital effluent using electrochemically activated persulfate was found to be less 
than that in pure electrolyte but still followed a first-order mechanism.  Considerable total organic 
carbon removal of ciprofloxacin and other organic components of the effluent was achieved.  
Similar degradation was achieved with persulfate and sulfate electrolyte in the effluent.  Chlorate, 
chlorite and perchlorate were formed in significant amounts during the electrochemical process, 
with formation independent of the presence of persulfate. 
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CHAPTER ONE:  INTRODUCTION 
 
Pharmaceuticals, including antibiotics, are classified as contaminants of emerging concern in 
ground and surface waters in the United States and worldwide1, 2.  In many aquatic ecosystems, 
individual antibiotics are detected in the ng L-1 to low µg L-1 range3-6.  As the antibiotic 
concentration increases, adverse ecological effects may include reproductive interferences in 
crustaceans7-9, disruption of the nitrification process in nitrifying bacteria10, toxicity to algae11 and 
growth of antibiotic resistant bacteria12.  Potential for ecological impacts arising from the 
cumulative or synergistic effect of multiple antibiotics in a single aqueous system may also exist, 
exacerbating the impacts of single contaminant behavior6, 7, 13, 14.  
Effluents from wastewater treatment plants (WWTPs) are a primary source of 
pharmaceutical introduction to surface water, and concern exists around localized “hotspots” 
where concentrations of antibiotics are relatively high1, 2, 15-17.  Pharmaceuticals most often enter 
the waste stream from un-metabolized fractions found in human waste18, 19.  Traditional 
wastewater treatment processes are ineffective in completely degrading pharmaceuticals, so a 
portion passes through the WWTP into surface water unchanged20, 21.  Hospital wastewaters have 
been identified as a significant source of pharmaceuticals entering WWTPs2, 22, 23.  Studies suggest 
a <10% to 50% hospital input to individual pharmaceuticals entering WWTPs, depending on the 
specific substance, and a hospital contribution from 10-94% to the amount of some 
pharmaceuticals found in the environment24, 25.  Discharge from WWTPs servicing pharmaceutical 
manufacturers has also been shown to contain elevated pharmaceutical levels26.   
The fluoroquinolone antibiotic ciprofloxacin has been identified as an environmentally 
high-risk pharmaceutical in multiple studies, making it a prioritization for environmental 
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monitoring and remediation1, 25, 27-32.  Hospital contribution to the environmental risk of 
ciprofloxacin was elucidated by Helwig et. al (2016), Ory et. al (2016), and Santos et. al (2013)25, 
28, 29.  Other sources of environmental ciprofloxacin include pharmaceutical manufacturer effluent 
and agricultural run-off, which are often untreated31, 33.  
The environmental hazards of ciprofloxacin include toxicity to algae and invertebrates, 
interference with plant growth /reproduction and contribution to antibiotic-resistance bacteria1, 27, 
28, 31.  Genotoxicity of hospital effluent has also been attributed to ciprofloxacin and other 
fluoroquinolone antibiotics34.  Ciprofloxacin has the potential to create toxic synergistic impacts 
in the presence of other hazardous compounds28.  Because of its high risk-factor and prevalence in 
hospital wastewater, ciprofloxacin has been selected as the compound of interest for the current 
series of studies.   
Point source treatment of hospital effluent, where pharmaceutical concentrations are high, 
offers an effective solution to mitigate antibiotic entry to surface water22, 28.  Membrane 
bioreactors, powdered activated carbon, ultraviolet light, and ozonation are the most commonly 
examined processes for the treatment of hospital wastewater35.  Advanced oxidation processes 
(AOP) using ozone/hydrogen peroxide (O3/H2O2), ozone/ultraviolet light (O3/UV), Fenton’s, 
sono-Fenton’s, and UV/O3/H2O2 have been studied for the destruction of ciprofloxacin, 
metronidazole, levofloxacin and trimethoprim in hospital effluent and other systems36-39.  Many of 
these options have been investigated as pre-treatment steps, secondary stages or tertiary steps in 
lab-scale, pilot-scale and full-scale processes24, 35, 40.  As noted by Verlicchi et. al (2015), the ideal 
treatment of hospital effluent takes into account a complex mixture of variables including hospital 
size, effluent composition, removal efficiencies for target compounds, receiving WWTP processes 
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and economic factors35.  Less selective treatment methods are warranted as antibiotics and other 
pharmaceuticals exhibit varying properties.  The availability of multiple treatment options enables 
better selection of the best process for a specific treatment challenge.   
Electrochemical advanced oxidation processes (EAOPs) are a candidate for removal of 
fluoroquinolone antibiotics, pharmaceuticals and other targeted pollutants like x-ray contrast 
media22, 41-45.  EAOPs are described in Chapter 4.1 and offer the advantage of eliminating total 
organic carbon (TOC), which may contain harmful transformation byproducts46, 47.  
Activated persulfate is another AOP recognized as a method to degrade an assortment of 
environmental contaminants, including many antibiotics that traditional wastewater treatment 
processes do not remove48.  A comprehensive review of activated persulfate processes to treat over 
70 organic compounds is offered in Chapter 2.  
Electrochemically activated persulfate (EAP), explained in Chapter 2.4.1, may offer the 
advantages of both activated persulfate and EAOP for treatment of pharmaceuticals in hospital 
effluent.  The research described in Chapters 3, 4 and 5 focuses on application of EAP to 
ciprofloxacin degradation.  Throughout these studies, ciprofloxacin removal is analyzed in detail, 
while ciprofloxacin is also used as a model compound to understand the fundamentals of EAP.  
Chapter 3 explores EAP using an iron anode with and without applied current.  Kinetics of 
persulfate activation and ciprofloxacin removal based on iron surface area and varying applied 
current are examined.  Chapter 4 concentrates on EAP using a boron-doped diamond anode. Iron 
introduction to the system is avoided.  Chapter 4 offers significant insight into anodic and cathodic 
processes involved in EAP. Kinetics of persulfate ciprofloxacin removal and persulfate activation 
are analyzed.  Chapter 5 expands the focus of Chapter 4 by exploring the effects of reactor 
 4 
 
configurations, cathode sizes and persulfate concentrates on ciprofloxacin removal using EAP 
without iron.  Chapter 5 also evaluates ciprofloxacin removal from synthetic hospital effluent and 
inorganic disinfection by-products formed during the EAP process. 
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CHAPTER TWO:  ACTIVATED PERSULFATE FOR ORGANIC DEGRADATION: A 
REVIEW 
 
This chapter is revised based on a paper published by Laura W. Matzek and Kimberly E. Carter, 
as follows: 
 
Matzek, L. W.; Carter, K. E., Activated persulfate for organic chemical degradation: A review. 
Chemosphere 2016, 151, 178-188. 
 
Excerpts are also included from a paper published by Laura W. Matzek and Kimberly E. Carter, 
as follows: 
 
Matzek, L. W.; Carter, K. E., Sustained persulfate activation using solid iron: Kinetics and 
application to ciprofloxacin degradation. Chem Eng J 2017, 307, 650-660. 
 
        
2.1 Introduction 
Peroxydisulfate, or persulfate, has been investigated for its ability to degrade recalcitrant 
organics49-51.  Stable at room temperature, persulfate can be activated via heat, transition metals, 
ultraviolet (UV) light, or other means, forming the highly reactive sulfate radical (Equation 2.1) 
49, 52, 53. 
(2.1) S2O8
2- + activator → SO4 -∙  +  (SO4 -∙ or SO4 2-)      
Like the hydroxyl radical 54, the sulfate radical has a high oxidation potential (Eo=2.60V)55, 
and is nonselective56, 57.  Activated persulfate has widespread application for environmental 
remediation,49, 58, 59 as formed radicals react with organic chemicals causing either partial or 
complete mineralization60-62.  In situ remediation with activated persulfate oxidation may be 
preferred over peroxide-based hydroxyl-radical oxidation processes, as the persulfate anion is 
more stable and may be transported further in the subsurface before being activated for 
contaminant degradation63, 64.  
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Tsitonaki et al. (2010) reviewed the use of persulfate for remediation of contaminated soil 
and groundwater, focusing on heat, iron and alkaline activations, effects of porous media, and in 
situ oxidation65.  Enhancing the effectiveness of activated persulfate includes manipulation of 
traditional methods and development of novel techniques56, 60, 66-68.  Recently, Zhang et al. (2015) 
reviewed sulfate radical technologies, covering radicals generated from peroxymonosulfate and 
peroxydisulfate52, photochemical and heterogeneous activation systems, in-situ remediation, 
hydrothermal oxidation treatment, and air pollution control technologies52. 
The following review provides an extensive assessment of recently published parameters 
and results for the destruction of various organic compounds in aqueous systems via activated 
persulfate. Applicable variables and impacts on activated persulfate reactions are provided. 
Emerging methodologies for persulfate activation, such as electrochemical and activated carbon, 
are highlighted, along with potential for expanding knowledge areas and obstacles that must be 
overcome for future practical implementation.  
2.2 Mechanisms of Persulfate Reactions 
2.2.1 Sulfate, Hydroxyl, and Other Radical Formation 
Heat, UV light, and ultrasound impart energy to the persulfate anion resulting in cleavage of the 
peroxide bond and forming two sulfate radicals (Equation 2.2)63, 69.  Alternately, persulfate can 
undergo an oxidation-reduction reaction with an electron donor from a transition metal or the 
radiolysis of water, generating a single sulfate radical (Equation 2.3)70, 71.  
(2.2) S2O8
2- + energy input → 2SO4-∙ 
(2.3)   S2O8
2- + e- →  SO42- + SO4-∙  
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Enhancing the effect of activated persulfate degradation reactions are secondary radicals 
propagating from sulfate radical reactions65, 72.  Sulfate radicals react with water at all pHs forming 
hydroxyl radicals (Equation 2.4)71,  which are the primary reactive species under basic conditions 
(Equation 2.5)73.  At pH <7 sulfate radicals are the dominant reactive species; however, hydroxyl 
and sulfate radicals participate equally in reactions at neutral pHs73.   
(2.4)  SO4
-∙ + H2O →  SO42- + OH∙ + H+    (k [H2O] < 2.7 x 10-3 s-1 ) 
(2.5)  SO4
-∙ + OH- →  SO42- + OH∙  
While hydroxyl radicals degrade a wide range of organic contaminants 4, chain reactions 
(Equations 2.6 and 2.7) synthesize more reactive intermediates63.  Likewise, peroxymonosulfate 
(HSO5
-) may be activated generating sulfate radicals, as hydrogen peroxide may react with 
inorganic compounds producing additional free radicals.  The formed radicals can subsequently 
participate in further reactions74, 75.   
(2.6) SO4
-∙ + OH∙ →  HSO5-  
(2.7) 2OH∙ → H2O2 
2.2.2 Degradation Mechanisms 
Sulfate radicals react with organic molecules through hydrogen abstraction, addition on double 
bond, and electron transfer76.  Because the sulfate radical is electrophilic, electron-donating groups 
will have faster reaction rates with the sulfate radical than electron-withdrawing groups65. 
Persulfate will react with some organics directly, forming sulfate radicals that propagate secondary 
reactions (Equation 2.8) or may create organic radicals (Equation 2.9)57, 77, progressively 
decomposing the intended contaminant53, 62, 78.  Overall contaminant degradation rates are 
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dependent on a complex combination of the sulfate radical chain propagation and terminating 
reactions. 
(2.8)   S2O8
2- + R →  SO42- + SO4-∙ + R* where R represents the organic and R* the 
oxidized organic 
 (2.9)  S2O8
2- + R →  2SO4-∙ + R∙ 
2.3 Degradation Reactions by Activation Type 
Without activation, the persulfate anion will react with some organic chemicals, but degree of 
removal is less than that obtained using activated persulfate because of the lower oxidation 
potential of the persulfate anion (Eo=2.01V)79-83.  Persulfate activators and their properties are 
critical to the rate and extent of analyte mineralization65, 84-86; therefore, results using various 
activators are presented in the following sections.   
2.3.1 Iron-Activated Persulfate for Analyte Degradation  
Persulfate can be activated through one-electron transfer using metals such as silver, copper, iron, 
zinc, cobalt and manganese to form the sulfate radical (Equation 2.10)61, 70, 87, 88. 
(2.10) S2O8
2- +Mn+ → Mn+1 + SO4 2- + SO4-∙   where M represents the metal 
Iron, the most widely studied metal, is an effective activator, relatively non-toxic, 
environmentally friendly, and more cost effective than other transition metals89.  Ferrous iron 
(Fe2+) reacts with persulfate to form the sulfate radical (Equation 2.11), with an activation energy 
of 50.23 kJ mol1 90.  The second-order rate constant of sulfate radical formation from ferrous iron 
is reported as 2 x 101 L mol-1 sec-1 at 22 oC91.  Indirect activation of persulfate by Fe0 proceeds via 
the pathway of Equation 2.1292.  The Fe2+ formed activates the persulfate per Equation 2.1192. 
(2.11) S2O8
2- +Fe2+ → Fe3+ + SO42- + SO4-∙   (k = 2.7 x 101 M-1 s-1 ) 
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(2.12)   Fe0 + S2O8
2- → Fe2+ + 2SO42- 
Insufficient iron concentration causes inefficient persulfate usage, while too much Fe2+ 
results in the iron scavenging the sulfate radical (Equation 2.13), reducing its effectiveness for 
degradation93, 94.  The second-order rate constant for this reaction is reported as 4.6 x 109 L mol-1 
sec-1 at pH 3-5 and the activation energy is -18 kJ mol-1  88.  
 (2.13) SO4
-∙ + Fe2+ → Fe3+ + SO42-   
Examples of iron-activated persulfate degradations and conditions contributing to optimal 
removal are presented in Appendix Table A1, and BTEX/phenols, pharmaceuticals, phenyls/dyes 
and various other organics are shown in Appendix Tables A2-A5.  
For iron-activated persulfate, much work has gone into understanding ideal ratios of 
contaminant to persulfate to iron that enhance removal of contaminants, including antibiotics.  
Successful ratios vary greatly with contaminant and reaction conditions, but almost always involve 
excess input of persulfate from 10 to 200 times the molar amount of contaminant95-97.  At least a 
1:1 persulfate to iron ratio is typically needed to achieve maximum analyte removal61, 98; however, 
exact ratios vary with iron forms/states, addition methods and target analytes.   
Sequential and continuous addition of iron to activate persulfate for analyte removal has 
been explored.  Sequential and continuous addition of ferrous (Fe2+) iron achieved success over 
batch additions for pharmaceuticals caffeine and phenacetin but not nicotine or ibuprofen97.  
Degradation of bisphenol A was enhanced from 49% to 97% using four sequential additions versus 
a single dose of Fe2+, and continuous Fe2+ addition achieved 100% removal using the same amount 
of total iron and reaction time (Appendix Table A1)99. 
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Results varied when using Fe0 and nano-Fe0 for activation as compared to Fe2+98, 100.  Fe0 
activates persulfate through a two-step process of ferrous iron generation as shown in equation 
2.12 followed by the persulfate activation reaction shown in equation 2.1192.  Fe0 provides a 
measured release of Fe2+ through its reaction with persulfate, with higher surface areas of micro- 
and nano-Fe0 amplifying persulfate activation98, 99, 101.  In a side-by-side comparison, Fe0 persulfate 
activation resulted in more complete removal of sulfamethoxazole than Fe2+ activation, with 100% 
removal achieved in the former case95.  In the same study, bimetallic  (cobalt/Fe0 and silver/Fe0) 
and trimetallic (cobalt/silver/Fe0 and silver/cobalt/ Fe0) plated activators also attained adequate 
sulfamethoxazole removal, with plating resulting in sustained persulfate activation in solution 95.  
The size of Fe0 has undergone further examination, with micrometric iron particles activating 
persulfate to remove 97% sulfamethoxazole in thirty minutes102.  Recently, Naim et al. (2016) 
demonstrated 95% removal of the pharmaceutical ranitidine with microscale industrial iron scrap, 
opening the door for low cost, sustainable activation material that may have broad application for 
iron-activated persulfate degradation systems, including the solid iron activated system examined 
in Chapter 3103.  Chapter 3 studies a sustained system for persulfate activation using solid iron, 
based on the need for in-depth development of persulfate to iron ratios and continuous persulfate 
activation identified in the preceding paragraphs. This system is applied to the degradation of 
ciprofloxacin. 
Chelation is a potential method for continuous Fe2+ release and is commonly used for in 
situ persulfate activation104, 105. Results are mixed, with chelated Fe2+ producing similar 
degradation results to Fe2+ for ciprofloxacin but slightly better degradation for 
sulfamethoxazole96.  EDTA is often used to chelate iron, forming strong Fe2+ complexes, while 
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citric acid is used for its biodegradability104, 106.  Experiments comparing chelation with citric 
acid, oxalic acid and EDTA showed 60% aniline removal was achieved using citric acid chelated 
Fe2+ versus 45% using only Fe2+ to activate persulfate (Appendix Table A1)106.  Sulfamethoxazole 
degradation removal was best achieved using EDTA rather than citric acid to chelate Fe2+, while 
both were better than using only Fe2+ (Appendix Table A5)96. Use of the inorganic chelator, 
Na2S2O3, for Fe
2+ persulfate activation led to equivalent or better contaminant degradation 
compared to citric acid and EDTA, and eliminated the TOC introduced by organic chelators107.  
2.3.2 Mineral-based activators  
Mineral-based activators including magnetite (Fe3O4), nano-magnetite (nano-Fe3O4), goethite (α-
FeO(OH)) and birnessite (a manganese-based oxide) have been employed for persulfate activation 
(Appendix Table A5)108, 109.  Unfortunately, minerals at naturally occurring levels have been 
proven to have limitations for practical application110.  It was suggested that concentrations of 
naturally occurring minerals in the soils are not sufficient to effectively activate persulfate110.  
Further examination into the ability of thirteen naturally occurring minerals to activate persulfate, 
showed seven minerals slowed the persulfate activation while only four (cobaltite, siderite, pyrite, 
and ilmenite) significantly enhanced the degradation of the target analytes. It was concluded that 
most naturally occurring minerals do not effectively activate persulfate for organic degradation, 
possibly due to localized differences in pH or redox potentials at the surface, or functional groups 
on the surface that may scavenge radicals111.  For specific minerals, including some Fe(III) and 
Mn(IV) oxides, mineral content greater than 2% of the aquifer solids increases the persulfate 
activation rates and higher percentages of these minerals could effectively aid contaminant 
degradation112.  
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2.3.3 Heat-Activated Persulfate for Analyte Degradation 
Persulfate forms two sulfate radicals through scission of the peroxide bond resulting from 
absorption of heat energy (Equation 2.14)69.  The activation energy for the reaction is 119 to 129 
kJ mol-1, 134 to 139 kJ mol-1, and 100 to 116 kJ mol-1 under neutral, basic and acidic conditions, 
respectively87.  The rate constant of sulfate radical formation ranges from 1 x 10 -7 sec-1 at 25 oC 
to 5.7 x 10-5 sec-1 at 70 oC, and pH 1.391. 
(2.14) S2O8
2- + heat → 2SO4-∙ 
Huang et al. (2005) studied heat-activated persulfate degradations of 59 volatile organic 
compounds113.  Appendix Table A1 and Appendix Tables A6 – A8 list more recent results for 
heat-activated persulfate degradation studies.  In all experiments, the reaction temperature was 
critical, resulting in increased degradation and solubility of the contaminants into the aqueous 
phase at elevated temperatures114-117.  However, temperature optimization is used to minimize the 
energy input required for achieving desired results.  For example, 100% removal of 
perfluorooctanoic-acid was accomplished at 60 oC and 90 oC, 60 oC was chosen for further 
experiments81.  
Comparing conventional to microwave heating for activated persulfate degradation 
(Appendix Tables A6-A7) concluded that microwave heating resulted in faster analyte 
degradation. It was suggested that microwave heating imparts the required energy more quickly to 
activate persulfate115, 118. Although both conventional and microwave heat-activated persulfate 
eliminate the need to remove dissolved solids and/or precipitants resulting from metal-catalyzed 
activation, heat activation is not typically used to remediate large groundwater zones due to the 
required energy input and associated costs119.  Furthermore, as the temperature increases, so does 
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the rate of reaction for both sulfate radical formation and the potential scavengers, (e.g. chloride 
and bicarbonate ions) with the latter decreasing removal efficiency120.   
Simultaneous use of iron- and heat-activated persulfate has produced mixed results49, 100, 
121. In the degradation of 1,4-dioxane at 60 oC, the addition of Fe2+ to the process decreased the 
pseudo-first order reaction rate from 0.0365 min-1 to 0.0250 min-1 (Appendix Table A1)49.  It was 
hypothesized that elevated temperatures increased the rate of Fe3+ formation (Equation 2.11), 
resulting in ferric hydroxide precipitant and reaction inhibition
49.  Further, experiments using Fe0 
with microwave heat-activated persulfate also exhibited no enhancement of cyclohexanoic acid or 
polyvinyl alcohol removal92, 120.  In these cases, it was assumed that reactions of the sulfate radical 
and iron at elevated temperatures decreased the effectiveness for organic degradation (Equation 
2.13)94.  
While the previously mentioned experiments exhibited decreased degradation rates, others 
achieved improved results with the addition of iron to heat-activated systems.  During the removal 
of p-nitrophenol, Fe2+ had positive synergistic effects with heat-activated persulfate below 50 oC, 
but as temperatures increased, heat activation was the dominant mechanism (Appendix Table 
A6)61.  The results suggested that the metal ions scavenged the sulfate radical at elevated 
temperatures, negating the synergistic effects observed at lower temperatures.  Furthermore, 
precipitates formed at the higher temperatures limited the diffusion of persulfate and sulfate 
radicals in the solution61.  
2.3.4 UV Light Activated Persulfate for Analyte Degradation  
Persulfate can be activated via UV light forming the sulfate radical (Equation 2.15)122:   
(2.15)   S2O8
2- + hν→ 2SO4-∙ 
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The UV energy breaks the O-O bond, similar to heat-activated persulfate, and a quantum yield of 
unity has been proven for acidic, basic, and neutral conditions123, 124.  The results from UV-
activated persulfate degradation are presented in Appendix Table A1 and Appendix Tables A9-
A10.  
With UV activation, the wavelength and UV fluence rate plays an important role in 
persulfate activation and organic degradation.  The most commonly utilized wavelength is 254 nm 
due to decreased reaction time requirements compared to other wavelengths125.  A comparative 
study using 254 nm and 365nm UV-activated persulfate for polyvinyl alcohol destruction found 
that 100% removal was achieved in less than 5 minutes at 254 nm but only 93% removal in 30 
minutes was observed using 365 nm, (Appendix Table A10)125.  When higher fluence rates were 
used to activate persulfate, increased degradation and mineralization of beta-lactam antibiotics 
were observed (Appendix Table A9)53.  For the removal of acid blue 113, 30 W of power resulted 
in a faster removal rate than 14 W (Appendix Table A1)126.  Though UV activation is a cost-
effective alternative to thermal activation, this method is limited as UV light has limited 
penetration into water and is unviable in the subsurface112, 118, 127. 
The synergistic effects of iron addition on UV-activated persulfate degradation of 
carbamazepine were tested and found enhanced removal was achieved by pairing the two methods 
(Appendix Table A9)128.  Adding 50 mM of Fe2+ to UV-activated persulfate resulted in 95% 
removal of phenol in five hours (Appendix Table A10).  Although the reaction took longer, a much 
lower concentration of persulfate was required to achieve 95% removal when Fe3O4 was added to 
the system129.  
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2.3.5 Base-Activated Persulfate 
Base-activated persulfate is one of the most commonly used techniques to for in situ remediation 
and is typically performed by adding sodium or potassium hydroxides to raise the pH between 11 
to 12105, 130.  The base catalyzes the hydrolysis of one persulfate molecule, forming the 
hydroperoxide (HO2
-) intermediate, which in turn reacts with another persulfate molecule in a one-
electron transfer generating a sulfate radical (Equation 2.16).  The reaction is second order with 
respect to persulfate and sodium hydroxide105.  Hydroxyl radicals are generated from sulfate 
radicals as previously illustrated (Equation 2.4). 
(2.16) S2O8
2- + 2H2O 
𝑂𝐻−
→
   2SO4
- + SO4
-∙ +O2-∙ +4H+  
Hydroxyl radicals are the dominant reactive species at pH > 12, resulting in widespread 
organic degradation, and the superoxide radical may play a role in the extensive reactivity of base-
activated persulfate73, 105, 131. 
Although higher base to persulfate ratios increases the reactive oxidizing species in a 
system, a 2:1 base to persulfate molar ratio is recommended to achieve neutral conditions at the 
end of the reaction for in situ use131.  Maintaining base-activation may require additional base to 
neutralize the natural buffering capacity of the water and soil or the sulfuric acid generated from 
persulfate reactions65, 118, 131.  Unfortunately, elevated base levels may cause changes in soil 
dispersion and metal concentrations, as well as increase the formation of scavenging species 
resulting in decreased analyte degradation65, 118, 131. 
Despite its prevalent use for in situ remediation of groundwater and soils, limited studies 
are available to determine ideal reaction parameters for specific recalcitrant organics using base-
activated persulfate. This is in contrast to most activator types, which have been widely studied 
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and modified in the lab but not put into practice.  Studies in which a wide range of organic analytes 
are degraded under variable conditions using base-activated persulfate would enable practitioners 
to quickly screen the efficacy of base-activated persulfate for specific remediation projects. 
2.4 Unique Methods for Persulfate Activation 
2.4.1 Electrochemically-Activated Persulfate for Analyte Degradation  
Electrochemical techniques have proven to fully mineralize recalcitrant compounds not degraded 
via activated-persulfate alone44, 132.  By combining electrochemistry and electrochemically-
activated persulfate, superior removal results compared to either technique alone may be achieved, 
reducing persulfate and/or electricity usage.  Few studies exist that describe the synergistic effects 
of combining electrochemistry and activated persulfate. Electrochemically activated persulfate 
(EAP) studies fall into two categories: those that use iron as a co-activator and those that use inert 
electrodes.  These are presented in Appendix Table A11.   
Studies investigating EAP without iron suggest persulfate activation, through direct 
electron transfer at the cathode, creates sulfate radicals (Equation 2.3)59, 133.  Activated persulfate 
at the cathode is predicted to work in tandem with anodic electrochemical advanced oxidation 
processes (EAOP) to degrade organic constituents.  The EAOP mechanism is attributed to 
hydroxyl radical formation (Eo = 2.74 V) that can occur at anode surfaces such as boron-doped 
diamond (BDD), tin dioxide, and lead dioxide (Equation 2.17)44, 45, 47, 134, 135.  These hydroxyl 
radicals react to degrade organic contaminants and propagate other radicals, which can participate 
in degradation reactions44, 45, 47, 134, 135.  Additionally, oxidation of the target contaminant by direct 
electron transfer at the anode can occur135, 136.  
(2.17)    H2O → OH ∙  + H
+  + e− 
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Increased TOC removal was observed for dinitrotoluene and aniline degradation using 
electrochemically-activated persulfate versus an electrochemical system without persulfate50, 59.  
Both studies found that the contaminant removal increased with the applied potential50, 59. 
Electrochemical persulfate activation accomplished with inert anodes and cathodes 
eliminates the need for iron addition.  Because persulfate can be electrochemically generated from 
sulfate ions, it has been suggested that persulfate could be regenerated at the anode (Equation 2.18) 
after completion of an activated persulfate degradation reaction78, 137-140.  In conjunction with 
cathodic activation (Equation 2.3), this would perpetuate a source of sulfate radicals. 
(2.18) SO4
2-  + SO4
-→    S2O82- + e-    (anode)    
Few if any publications are available that conclusively demonstrate persulfate regeneration during 
an organic chemical degradation reaction. Proof of this concept may lead to development of 
methods that reduce persulfate consumption while achieving desired contaminant removal. 
Chapter 4 focuses on understanding the fundamentals and mechanisms of EAP without iron as a 
co-activator. EAP is then applied to the degradation of ciprofloxacin. 
Moving forward, studies are needed to determine electrode materials, including those 
commonly used for organic destruction (BDD, Ti/RuO2-IrO2, and Ti/SnO2-Sb), best suited for 
activating persulfate, the relationship between current density and activation, and the synergistic 
effects on degradation and mineralization of various classes of organics140.  Chapter 4 covers some 
of these topics by comparing cathode materials for electrochemical persulfate activation and 
studying the relationship between current density and activation. Chapter 5 further explores 
variables influencing organic degradation by EAP, by examining anode:cathode size ratios, reactor 
configurations, and ciprofloxacin degradation in a complex matrix. 
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The effects of adding iron into a persulfate reaction vessel by applying an anodic current 
to iron electrodes have been investigated141, 142.  Solid iron produces Fe2+ through chemical and 
anodic reactions (Equation 2.19), activates persulfate (Equation 2.11), and can be regenerated at 
the cathode (Equation 2.20) for additional persulfate activation141.  Some studies found that the 
amount of iron added to solution is proportional to the applied current, thus controlling and 
enhancing the persulfate reaction through a slow release of iron, similar to other slow release 
methods that enhance degradation reactions96, 97, 141. 
(2.19)  Fe0 →  Fe2+ + e- 
(2.20)   Fe3+ + e- →  Fe2+ 
Fe2+ generated from solubilized Fe3+ at the cathode can also activate persulfate (Equation 
2.11)141, 143.   The use of ferric iron to electrochemically generate ferrous iron resulted in significant 
achieved 76.5% bisphenol A removal.  Optimized conditions of low pH, high persulfate 
concentration and high current density improved the removal to 100%143. 
Electrochemical generation of ferrous iron for persulfate activation, if controlled by 
current, may eliminate the need for further iron dosing.  However, more work is needed to verify 
that Fe2+ recycling reduces iron requirements while achieving the same degradation results as 
traditional iron addition. Additionally. the synergistic effects of iron and electrochemically-
activated persulfate on organic degradation, especially with regard to mineralization and the initial 
form of iron, are needed.  Chapter 3 addresses these topics with an in-depth exploration of 
electrochemically-enhanced iron activated persulfate for the degradation of ciprofloxacin. 
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2.4.2 Ultra-sonication, Activated-Carbon, and Other Methods of Persulfate Activation for 
Analyte Degradation 
Current publications covering lab-scale experiments of various novel activated-persulfate 
techniques are presented in Appendix Table A12. Degradation by ultrasonically-activated 
persulfate has shown promising results56, 58, 144.  Localized high temperatures and pressures from 
ultrasonically produced cavitation result in homolysis of the O-O bond producing two sulfate 
radicals in the same energy-induced mechanism as heat and UV light radical generation52.  The 
degradation of ammonia perfluorooctanoate significantly increased by combining persulfate and 
ultra-sonication (Appendix Table A12)56.  Combining ultra-sonication with persulfate and Fe0 
achieved 99.1% removal of sulfadiazine versus only 50% using Fe0 activated persulfate 144. 
The addition of persulfate to gamma-irradiated for the destruction of ibuprofen achieved 
the same removal using less radiation, while combining persulfate/electron beam to degrade p-
hydroxybenxoic acid did not enhance removal (Appendix Table A12)60, 66.  Inducing a weak 
magnetic field on Fe0 added to persulfate increased the removal rate of caffeine, 4-nitrophenol, 
benzotriazole and diuron and increased TOC removal of orange G from 7.6% to 36.4% in three 
hours86. 
Activated carbon (AC) was found to activate persulfate by a mechanism postulated by 
Liang et al. (2009) and shown in Equations 2.21 and 2.22145. 
(2.21) AC surface-OOH + S2O8
2- →  SO4-∙ + AC surface-OO∙ + HSO4- 
(2.22) AC surface-OH + S2O8
2- →  SO4-∙ + AC surface-O∙ + HSO4- 
Greater removal of perfluorooctanoic acid and trichloroethylene was achieved for an AC-
persulfate system than could be accounted for through adsorption using AC alone67, 145.  The 
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synergistic effects of persulfate and granular activated carbon (GAC) enabled the mineralization 
of azo dye acid orange 7146 and the GAC was reused several times.  Activated carbon fiber has 
also been shown to activate peroxymonosulfate147, thus showing potential for peroxydisulfate 
activation.  
Activated carbon is ubiquitous in water treatment, so widespread potential for adaption of 
an AC-persulfate process exists.  The advantages over current AC systems include: decreased 
carbon usage rate (as the contaminant would be more fully mineralized by the persulfate rather 
than taking up sites on the carbon surface) and greater mineralization of the contaminant itself. 
2.5 Additional Factors Influencing Activated Persulfate Degradation Reactions   
2.5.1 Effects of Persulfate Concentration on Analyte Degradation 
It has been widely recognized that analyte removal rate increases as the amount of persulfate 
increases49, 106, 148.  Typical analyte to persulfate ratios range from 1:20 to 1:250, as shown in 
Appendix Tables A1-A12, but effective analyte removal has been achieved using a minimum 
molar ratio of 1:292, 149.  Alternatively, studies suggest there is an optimum amount of persulfate 
above which degradation is inhibited by the reaction of excess persulfate with sulfate radicals 
(Equation 2.23) reducing the effectiveness organic oxidation82, 120, 150, 151. 
(2.23) SO4 
-∙  + S2O82-  → SO4 2- + S2O82-∙    
Customization of persulfate levels can optimize degradation of target analytes; however, 
this is not always feasible in the presence of multiple analytes with different degradation rates or 
the presence of scavenging species.  While almost always reported as pseudo-first order based on 
the analyte concentrations93, 115, 144, 152, reaction rates, in fact, follow second order kinetics with 
respect to the analyte and persulfate concentrations.  Establishing second-order kinetics and rate 
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constants across categories of organic contaminant can help minimize the amount of persulfate 
needed to achieve desired results.  Chapter 5 examines effects of persulfate concentration on 
ciprofloxacin degradation using three reactor configurations.  It also evaluates second-order 
mechanisms between ciprofloxacin and persulfate on a rotating-disk electrode reactor. 
2.5.2 Effects of pH on Analyte Degradation 
The pH of the activated persulfate reaction has a significant effect on analyte removal, even in 
most cases where pH is below the range required for base activation.  Although degradation 
reactions at acidic pH most frequently improve the degradation of the contaminants by forming 
hydroxyl radicals (Equation 2.4), improved removal was also observed at neutral pH (between 6 
and 8) and slightly basic pH (between 9 and 10) depending on the analyte and activator type79, 87, 
100, 150, 153-155. 
2.5.3 Interfering Effects of Ions on Activated Persulfate Reactions 
Several ions naturally found in groundwater affect activated persulfate degradation of aqueous 
contaminants128, 156.  The impacts of bicarbonate and chloride ions for the destruction of p-
nitrosodimethylaniline using different persulfate activation types were studied and concluded that 
neither species affected iron-activated reactions at neutral pH.  Heat-activated reactions were 
enhanced by chloride, while base-activated reactions were improved by the presence of both 
chloride and bicarbonate157.  Enhanced UV-activated persulfate degradation of acetaminophen was 
followed by decreased removal reaction when the chloride concentration was greater than 20 
mM158.  Citric acid chelated Fe2+ activated persulfate degradation of trichloroethene experienced 
no hindrances with 1 mmol L-1 chloride, but removal decreased from 99% to 46% in the presence 
of 100 mmol L-1chloride159.  Similar results were seen for the microwave heat-activated persulfate 
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reaction of sulfamethoxaole118.  Enhanced degradation may have occurred as low concentrations 
of chloride in solution can react with sulfate radicals forming chloride radicals that can degrade 
organic species while high levels may result in sulfate radical scavenging151. 
Bicarbonate was observed to have a negative effect on degradation reactions, across the 
range of activator types57, 63, 94.  Natural organic matter (NOM) impedes activated persulfate 
reactions with reactions tylosin, geosmin, 2-methylisoborneol, atrazine and florfenicol148, 150, 160, 
161.  Subsequent studies for the degradation of 1,4-dichlorobenzene, benzene, and 1,4-
dichloropropane in artificially contaminated water and real groundwater, determined the removal 
efficiency decreased in the groundwater due to the competing reaction of NOM with the sulfate 
radical162.   
2.6 Practical Applications for Activated Persulfate Use in Water Treatment 
2.6.1 Wastewater Treatment 
Specific wastewater applications, including industrial discharge and landfill leachate, have been 
investigated.  Microwave heat activated persulfate at 85 oC was shown to remove 79.4% of the 
TOC from mature landfill leachate in 30 minutes (Appendix Table A8)163, while an 
electrochemical Fe2+ persulfate activation system achieved 62% removal of chemical oxygen 
demand from landfill leachate (Appendix Table A11)164.  Ibuprofen removal from aqueous 
solutions using heat-activated persulfate suggests that this process may be able to treat small 
volumes of concentrated effluents from hospitals or pharmaceutical manufacturers (Appendix 
Table A7)165.  Additionally, heat activated persulfate at 65 oC resulted in 100% removal of the 
pharmaceutical bisoprolol in thirty minutes165, 166.  In the degradation of the antibiotic florfenicol, 
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58.8% mineralization was achieved in two hours with UV/PS versus only 14% in the same time 
using UV/H2O2, and with less cost
167.  
Activated persulfate may have broader applications for treating concentrated effluents 
containing a variety of contaminants and pharmaceuticals, including fluoroquinolones, 
penicillins, and piperacillins, as well as textile dyes53, 96, 168, 169.  Unfortunately, limitations 
regarding persulfate reuse, as well as iron and sulfate removal, must be addressed.  The recovery 
of nano-Fe3O4 using magnets after persulfate/nano-Fe3O4 reaction enabled the re-use of Fe3O4 up 
to four times with minimal leaching into water and was suggested as a cost-effective approach109. 
Chapter 5 applies EAP to synthetic hospital effluent to screen this technique for real-world 
application.  In this final research chapter, the degradation of ciprofloxacin in synthetic hospital 
effluent using two reactor configurations is evaluated. 
2.6.2 In Situ Groundwater Remediation 
The most wide-spread use of activated persulfate includes in situ remediation of contaminated 
groundwater130.  The subsurface properties affect reactivity and maintaining persulfate/activator 
levels in the subsurface are critical for successful implementation162, 170, 171.  For instance, soil 
organic matter under basic conditions enhanced activated persulfate degradation of nitrobenzene 
and hexachloroethane, while a subsequent study proposed that activation by phenols contained in 
the soil was partially responsible110, 171.  Superior removal of diclofenac was exhibited in real 
groundwater containing naturally occurring mineral ions as opposed to reactions in deionized 
water172.  The exhibited enhancement contrasts with previous studies showing ions interfering with 
analyte degradation  may be due to the differences in the ion species found in groundwater at 
various locations.  
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Properties of the organic species and the subsurface regions can affect the degradation of 
contaminants.  For instance, though catalyzed hydrogen peroxide propagations can enhance 
removal of hydrophobic compounds sorbed to soil and subsurface solids, the same result was not 
accomplished using activated persulfate119.  Preferential reactions between activated persulfate 
with soil organic matter may reduce adsorption of contaminants onto soils, enabling mobilization 
of the contaminants into uncontaminated regions91.  A study into the effects of aquifer solids on 
persulfate activity determined that exhaustion of persulfate and activating agents inhibits long-
term availability of persulfate170.  
Studies for overcoming the challenges and limitation of persulfate and activator 
maintenance have been undertaken.  A proposed solution to maintain iron levels in situ is the use 
of hydroxylamine to quickly cycle Fe3+ back to Fe2+ has proven successful for completely 
degrading trichloroethylene (Appendix Table A1)173.  Permeable reactive barriers can provide 
continuous persulfate release overcoming depletion issues while enabling the degradation of 
contaminants174.  Slow release persulfate-paraffin-Fe0 candles have been utilized to maintain 
activated persulfate concentrations for the removal of BTEX compounds175. 
2.7 Conclusions and Outlooks 
Extensive review of recently published results confirms activated-persulfate is a viable method for 
the destruction of organic analytes for soil and groundwater remediation.  Using optimized 
conditions, 100% removal can be accomplished for some recalcitrant organics.  Unfortunately, 
challenges remain to optimize degradation reactions for efficient, cost-effective and timely 
contaminant removal in practical systems. 
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Development of methods to maintain persulfate and activator concentrations will improve 
utilization in situ.  Broader understanding of environmentally friendly iron-chelator functionality 
under groundwater conditions will help identify cases where chelators can improve longevity of 
iron.  At the same time, practitioners can move away from using traditional chelators that are now 
considered undesirable environmental additives.  Determining second-order reaction kinetics 
between persulfate and analytes in the presence of chelated iron may help enhance optimization of 
reaction longevity.  Relating subsurface parameters, including mineralogy and NOM, to activated 
persulfate degradation outcomes, will enable efficient assessment and prediction of activated 
persulfate treatment outcomes.  Finally, physical techniques offering slow releases of persulfate 
into groundwater systems have been successful; however, supplementary experiments covering a 
broader range of chemicals and reaction conditions are needed. 
Studies comparing or correlating organic degradation using persulfate activator type, 
particularly under groundwater or wastewater conditions, will offer a better understanding of the 
reaction mechanism and outcomes for activated persulfate degradation of various classes of 
organic species.  Formulation of practical guidelines would increase the ability to theoretically 
predict and achieve desired degradation outcomes.  
Studies regarding the cost-effectiveness of energy input versus degradation outcomes for 
energy-intensive activation methods, including heat, UV light, ultra-sonication and 
electrochemical, may have repercussion for implementation of activated persulfate. Persulfate is 
often successful for destroying relatively concentrated pollutants and removing recalcitrant 
organics at the site of contamination.  Nonetheless, little work has been done to combine activated 
persulfate reactions with subsequent sulfate ion removal such as ion exchange or filtration.  As 
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coupling different processes may be required for implementing activated persulfate in certain 
systems, assessment of the additional costs of sulfate ion removal against the potential to remove 
certain contaminants or by-product is necessary. 
Although reaction outcomes typically improve with increased persulfate addition, the 
“more is better” approach can lead to wasted resources and depletion of reactants, limiting 
degradation of targeted contaminants.  Improved understanding of second-order reaction rates with 
respect to both analyte and persulfate can allow for optimization of persulfate usage in specific 
systems.  The novel technique of electrochemical persulfate activation may minimize persulfate 
or iron usage through regeneration, resulting in better mineralization than some other activation 
techniques.  Other novel techniques may also be advantageous for complete contaminant removal 
or mineralization; for instance, activated-carbon can function as both a catalyst for persulfate 
activation and adsorbent for removal of some contaminants and by-products.  Implementation of 
these novel methods requires follow-up studies verifying their usefulness for promoting effective 
activated persulfate degradation and refined parameters for practical application. 
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CHAPTER THREE:  SUSTAINED PERSULFATE ACTIVATION USING SOLID IRON: 
KINETICS AND APPLICATION TO CIPROFLOXACIN DEGRADATION 
 
This chapter is revised based on a paper published by Laura W. Matzek and Kimberly E. Carter, 
as follows: 
 
Matzek, L. W.; Carter, K. E., Sustained persulfate activation using solid iron: Kinetics and 
application to ciprofloxacin degradation. Chem Eng J 2017, 307, 650-660. 
 
3.1  Background 
Limited studies have examined the use of Fe0 in the form of solid iron bars/rods to sustain a 
controlled persulfate degradation reaction141, 142.  With this method, current is applied to an iron 
electrode to electrochemically augment (Equation 2.19) the chemical corrosion of solid iron 
(Equations 2.12 and 3.1) into solution where it can react to activate persulfate (Equation 2.11)92, 
141, 153.  Additional ferrous ions are produced at the surface of the solid iron per equation 3.2153.  
Excess ferrous ions in solution may scavenge persulfate radicals via equation 2.13, decreasing the 
efficiency of persulfate to degrade the intended compound98, 142.  
(3.1) Fe0 + O2 + 2H2O
  → Fe2+ + 4OH- 
(3.2) Fe0 + 2Fe3+ → 3Fe2+   
Govindan et al. (2014) demonstrated degradation of pentachlorophenol (PCP) using an iron 
anode and cathode to activate persulfate142.  Successively larger first-order PCP degradation rate 
constants were observed with increasing applied current142.  Yuan et al. (2014) manipulated 
persulfate activation using current applied to an iron anode.  It was established that the iron 
production increased with current and that a linear relationship (R2=0.933) between iron 
production rate and persulfate decomposition existed when measured with analyte in solution.  A 
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linear relationship between current and the trichloroethylene first-order reaction rate constant was 
also established141.   
It is postulated that solid iron activated persulfate offers an avenue for optimizing persulfate 
to iron ratios and minimizing the amount of iron needed to sustain the persulfate activation 
reaction.  Solid iron may be advantageous over zero-valent nano- micro- and granular iron because 
unreacted amounts can more easily be removed from solution upon reaction completion.  The 
addition of current or manipulation of surface area, which is simpler to accomplish with solid iron 
versus other forms, is expected to provide a way to control the solid iron dissolution rate.  The 
current-regulated introduction of iron into the system should enable both controlled and sustained 
persulfate activation.  The first stage of this study aimed to enhance current knowledge of solid 
iron activated persulfate systems by determining the fundamental relationships between iron 
surface area, applied current, iron production and persulfate activation.  These experiments were 
completed without analyte in solution, a step often bypassed in current research which is critical 
to provide a foundation for the use of solid iron activated persulfate for environmental contaminant 
removal.  The objective of the second stage of this study was to demonstrate the efficacy of solid 
iron activated persulfate in degrading environmental contaminants.  The fluoroquinolone antibiotic 
ciprofloxacin was used as a model compound. Ciprofloxacin has been successfully degraded with 
granular ferrous iron activated persulfate and its use in this study is intended to provide an 
understanding of the solid iron activated persulfate process96.   
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3.2 Materials and Methods 
3.2.1 Chemicals 
Acros Organics ciprofloxacin (98%) was purchased from Fisher Scientific (Pittsburg, PA).  
Sodium persulfate (98%) was purchased from Fisher Chemical. Iron rods were purchased from 
Sigma Aldrich (99.98%, 6.3 mm diameter).  Electron Microscopy Science graphite rods (0.120-
inch diameter) were purchased from Fisher.  Other chemicals include 100 ppm fluoride standard 
(ThermoScientific Orion Ionplus Application solution), 1N sulfuric acid (J.T. Baker), Optima 
formic acid (Fisher Scientific), nitric acid (Fisher Scientific), hydrochloric acid, (Fisher Scientific) 
sodium hydroxide (Fisher), Optima Methanol (Fisher Chemical), potassium iodide (99+%, Acros 
Organic from Fisher), potassium sulfate (Fisher Scientific), sodium bicarbonate (Fisher Scientific), 
tert-butanol (Fisher) and Ferrover iron reagent powder pillows (Hach®, Loveland, CO). Deionized 
water (DI) (18.2 MΩ-cm) was generated by a Millipore Milli-Q system for all experiments. 
3.2.2 Experimental Procedures 
Physical Setup: All experiments were completed at 20 °C. Iron rods were rinsed with aqua Regia 
(3:1 hydrochloric acid to nitric acid) then DI water to ensure starting uniformity of the surface for 
each run176.  700 mL volumes were used for all experiments.  All experiments were completed at 
least in duplicate.  Stirring was maintained for the duration of each experiment using a magnetic 
stir bar.  An iron rod was inserted to a depth corresponding with the desired surface area at time = 
0 (immediately after first sampling).  Surface areas were chosen based on the range of areas 
attainable within the physical limitations of iron rod and iron rod holder. For each series with 
applied current, a graphite rod was inserted 7 cm from the iron rod, to a depth of 4 cm.  A constant 
current was applied to these systems with the positive terminal connected to the iron rod and the 
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negative terminal connected to the graphite rod.  Current density was adjusted by adjusting current 
at a constant surface area.  The physical set-up is illustrated in supplementary Figure 3.1. 
Persulfate Activation Experiments:  For each time series, 200 mL of a prepared 63 mmol 
L-1 sodium persulfate solution was mixed with 500 mL deionized water in an open 1 L beaker.   
The solution was stirred at 750 rpm for 5 minutes and sampled.  3 mL samples were taken at pre-
designated time intervals and frozen to quench the persulfate activation reaction.  The initial 
persulfate concentration was chosen to correspond with that used in ciprofloxacin degradation 
experiments as outlined in section 2.2.3.  The pH was not controlled or buffered during the 
experiment to better examine natural reaction pathways of the system104, 141, 177.  Initial pH values 
averaged 3.5, similar to initial reaction conditions of some other persulfate-based experiments101, 
104, 178.  Final pH values averaged 2.5, a drop in pH noted in several studies and attributed to 
generation of acid during persulfate decomposition104, 177.   
 
 
 
Figure 3.1. Schematic of iron-activated persulfate experimental setup 
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Ciprofloxacin degradation experiments:  Batches of ciprofloxacin were prepared in 0.338 
mmol L-1 concentration with 0.1% sulfuric acid (to aid dissolution) at least one day before 
experiment (also to ensure complete dissolution)44.  For each time series, 200 mL of a prepared 63 
mmol L-1 sodium persulfate solution was added to an open 1 L beaker.  A predetermined amount 
of 0.338 mmol L-1 solution of ciprofloxacin was added to achieve the desired initial concentration 
(for example, 250 mL was added to reach 0.121 mmol L-1 in the final 700 mL mixture).  An initial 
concentration of 0.121 mmol L-1 ciprofloxacin was used for all degradation experiments unless 
otherwise noted.  This initial concentration falls within the range used in related pharmaceutical 
degradation experiments44, 96, 97, 176. It is above concentrations typically found in the environment 
in order to facilitate analysis of ciprofloxacin and avoid errors associated with dilution when 
working on the low microscale97.  The persulfate concentration was chosen to achieve a 1:150 
molar ratio of ciprofloxacin to persulfate. This ratio is within the range established by other 
successful contaminant degradation studies incorporating iron activated persulfate96, 97, 179.  An 
appropriate amount of water was added to attain a total volume of 700 mL.  The solution was 
stirred at 750 rpm for 5 minutes and sampled.  The solution was then stirred an additional 25 
minutes and sampled before insertion of iron rod, for a total of 30 minutes of stirring before iron 
rod inserted.  All tests, with and without applied current, were completed using a constant iron 
surface area of 6.1 cm-2.  This surface area was high enough to minimize effects of surface area to 
reaction volume changes as samples were taken, while keeping the amount of iron introduced into 
the system to a minimum.  15 mL samples were taken at pre-designated time intervals and frozen 
to quench the persulfate activation reaction.  As previously mentioned, pH was not controlled 
during the experiment to better investigate reaction pathways of the system104, 141, 177.  Initial pH 
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values averaged 4.0 upon mixing of ciprofloxacin and persulfate and final pH values averaged 2.5 
after 120 minutes of reaction.  The ciprofloxacin was extracted after 24 hours as outlined in section 
2.3.2.  Radical scavenging experiments were completed using the same methodology but with the 
addition of 220 mmol L-1 methanol or tert-butanol.   
3.2.3 Analytical Methods 
Persulfate and Iron Analysis:  Persulfate concentration was analyzed using a ThermoScientific 
Evolution 600 UV-Vis spectrometer (ThermoFisher, Pittsburg, PA) at a wavelength 352nm, based 
on a modification of the spectrophotometric technique180, 181.  A 1 mol L-1 solution of potassium 
iodide (KI) containing 0.15 mmol L-1 sodium bicarbonate was prepared using high purity water 
(18.2 mΩ).  For each analysis, 40 μL of persulfate sample was combined with 1 mL the potassium 
iodide-sodium bicarbonate solution to give an approximate molar ratio of 1:1000 persulfate to KI 
providing an overabundance to react with the persulfate.  A 20-minute wait time followed, to allow 
a yellow color, created from the reaction of persulfate with potassium iodide to form iodine, to 
develop.  The sample was diluted to an absorbance level within the calibration range by adding 
9.5 mL of DI water and mixing.  Each sample was measured against of background of potassium 
iodide-sodium bicarbonate solution.  Calibration standards with known amounts of sodium 
persulfate were prepared and measured using the same technique.  The linear dynamic range of 
the calibration curve is 4 to 120 µmol L-1 persulfate as diluted and measured, which corresponds 
to original sample concentrations of 0.8 mmol L-1 to 30.7 mmol L-1 persulfate.  The method 
detection limit was 0.6 mmol L-1 persulfate in original, non-dilute samples.  See additional 
statistical analysis in Table 3.1. 
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Table 3.1. Statistical Parameters for Persulfate Calibration Curve 
 Slope 
(absorbance unit per µmol L-1) 
Abs. 
Value 0.0245 -0.0415 
Standard error 0.00033 0.0315 
R2 0.9995  
 
Total iron concentration was analyzed using a ThermoScientific Evolution 600 UV-Vis 
spectrometer (ThermoFisher, Pittsburg, PA) at a wavelength of 510 nm, based on a modification 
of the spectrophotometric technique created by Hach® for use with their Ferrover iron reagent 
powder pillows for 5mL samples.  These powder pillows make use of the 1,10 phenanthroline 
method.  A small amount of sample solution (100-200 μL) was added to 5 mL of DI to dilute 
sample within analysis range of powder pillows.  One Ferrover powder pillow was added to each 
diluted sample and allowed to react for 5 minutes before absorbance was measured.  Standards 
were prepared and measured using the same procedure.  The linear dynamic range of the 
calibration curve was 5.6 to 261 µmol L-1 total iron as diluted and measured.  Sample dilution 
factors were adjusted from as needed so that samples ranging from 0.146 mmol L-1 to 13.3 mmol 
L-1 could be measured.  The method detection limit was 0.08 mmol L-1 iron in original sample.  
See additional statistical analysis in Table 3.2. 
 
Table 3.2. Statistical Parameters for Iron Calibration Curve 
 Slope 
(absorbance unit per µmol L-1) 
Abs. 
Value 0.0113 -0.0279 
Standard error 4.38E-05 0.00635 
R2 0.9999  
 
Ciprofloxacin analysis: Ciprofloxacin concentration was analyzed using a Thermo 
Scientific  Evolution 600 UV-Vis spectrometer at a wavelength of 272nm (ThermoFisher, 
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Pittsburg, PA). To prepare for analysis, ciprofloxacin was extracted from the sample to avoid 
absorbance interference by iron.  Prior to extraction, the pH of each sample was lowered to 1.5 
using sulfuric acid.  This adjustment to a low pH provided >98% extraction efficiency during 
development of the extraction method, versus 90% extraction efficiency at a pH of 3.0, and 80% 
efficiency at a neutral pH, so pH adjustment by sulfuric acid was established as part of the method.  
As >98% of the ciprofloxacin was recovered, it was assumed that hydrolysis did not occur under 
the low pH conditions.  Ciprofloxacin was extracted using solid-phase extraction with Waters Sep-
Pak tC2 cartridges.  Cartridges were conditioned with 1mL methanol and rinsed with 1mL of DI 
water. 0.5mL of sample was loaded onto cartridge followed by a 0.5mL rinse with DI to remove 
all iron from cartridge.  The sample was eluted under vacuum with three subsequent 1mL quantities 
of a methanol/0.1% formic acid solution.  Extracted ciprofloxacin samples were quantified using 
standards prepared in methanol/0.1% formic acid.  The linear dynamic range of the calibration 
curve was 1.1 to 83 µmol L-1 ciprofloxacin, which corresponds to 0.003 to 0.250 mmol L-1 
ciprofloxacin before dilution by the extraction process.  The method detection limit was 0.003 
mmol L-1 in the original, non-dilute samples.  (See additional statistical analysis in Table 3.3.) 
 
Table 3.3. Statistical Parameters for Ciprofloxacin Calibration Curve 
 Slope 
(absorbance unit per µmol L-1) 
Abs. 
Value 0.1148 -0.0283 
Standard error 0.00164 0.0261 
R2 0.9994  
 
 Ciprofloxacin extracts were diluted 1:25 in methanol and analyzed for intermediates and 
transformation by-products using a Thermo Scientific Exactive™ Plus Orbitrap LC-MS with 
ultimate 3000 RS pump, column compartment, autosampler, and diode array detector 
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(ThermoFisher, Pittsburg, PA) with scan range 50-500m/z; resolution 140,000; positive mode 
electrospray ionization; AGC target 3e6; max inject time 200ms.  The ESI settings were: sheath 
gas 25, aux gas 6, sweep gas 3, capillary temp 300oC.  The column temp was 30 C; UPLC with 
mobile phase 80:20 MeOH:H2O with flow rate of 0.2mL/min, 10-minute run, 10 µL was injected.  
UV-vis at 272nm and 3D field from 200-400nm.  The linear dynamic range of the calibration curve 
for ciprofloxacin was 1.2 µmol L-1 to 193 µmol L-1.  The limit of detection for the ciprofloxacin 
analysis was less than 1.2 µmol L-1. See additional statistical analysis in Table 3.4. 
 
 
 
 
 
 
Fluoride Ion Analysis:  Fluoride ion (F-) concentrations were analyzed using ion 
chromatography.  In preparation, the pH of all samples was raised to 7 to precipitate iron and 
dissociate any hydrofluoric acid that may have formed during the degradation process. Samples 
were then filtered through successive 3.1, 1.2, 0.7 µM ThermoScientific™ Target 2™ glass 
microfiber syringe filters and 0.45 µM polypropylene hydrophilic syringe filters to remove 
particulates.  Samples were transferred to low-density polyethylene (LDPE) IC vials in preparation 
for ion chromatography (IC; Thermo-Element, FL) using a Dionex 2100/1100 dual column system 
with background suppression.  F- ions were quantified using a standard calibration curve.  The 
linear dynamic range of the calibration curve was 10.5 to 526 µmol L-1 F- ions.  The analytical 
Table 3.4. Statistical Parameters for HPLC-MS Calibration Curve 
 Slope 
(peak area per µmol L-1) 
Peak Area 
Value 5.42E-07 n/a 
Standard error 3.82E-09 n/a 
R2 0.9999  
 36 
 
detection limit of the IC for fluoride analyte was less than 5.2 µmol L-1 F- ions.  See additional 
statistical analysis in Table 3.5. 
Total Organic Carbon Analysis:  Total organic carbon (TOC) was determined using a 
Shimadzu TOC-L analyzer with autosampler ASI-L.  In preparation, the pH of all samples was 
raised to 7 to precipitate iron and dissociate any hydrofluoric acid that may have formed 
 
Table 3.5. Statistical Parameters for Fluoride Ion Calibration Curve 
 Slope 
(µS*min per µmol L-1) 
Intercept 
(µS) 
Value 0.007925 -0.0251 
Standard error 9.27E-05 0.0210 
R2 0.9993  
 
during the degradation process. Samples were then filtered through successive 3.1, 1.2, 0.7 µM 
ThermoScientific™ Target 2™ glass microfiber syringe filters and 0.45 µM polypropylene 
hydrophilic syringe filters to remove particulates.  The linear dynamic range of the calibration 
curve was 146 µmol L-1 to 4167 µmol L-1 TOC.  The method detection limit for the TOC analysis 
was 52 µmol L-1 TOC.  See additional statistical analysis in Table 3.6. 
 
Table 3.6. Statistical Parameters for TOC Calibration Curve 
 Slope 
(mV*min per µmol L-1) 
Intercept 
(mV*min) 
Value 2357 40.86 
Standard error 1286 21.46 
R2 0.9996  
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3.3 Results and Discussion 
3.3.1 Persulfate Activation Experiments 
Persulfate activation controlled by current applied to iron:  Persulfate activation is represented by 
persulfate decomposition, which is inversely proportional to radical formation.  Figure 3.2a shows 
the decrease in persulfate with time when exposed to solid iron with and without an applied current 
and no analyte present in solution.  The R2 correlation coefficients of >0.97 for a linear relationship 
between persulfate decomposition and time for all series (Table 3.7) establish that persulfate 
decomposes through a zero-order mechanism when exposed to a solid iron surface.  For a constant 
surface area of 6.1 cm2, a persulfate reaction rate constant of 4.3 x 10-7  
mol L-1 s-1 was found, while an average maximum reaction rate constant of 7.1 x 10-7 mol L-1 s-1 
at higher current densities was achieved.  See Table 3.7 for reaction rate constants at all current 
densities. 
 The chemical corrosion of iron due to acidic conditions contributed to over 55% of the 
maximum persulfate decomposition rate achieved with use of applied current, based on a 
comparison of reaction rate constants with no current and with applied current using equation 3.3.   
(3.3)  Contribution to persulfate activation by chemical corrosion 
(Avg. max. reaction rate constant − Reaction rate constant with no current) 
Avg. max. reaction rate constant
 𝑋 100 
The “average maximum reaction rate constant” is the average of all reaction rate constants 
for current densities greater than or equal to 8.2 mA cm-2.  At or above current densities of 8.2 mA 
cm-2, all reaction rate constants are +/- 5% of a horizontal plateau, as shown in Figure 3.3b.   
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Figure 3.2. Persulfate decomposition by solid iron 
(a) Persulfate decomposition by solid iron with and without applied current, as a function of time. 
R2 = 0.9857 for 0 mA cm-2.  R2 = 0.9838 for 3.3 mA cm-2  . R2= 0.9930 for 11.5 (b) Persulfate 
decomposition as a function of iron production, shown at no current.cm-2.  The linear fits indicate 
a zero-order reaction mechanism between the solid iron and persulfate at all current densities. R2 
= 0.9907.  The linear correlation suggests iron dissolution as the driving factor in persulfate 
decomposition.  Initial persulfate concentrations were 18 mmol L-1, iron surface area=6.1 cm2. 
Error bars represent 95% interval. pH was not controlled. The final pH of all experiments at 240 
minutes was 2.5.   
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 Applied current enhanced iron production above levels achieved with the naturally 
occurring acidic conditions of the system.  Figure 3.2b displays the relationship between iron 
production and persulfate decomposition without current applied.  A similar linear relationship 
exists at all current densities tested, with R2 values > 0.98, as shown in Table 3.8. The slope of the 
line elucidates the average molar decomposition of persulfate per mole of iron produced, or the 
persulfate to iron ratio (PS:Fe).  Without electrochemical supplementation, every 1.00 mole of iron 
production resulted in 1.14 moles of persulfate consumed for the duration of each experiment.  
With equation 2.12 a proposed mechanism of ferrous iron dissolution into solution, one mole of 
zerovalent iron should decompose one moles of persulfate, and then the same iron, now ferrous, 
would decompose another mole of persulfate per equation 2.11 to generate sulfate radicals, giving 
an overall 2:1 PS:Fe ratio.  The near 1:1 ratio can be attributed to the acidic reaction conditions of 
this study.  In this case, the oxygen reactions with iron under acidic conditions are also a factor in 
iron production according to equations 3.4 and 3.5182.  More ferrous iron is made available to 
generate sulfate radicals without the unproductive persulfate decomposition indicated in equation 
2.12.  A Fenton reaction, generating additional hydroxyl radicals to degrade the intended 
contaminant, may result from the reaction between H2O2 generated according to equation 3.5 and 
the ferrous iron182.   
(3.4) Fe0 + O2+4H
+→ 2Fe2+ + 2H2O 
(3.5) Fe0 + O2+2H
+→ 2Fe2+ + H2O2 
 Figure 3.3a shows the PS:Fe ratio as a function of current density.  With applied current, 
there is the possibility of activating persulfate through direct electron transfer (Equation 1.3), a 
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Table 3.7. Statistical Parameters for Figure 3.2a. 
Current Density  
(mA cm-2) 
Parameter Slope (zero-order reaction 
rate constant) 
(mmol L-1 persulfate  min-1) 
Intercept 
(mmol L-1 persulfate) 
0.0 Value -0.0258 17.87 
 Standard error 0.00068 0.0850 
 R2 0.9857 17.45 
3.3 Value -0.0347 17.45 
 Standard error 0.0010 0.123 
 R2 0.9838  
6.2* Value -0.0371 18.25 
 Standard error 0.00086 0.130 
 R2 0.9915 17.64 
8.2* Value -0.0407 0.318 
 Standard error 0.0023  
 R2 0.9581  
11.5 Value -0.0415 17.72 
 Standard error 0.0009 0.1065 
 R2 0.9930  
*not shown on figure 
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Figure 3.3a shows the PS:Fe ratio as a function of current density.  With applied current, there is 
the possibility of activating persulfate through direct electron transfer (Equation 1.3), as well as 
the possibility of regenerating Fe2+ from Fe3+ at the anode (Equation 1.20), introducing more 
ferrous iron into solution for persulfate activation71, 141.  If these mechanisms play a significant role 
in persulfate decomposition, it would be expected that the PS:Fe ratio would increase with current.  
In fact, the efficiency of iron use decreased slightly with applied current, with 1.00 mole of iron 
production resulting in 1.00 mole of persulfate decomposed (+/- 5%), at all applied current levels.  
While the electrochemical activation or persulfate and ferrous ion regeneration are theoretically 
possible, they do not play significant roles in the overall decomposition rate.  
Figure 3.3b illustrates the iron production rate and zero-order persulfate reaction rate 
constant as a function of current density.  These inter-related variables follow the same trend, with 
Table 3.8. Statistical Parameters for Iron Dissolution Versus Persulfate Reduction  
Current Density  
(mA cm-2) 
Parameter Slope 
(mmol L-1 persulfate / 
mmol L-1 iron) 
Intercept 
(mmol L-1 iron) 
0.0 Value -1.14 17.93 
 Standard error 0.0254 0.0845 
 R2 0.9907  
3.3* Value -1.06 17.41 
 Standard error 0.0316 0.121 
 R2 0.9851  
6.2* Value -0.977 18.42 
 Standard error 0.0207 0.122 
 R2 0.9928 17.83 
8.2* Value -0.988 0.246 
 Standard error 0.0414  
 R2 0.9760  
11.5* Value -1.00 17.91 
 Standard error 0.0266 0.141 
 R2 0.9895  
*not shown on figure 
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Figure 3.3. Persulfate-iron relationships as a function of current 
 (a) Molar ratio of persulfate decomposition to iron production as a function of current density. 
The solid horizontal line illustrates the average ratio. (b) Iron production rate and zero-order 
persulfate reaction rate constant as a function of current density.  Initial persulfate concentration 
was 18 mmol L-1, iron surface area=6.1 cm2. Error bars represent 95% interval.  
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an increasing reaction rate as current density increases to 8.2 mA cm-2.  The plateau above 8.2mA 
cm-2 is attributed to diffusion limitations of reactants entering and leaving the surface, which is 
associated with the surface dominated zero-order reaction rate.  Reaction rate limits are an 
important consideration for use of solid iron as a persulfate activator, since the limiting current 
density should be quantified in order to maximize persulfate activation without excess electricity 
used.   
  Persulfate decomposition controlled by iron surface area:  It was postulated that 
manipulating the surface area of solid iron exposed to solution controls the persulfate activation.  
Figure 3.4 shows persulfate decomposition at iron surface areas of 3.2 cm2, 6.1 cm2, 9.4 cm2 and 
12.8 cm2.  The linear trends of each time series, with R2 values >0.95 (Table 3.9), indicate that 
persulfate decomposes by a zero-order mechanism.  Within the surface areas tested, there were no 
limiting conditions. The largest reaction rate constant was found at the largest surface area, with 
an average value of 8.4 x 10-7 mol L-1 s-1.  The reaction rate constant increased close to 
proportionally with an increase in iron surface area.  Increasing the surface area by a factor of 2.1 
garnered an 18% improvement in comparison the maximum reaction rate achieved with applied 
current. In Figure 3.5, by increasing the surface area, iron production and persulfate activation 
followed similar linear trends.  Parameters and statistical details can be found in Table 3.10.  The 
reaction rate constant for persulfate, as a function of iron surface area, can be modeled as shown 
in equation 3.6. 
(3.6)  k0,ps =7.2 x 10
-8 x A – 6.1 X 10-8  
The k0,ps is the persulfate reaction rate constant (mol L
-1 s-1) and A is surface area of iron 
(cm2).  Iron utilization was 1.14 moles of persulfate decomposed for every 1 mole of iron released. 
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Figure 3.4. Persulfate decomposition by solid iron at different iron surface areas 
Displayed as a function of time. The linear fits indicates a zero-order persulfate activation 
mechanism at all iron surface areas.  Initial persulfate concentration was 18 mmol L-1. Error bars 
represent 95% interval. pH was not controlled.  The final pH of all experiments at 240 minutes 
was 2.5. 
 
 
 
  
Table 3.9. Statistical Parameters for Figure 3.4.  
Iron Surface Area 
(cm2) 
Parameter Slope 
(mmol L-1 persulfate 
min-1) 
Intercept 
(mmol L-1) 
3.2 Value -0.00757 18.00 
 Standard error 0.0039 0.0644 
 R2 0.9721  
6.1 Value -0.0259 17.88 
 Standard error 0.00065 0.0798 
 R2 0.9863  
9.4 Value -0.0373 17.58 
 Standard error 0.0013 0.189 
 R2 0.9839  
12.8 Value -0.0503 17.305 
 Standard error 0.0027 0.392 
 R2 0.9575  
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Figure 3.5. Iron production and zero-order persulfate reaction rate by iron surface area  
Iron production rate and zero-order persulfate reaction rate constant as a function of solid iron 
surface area.  The initial persulfate concentration was 18 mmol L-1. Error bars represent 95% 
interval. 
 
 
 
Table 3.10. Statistical Parameters for Figure 3.5. 
Analyte Parameter Slope 
(mol L-1 s-1 per cm2) 
Intercept 
(mol L-1) 
Iron Value 6.526E-08 -7.663E-08 
 Standard error 5.656E-09 4.757E-08 
 R2 0.9500  
Persulfate Value 7.188E-08 -6.075E-08 
 Standard error 4.670E-09 3.927E-08 
 R2 0.9713  
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For surface areas and current densities, the solid iron decomposition of persulfate followed 
a zero-order mechanism, which is suggestive of a surface-interface dominated process.  Important 
implications include (1) persulfate decomposition rate can be finely controlled by iron surface 
area, (2) persulfate decomposition can also be enhanced with the use of applied current, but 
diffusion limitations exist, (3) the amount of iron required to sustain the persulfate reaction can be 
minimized to the lower end of the PS:Fe ratio typically used to degrade contaminants with granular 
iron products 48, 52, and (4) solid iron can easily be removed upon reaction completion so that only 
the amount of iron required by the chemical reactions is introduced into the system.  
3.3.2 Ciprofloxacin Experiments 
Mixing phenomena:  Before inserting the iron into the reaction container, a reduced ciprofloxacin 
concentration was noted after 5 minutes of mixing with sodium persulfate, with a significant 
increase in measured ciprofloxacin after 30 minutes of mixing.  In a similar manner, Ji et al. (2014) 
noted a decrease in ciprofloxacin concentration upon mixing with persulfate, with a subsequent 
return to expected concentration over time 96.  Because these phenomena made it difficult to 
measure the true initial concentration of ciprofloxacin in solution with unactivated persulfate, the 
initial ciprofloxacin for all measurements was taken as the concentration of ciprofloxacin prior to 
mixing with persulfate, adjusted for dilution by aqueous persulfate.  Ciprofloxacin concentrations 
as measured by HPLC-MS peaked at 30 minutes, so this was designated as the minimum time for 
adequate mixing, after which persulfate activation using the solid iron was initiated.  At higher 
ciprofloxacin concentrations (0.242 mmol L-1 and 0.302 mmol L-1), a white floc-like substance 
was observed to form in solution within five minutes of mixing sodium persulfate with 
ciprofloxacin.  This floc was pH dependent and was only observed below the third pKa (8.7) of 
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ciprofloxacin96 and may be attributable to the zwitterionic characteristic of the ciprofloxacin177.  
Side-by-side comparisons did not show this effect when ciprofloxacin was mixed with potassium 
persulfate, potassium sulfate or sodium sulfate, which may have indicated which species 
(persulfate, sulfate or sodium) was responsible for the floc.  The floc dissipated immediately upon  
addition of the iron rod and was not expected to affect results of this study. 
Using HPLC-MS and IC analysis, it was determined that ciprofloxacin degradation began 
before persulfate activation was initiated by the iron rod, as observed by formation of expected by-
products during mixing, as well as defluorination of the ciprofloxacin44, 96, 176.  By-products with a 
m/z of 362, 330, and 306, as listed in Table 3.11, were observed to form in solution after 5 minutes 
of mixing and increase after 30 minutes of mixing.  Approximately 12% defluorination was 
observed during the 30 minutes of mixing.  Furthermore, the ciprofloxacin concentration was 
measure as 25% lower than expected based on ciprofloxacin concentration prior to mixing.  A 
comparison of ciprofloxacin removal before mixing (section II) and after activation (section II) 
can be seen in the inset of Figure 3.6.  A corresponding decrease in persulfate concentration, which 
would indicate persulfate activation by ciprofloxacin, was not detected.   
Ciprofloxacin degradation by activated persulfate:  Upon insertion of the iron rod into the 
ciprofloxacin-persulfate solution, ciprofloxacin degradation accelerated, as highlighted in section 
II of the inset of Figure 3.6.  Ciprofloxacin removal increased from 20% before persulfate 
activation to 92% in activated persulfate after 5 minutes.  Degradation plateaued at 95% removal 
after 15 minutes of contact with solid iron activated persulfate.  These results are comparable to 
ferrous activated persulfate for ciprofloxacin degradation, which achieved 80% removal of 
ciprofloxacin in the first five minutes of the study, and overall 95.6% removal with a ciprofloxacin 
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Figure 3.6. Ciprofloxacin and ciprofloxacin/TP matrix degradation as a function of time 
Initial persulfate concentration was 18 mmol L-1.  Iron surface area=6.1 cm2. Error bars represent 
95% interval.  [Ciprofloxacin]0=0.121 mmol L
-1 upon mixing with persulfate, 0.090 mmol L-1 
upon initiation of persulfate activation at t=0.  Inset: Ciprofloxacin degradation by persulfate.  
Section I. is ciprofloxacin removal upon mixing with persulfate, with initial concentration 
determined by ciprofloxacin concentration pre-mixing.  Section II. is ciprofloxacin degradation 
upon persulfate activation by insertion of solid iron rod.  
 
Table 3.11. Primary Transformation Products   
m/z  Time formed ***Time removed Also Detected 
    
334 
306 
330 
362 
263 
*Upon activation 
**Upon mixing  
**Upon mixing 
**Upon mixing 
*Upon activation 
 
30 minutes 
30 minutes 
15 minutes 
15 minutes 
60 minutes 
96, 176, 183 
96, 183, 184 
44, 60, 96, 176 
96 
96, 183 
*Upon activation indicates that this product was formed after initiation of persulfate activation by insertion of iron 
rod into persulfate-ciprofloxacin mixing 
*Upon mixing indicates product was formed upon 5 minutes of mixing persulfate with ciprofloxacin 
***Time removed indicates the time elapsed after initiation of persulfate activation 
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to persulfate to iron ratio of 1:20:20 96.  Results also align with UV activated persulfate, in which 
70% ciprofloxacin removal was achieved in five minutes and 98% removal overall 185.  Achieving 
similar removal to those established in previous studies validates solid iron as a viable method for 
activating persulfate to achieve contaminant removal, a key objective of this study.  
While much attention has focused on removal of primary pollutants in the environmental, 
the formation and degradation of intermediates and by-products is gaining attention, as many of 
these secondary components have the potential for negative environmental impact165, 186.  Limited 
information is available about the environmental effect of ciprofloxacin transformation products 
(TPs), but some studies have found these compounds to be mutagenic and/or genotoxic to several 
cell lines187, 188.  Because of the potential environmental impact of both ciprofloxacin and its TPs, 
the effect of solid iron activated persulfate on generating and degrading these compounds warrants 
further investigation.  Using HPLC-MS, this study identified the formation and removal of five 
TPs with the core quinolone structure intact, as well as smaller amounts of several unidentified 
TPs. These are listed in Table 3.11.  Removal of the ciprofloxacin/TP matrix, as determined by 
HPLC-MS, is illustrated on the “ciprofloxacin/TP matrix (HPLC-MS)” curve on Figure 3.6.  The 
ciprofloxacin/TP matrix undergoes removal by iron activated persulfate, albeit at a slower rate 
than ciprofloxacin itself.  90% of the ciprofloxacin/TP matrix was degraded in 30 minutes, with 
negligible removal after that time period.  Because only partial mineralization occurred, as 
discussed in section 3.2.4, it is clear that one or more transformation products remained in solution 
and were not detected by the current HPLC-MS analytical methods, which is similar to the finding 
by Toolaram et al. (2016) in a study of photo-transformation products of ciprofloxacin 187.  It was 
also noted that the ciprofloxacin/TP matrix had a strong UV/Vis absorbance at 272 nm when 
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measured directly (without HPLC separation).  The presence and removal of the matrix, 
determined by an examination of relative absorbance peak heights at each time point, followed a 
similar trend as the presence and removal measured by HPLC-MS.  This trend is demonstrated on 
the “ciprofloxacin/TP matrix (UV/Vis)” curve in Figure 3.6. 
According to UV/Vis analysis, 78% of the ciprofloxacin/TP matrix is degraded by iron 
activated persulfate in 45 minutes, while degradation plateaued at 83%.  Although the overall 
removal is slightly lower than that determined by HPLC-MS, it is still higher than TOC removal 
discussed in Section 3.2.4.  Like the HPLC-MS data, these results indicate that one or more by-
products remain in solution undetected by the UV/Vis technique.  Because UV/Vis provided 
consistent results within the range of HPLC-MS and TOC analysis, it was decided that using the 
UV/Vis method to compare ciprofloxacin/TP matrix removal with and without current applied to 
the iron anode was appropriate for the bulk solution. 
Effects of applied current on ciprofloxacin/TP matrix degradation:  Figures 3.7a and 3.7b 
show ciprofloxacin/TP matrix degradation by solid iron activated persulfate with and without an 
applied current.  A maximum current density of 11.5 mA cm-2 was tested because persulfate 
activation plateaued at this level per Figure 3.3b.  The ciprofloxacin/TP matrix was characterized 
to degrade in a pseudo-first-order manner with respect to the matrix.  Data from the 0.121 mmol 
L-1 experiments without applied current resulted in a pseudo-first-order reaction rate constant, k1,cip 
, of 6.58 x 10-4 s-1.  This pseudo-first-order reaction rate constant was independent of current, as 
discussed below and tabulated in Table 3.12.  An average of 83% ciprofloxacin/TP matrix removal 
was achieved across all data sets in Figure 3.7a and a total of 1.1 mmol L-1 iron was added to 
solution to achieve this removal.  Although most degradation reactions using persulfate are 
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characterized as pseudo-first-order with respect to the analyte, the predicted higher order nature of 
these reactions leads the reaction rate to vary slightly with different ratios of analyte to persulfate.  
In many cases, less analyte and or more persulfate will drive the reaction more quickly or vice-
versa 96.  This effect is seen currently, with a pseudo-first-order reaction rate constant, k1,cip , of 
4.59 x 10-4 s-1 when initial ciprofloxacin concentration is doubled to 0.242 mmol L-1.   
In iron activated persulfate degradation studies of trichloroethylene and pentachlorophenol, 
increasing current applied to an iron rod enhanced removal rates141, 142.  In contrast, the rate and 
extent of ciprofloxacin/TP matrix removal in this study was independent of applied current, as 
shown by the overlapping curves in Figures 3.7a and 3.7b.  Ciprofloxacin/TP matrix removal was 
constant at the four current densities tested despite higher rates of persulfate decomposition as 
current density increased (Figure 3.8).  Increased iron introduction by the applied current, and the 
resulting increased persulfate activation, may generate an overabundance of radical scavenging 
ferrous ions (equation 1.13) as well as propagate self-scavenging by sulfate and  
hydroxyl radicals.  These effects have been noted to inhibit contaminant removal at high iron or 
persulfate levels in some other studies48. 
Defluorination, mineralization and degradation mechanism:  Fluoride abstraction is an 
important outcome in the degradation of fluorinated pharmaceuticals, as it may lower their 
toxicity189.  Figure 3.9a shows ciprofloxacin degradation along with fluoride generation from 
ciprofloxacin.  Defluorination slightly lags ciprofloxacin removal, with 75% de-fluorination 
achieved in 5 minutes, as shown in Figure 3.9b.  De-fluorination reached >95% after 15 minutes, 
in line with the 95%  ciprofloxacin removal achieved in this same time period.  This degree of 
fluoride removal is significantly higher than that achieved by some other ciprofloxacin degradation 
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Figure 3.7. Ciprofloxacin degradation at various current densities, as a function of time 
Initial persulfate concentration was 18 mmol L-1.  Iron surface area=6.1 cm2. Error bars represent 
95% interval. (a) [Ciprofloxacin]0=0.121 mmol L
-1 (b) [Ciprofloxacin]0=0.242 mmol L
-1.  
Measured via UV/Vis absorbance. 
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Table 3.12. Statistical Parameters for ciprofloxacin/TP matrix pseudo-
first order degradation reaction rate constants  
 
[Ciprofloxacin]o = 0.121 mmol L-1] 
Current Density  
(mA cm-2) 
Parameter Slope 
(s-1) 
Intercept 
(LN (C/Co cipro) 
0.0 Value -0.000658 -0.2129 
 Standard error 0.000111 0.167 
 R2 0.9220  
3.3 Value -0.000653 -0.18451 
 Standard error 0.000136 0.199 
 R2 0.9199  
11.5 Value -0.000628 -0.202 
 Standard error 0.000104 0.157 
 R2 0.9244  
MeOH Quench Value -0.000115 0.0608 
(no current) Standard error 2.0E-05 0.062 
 R2 0.9138  
TBA Quench Value -0.000151 0.0380 
(no current) Standard error 1.3E-05 0.024 
 R2 0.9861  
 
[Ciprofloxacin]o = 0.242 mmol L-1] 
Current Density  
(mA cm-2) 
Parameter Slope 
(s-1) 
Intercept 
(LN (C/Co cipro) 
0.0 Value -0.000460 -0.116 
 Standard error 3.29E-05 0.0621 
 R2 0.9848  
11.5 Value -0.000487 -0.0293 
 Standard error 4.09E-05 0.0836 
 R2 0.9726  
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Figure 3.8. Persulfate decomposition rate with and without ciprofloxacin 
Shown for three different current densities.  [Ciprofloxacin]0= 0.121 mmol L
-1  [Persulfate]0=18 
mmol L-1 .  Iron surface area=6.1 cm2.  Quinoline degradation intermediates are suggested to 
enhance persulfate activation. 
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Figure 3.9. Fluoride generation and TOC removal as a function of time 
(a) Ciprofloxacin degradation and fluoride generation from ciprofloxacin as a function of time.  
(b) Comparison of relative degrees of ciprofloxacin or TOC removal and fluoride generation as a 
function of time.  Initial ciprofloxacin and persulfate concentrations were 0.121 mmol L-1  and 18 
mmol L-1, respectively .  Iron surface area=6.1 cm2. Error bars represent 95% interval.  
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studies indicating that solid iron activated persulfate may offer an advantage for removal of some 
fluorinated compounds176, 183.   
As mention previously, TPs with m/z of 362, 330, and 306 formed upon mixing of 
ciprofloxacin with persulfate. Additionally, upon activation of persulfate, compounds with m/z of 
334 and 263 were detected, as outlined in supplementary table 3.11.  The presence of these TPs 
corresponds with degradation pathways of piperazine ring cleavage and substitution described in 
other studies 96, 176.  The compound with m/z 330, where fluoride is replaced by a hydroxyl radical, 
was detected at high levels upon mixing, as well as in the initial 15 minutes of the reaction, which 
corresponds with the quick de-fluorination observed in the first 15 minutes.  Based on these 
findings, substitution is suggested as the primary degradation mechanism for ciprofloxacin 
removal by solid iron activated persulfate.  At the end of 60 minutes, the five primary TPs named 
in this study were non-detectable in solution, and only unidentified compounds remained. 
Total organic carbon (TOC) removal is shown in Figure 3.9b.  At the end of 60 minutes, 
an average of 44% TOC was removed from solution, afterwards which removal plateaued.   
Incomplete mineralization was achieved with this process and follow-up studies are recommended 
to identify the presence and hazards of compounds remaining in solution. 
Quenching studies to determine dominant radicals:  The relative contribution of the sulfate 
and hydroxyl radicals to ciprofloxacin degradation was studied using radical quenchers methanol 
and tert-butanol (TBA).  Methanol has high reaction rates with both radicals, with a reaction rate 
constant of 1.0 x 107 M-1 s-1 for the sulfate radical and 9.7 x 108 M-1 s-1 for the hydroxyl radical 42. 
TBA has a slower reaction rate with the sulfate radical, with a rate constant of (4.0-9.1) x 105 M-1 
s-1 for the sulfate radical versus a reaction rate constant of (3.8-7.6) x108 M-1 s-1 with the hydroxyl 
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radical 42.  The ciprofloxacin pseudo-first order reaction rate constants with and without quenching 
are illustrated in Figure 3.10.  With TBA preferentially quenching hydroxyl radicals, the 
ciprofloxacin rate constant decreased by 77.1% (from 6.58 to 1.51 x 10-4 s-1), indicating that 
hydroxyl radicals play a substantial role in the degradation process.  With methanol quenching 
both hydroxyl and sulfate radicals, the ciprofloxacin rate constant only decreased another 5.4% to 
a value of 1.15 x 10-4 s-1, suggesting that sulfate radicals play a far less significant role in the 
degradation mechanism than hydroxyl radicals.  Some studies suggest that the hydroxyl radical is 
the dominant reactive species in iron-activated persulfate systems, even at acidic pH, and the 
current findings supports this conclusion141, 190.  This hydroxyl dominated process may explain the 
primary degradation pathway of fluoride substitution by hydroxyl species noted in section 3.2.4.  
As noted by Yuan et al. (2014) during quenching studies of trichloroethylene degradation with 
iron activated persulfate, the degradation reaction was not completely quenched by the radical 
scavengers, which implies that other reactive species may be involved in the degradation 
mechanism 141.  Hydrogen peroxide, theoretically present in solution, was not detectable in this 
study.  
Persulfate usage during ciprofloxacin degradation:  Of note is the enhanced persulfate 
decomposition with ciprofloxacin in solution (Figure 3.8).  Fang et al. (2013) demonstrated 
persulfate activation by quinones and compounds containing quinone structures such as 
ciprofloxacin51.  Control experiments in this study did not show persulfate activation by 
ciprofloxacin directly, so it is theorized that, in this case, a quinone degradation intermediates 
enhanced the reaction.  This may have broad implication for activated persulfate degradation of 
ciprofloxacin using other persulfate activators. 
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Figure 3.10. Ciprofloxacin/TP matrix pseudo-first order rate constants with quenching. 
Initial ciprofloxacin and persulfate concentrations were 0.121 mmol L-1  and 18 mmol L-1, 
respectively .  Iron surface area=6.1 cm2. Concentration  of methanol and TBA quenchers was 220 
mmol L-1.  Measured by UV/Vis. 
 
The reaction stoichiometric ratio (RSE) can be used to compare degradation results for 
different analytes and between activation techniques.  It is defined as the number of moles of 
analyte removed divided by the number of moles of persulfate consumed, reported as a percentage 
166.  The RSE for the ciprofloxacin/TP matrix for experiments without current (Figure 3.7a) was 
7.7% at 30 minutes and 5.6% at 60 minutes. In comparison, the RSE for ibuprofen degradation by 
heat activated persulfate was 7.5% and the RSE for sulfamethoxazole removal by Fe0 activated 
persulfate was 6.0%, both measured at 60 minutes95, 165.  For sulfamethoxazole removal by 
micrometric Fe0 activated persulfate, the RSE was 3.7% in 60 minutes102.  The similar scale of 
pharmaceutical to persulfate ratios achieved across studies may provide guidance or expectations 
for future work in this area.  For experiments in this study conducted with 8.2 mA cm-2 applied 
current, (Figure 3.7a), the RSE for the ciprofloxacin/TP matrix was 3.5% at 30 minutes and 1.0% 
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at 60 minutes.  The lower RSE with applied current was a result of similar ciprofloxacin/TP matrix 
degradation with higher persulfate activation when current was applied. 
3.4 Conclusion 
Persulfate activation by solid iron is proposed to be a surface dominated mechanism.  The 
fundamental relationships between iron surface area, applied current, iron production and 
persulfate activation were elucidated by experimentation without analyte in solution.  Sustained 
persulfate activation can be accomplished with the use of solid iron, with 1.14 moles of persulfate 
activated for 1 mole of iron used.  The surface area of the solid iron can be adjusted to control the 
persulfate activation rate.  Applied current enhances persulfate activation until diffusion 
limitations are reached.  Ciprofloxacin was degraded by solid iron activated persulfate, with 95% 
removal achieved in 15 minutes under experimental conditions.  Furthermore, the corresponding 
transformation product matrix was also removed by 90% in 30 minutes by solid iron activated 
persulfate process.  The ciprofloxacin/transformation product matrix degrades via a pseudo-first 
order mechanism with respect to the matrix, with hydroxyl radicals identified as the primary 
reactive species.  Defluorination under the same conditions was >95%, demonstrating that solid 
iron activated persulfate may offer an advantageous technique for removal of fluorinated 
environmental contaminants.  Enhancement of the ciprofloxacin degradation was not achieved by 
applying a current to the iron electrode despite increased persulfate activation.  This is possibly 
due to the scavenging effect of excess ferrous ions and radical species.   
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CHAPTER FOUR:  UNDERSTANDING ELECTROCHEMICALLY ACTIVATED 
PERSULFATE AND ITS APPLICATION TO CIPROFLOXACIN ABATEMENT 
 
This chapter is revised based on a paper published as follows: 
 
Matzek, L.W., Tipton, M.J., Farmer, A.T., Steen, A., Carter, K.E., 2018. Understanding 
Electrochemically Activated Persulfate and Its Application to Ciprofloxacin Abatement. Environ 
Sci Technology. 
 
4.1 Introduction 
Electrochemically activated persulfate (EAP) analyte removal has not been widely addressed 
except in cases where iron is a co-activator48, 191.  EAP without an iron co-activator avoids the use 
of a sacrificial anode and the introduction of iron in systems where this would not be suitable.  
Studies investigating EAP without iron suggest persulfate activation, through direct electron 
transfer at the cathode, creates sulfate radicals (Equation 2.3)59, 133. 
Recent studies found persulfate addition to electrochemical abatement of industrial 
wastewater improved removal of dinitrotoluene and aniline but did not compare the effects created 
by sulfate addition59, 133.  Another report indicated persulfate addition to sodium chloride 
electrolyte increased COD removal for malachite green and 2,4-dinitrophenol while sulfate did 
not, though differences between these electrolytes was not the focus192.  Farhat et al. (2015) found 
that persulfate addition to nitrate electrolyte did not result in as fast of a diatrizoate removal rate 
as in pure sulfate42.  However, equimolar amounts of persulfate and sulfate were not compared, 
and cathodic persulfate activation was not explored42.  
Other studies have examined the role of sulfate radicals (Eo = 2.5-3.1 V) in EAOP42, 193. 
Sulfate radicals form anodically using BDD electrodes (Equation 4.1) and will degrade many 
organic analytes42, 48.  These radicals can also form reactive hydroxyl radicals (Equation 4.1) 48.  
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Higher removal rates for diatrizoate and carbamazepine were achieved in sulfate versus nitrate 
electrolyte, which was credited to anodic sulfate radical formation42, 193.  
(4.1) SO4
2− → SO4
∙− +  e− 
The purpose of this study is to explore/characterize/quantify enhanced electrochemical 
removal of organic species observed in sulfate and persulfate electrolytes, including the roles 
played by sulfate radical formation at the anode and persulfate activation at the cathode.133, 192  
Elucidating the sources and roles reactive species play in sulfate radical-based systems lends 
insight to appropriate application and design of electrochemical abatement systems.  Finally, 
although fluoroquinolone removal has previously been demonstrated at a boron-doped diamond 
(BDD) anode in synthetic urine and a SnO2/Sb-Ti anode in sodium sulfate, it has not been 
evaluated in the EAP system44, 194.  Thus, this study aims to assess EAP’s ability to remove 
ciprofloxacin and investigate removal mechanisms as a step in screening EAP as an appropriate 
point source treatment for wastewaters with high antibiotic content22, 44.  
4.2 Materials and Methods 
4.2.1 Chemicals 
Ciprofloxacin (98%), sodium persulfate (98%), potassium sulfate, sodium nitrate, potassium 
iodide (99+%), sodium bicarbonate (Acros Organic, Fair Lawn, NJ), Optima formic acid, sodium 
hydroxide, hydrochloric acid, Optima Methanol (MeOH), tert-butanol (TBA), dimethyl sulfoxide 
(DMSO), and fluoride standard were purchased from Fisher Scientific (Pittsburg, PA) and 1N 
sulfuric acid  was from J.T. Baker.  Deionized water (DI) (18.2 MΩ-cm) was produced by a 
Millipore Milli-Q system. 
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4.2.2 Experimental Setup   
Rotating disk electrode (RDE) experiments were performed using a SP-150 potentiostat (Bio-
Logic Science Instruments, Knoxville, TN) with a mercury-mercury sulfate reference electrode in 
single-cell or split-cell configuration, illustrated by Figures 4.1a and 4.1b.  A multi-speed rotator 
(Pine Research Instrumentation, PRI, Durham, NC) was set to 2000 rpm for RDE experiments 
with bulk mixing with a magnetic stir-bar. Anodes (0.5 cm O.D., 0.196 cm -2 surface area) were a 
change-disk RDE tip (PRI) with BDD electrode insert (Fraunhofer Center for Coatings and 
Diamond Technologies, East Lansing, MI), or fixed-disk platinum (Pt) RDE tip (PRI). The 
potential window for the BDD was -1.2V to 2.5V vs. SHE.  Cathodes were Electron Microscopy 
Science graphite (Gr) rods (0.30 cm O.D) (Fisher Scientific, Pittsburg, PA), or a platinum wire 
(0.5 mm O.D.) (PRI).  Cathodic surface areas exposed to solution were 4.8 cm2 for graphite and 
3.69-4.76 cm2 for Pt.  Potential windows for cathode materials are  -1.5 to 1.5 V (Gr) and -0.85 to 
1.9 V (Pt) 195.  
For single-cell persulfate experiments, 200 mL of 22 mmol L-1 persulfate was electrolyzed 
and sampled periodically.  Single-cell ciprofloxacin experiments used 50 mL of 0.171 mmol L-1 
ciprofloxacin (0.1% sulfuric acid to aid dissolution) mixed with 140 mL DI water.  The solution 
was spiked with 10 mL concentrated electrolyte just before applying constant anodic current 
density of 76 mA cm-2, unless noted otherwise.  Initial concentrations were 0.043 mmol L-1 
ciprofloxacin plus 22 mmol L-1 sulfate or persulfate, or 66 mmol L-1 nitrate, maintaining the same 
ionic strength for all solutions.  Quenching experiments were performed by replacing some water 
with TBA or DMSO to achieve quencher concentration of 2200 mmol L-1, which provided 100:1 
a quencher to persulfate ratio158, 185.  
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Split-cell experiments were performed using 300-mL anodic and 80-mL cathodic 
compartments.  Reaction times were normalized to a 200-mL volume per Equation 4.2. 
(4.2) reaction timenormalized = timereaction x 
normalzied volume
reactor volume
   
 
A cation-exchange Chemours 115 Nafion membrane (Fuel Cell Store, College Station, 
TX), separated the compartments and was experimentally confirmed not to transmit 
nitrate/sulfate/persulfate anions. Current density of 28.5 mA cm-2 was employed due to system 
physical limitations.  For ciprofloxacin removal, outcomes are indicative of behavior in the single-
cell reactor, but numerical results are not directly comparable due to current densities utilized.  
Experiments were performed in duplicate at 20˚C. Initial pHs averaged 4.5 upon mixing 
ciprofloxacin and electrolytes.  Average final pHs were 2.5, 6.5, and 8.0 in persulfate, sulfate, and 
nitrate, respectively.  pH was not controlled in any experiments as buffer anions can significantly 
alter the system chemistry confounding interpretation of the results104, 135, 141, 177, 196, 197.  As the pH 
range impacts the kinetics of electrochemical degradation reactions by influencing the active 
radical species involved (hydroxyl or sulfate)48, this study aims to understand the natural 
progression of these reactions, including the possibility that different reaction kinetics may occur 
due to pH shifts from different species formed in the three electrolytes.   
4.2.3 Analytical Methods   
Persulfate and ciprofloxacin-matrix concentrations were analyzed using a ThermoScientific 
Evolution 600 UV/Vis spectrometer (ThermoFisher, Pittsburg, PA) at 272 and 352 nm, 
respectively, with methodology described in Chapter 3180, 181, 191.  
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Figure 4.1a. Single-cell reactor with rotating disk electrode (RDE) 
Total volume = 200 mL. 
 
Figure 4.1b. Split-cell reactor with rotating disk electrode (RDE)   
Anode Volume = 300 mL. Cathode volume = 80 mL. 
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In Chapter 3, it was shown that the “ciprofloxacin-matrix” concentrations measured by 
UV/Vis without HPLC separation were proportional to the total concentration determined by 
HPLC-MS analysis of a mixture containing ciprofloxacin and its transformation byproducts, which 
includes core quinolone structures with potentially negative environmental effects187, 188, 191.  This 
matrix’s UV/Vis absorbance is attributed to ciprofloxacin and its transformation products 
containing the C=C-C=C-C=C-C=0 chromophore198.  While ciprofloxacin-matrix concentration 
does not account for every degradation by-product that may be generated, it is a consistently 
reproducible and easily modeled variable found to be proportional to actual ciprofloxacin and TOC 
concentrations.  Because of its repeatability, proportionate relationship to TOC, and inclusion of 
significant by-products, the ciprofloxacin-matrix concentration is utilized in this study to compare 
results between experimental runs. 
Waters Sep-Pak tC2 cartridges were used to extract ciprofloxacin for HPLC-UV and 
HPLC-MS analysis.  Cartridges were conditioned with 1 mL methanol then 1mL DI water. A 0.5-
mL sample was loaded then extracted using 2X1-mL quantities of methanol/0.1% formic acid.191  
The extraction efficiency was 80%, measured by comparing extracted standards to standards made 
in methanol/0.1% formic acid. 
Extracted ciprofloxacin was quantified by separation using a Shimadzu HPLC equipped 
with binary pumps, a Hypersil Gold column (100 mm × 4.6 mm I.D. , 5 µm  diameter) 
(Thermoscientific, Waltham, MA) and a SPD-M20A diode array detector. A gradient eluent 
separation was used with eluent “A” DI water/0.1% formic acid and eluent “B” acetonitrile/0.1% 
formic acid.  A multi-step gradient program varied from 5% - 95% eluent A over 20 minutes (Table 
4.1).  Column temperature was held at 40˚C. Sample absorbance was measured at 278 nm, which 
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was confirmed to be the absorbance maximum of ciprofloxacin standards.  Statistics for the 
calibration curve are provided in Table 4.2.  The instrument detection limit was 0.30 µmol L-1 and 
method detection limit was 0.38 µmol L-1.   
 
Table 4.1. HPLC-UV Multi-step Gradient Program 
Time (min) % A  
0 5  
2 5  
8 75  
12 75  
14 95  
16 95  
19 5  
20 5  
 
 
Table 4.2. Statistical Parameters for HPLC-UV 
 Slope 
(peak area per µmol L-1) 
Intercept 
(peak area) 
Value 14004 -12353 
Standard error 211 4835 
R2 0.9993  
 
Extracted samples were diluted with methanol and analyzed for intermediates and 
transformation by-products using a Thermo Scientific Exactive™ Plus Orbitrap LC-MS with 
ultimate 3000 RS pump, column compartment, autosampler, and diode array detector 
(ThermoFisher, Pittsburgh, PA).  The mobile phase consisted of 80/20 methanol/water with flow 
rate 0.2mL min-1, 10-minute run time, and 10-µL sample injection.  UV/Vis was used to detect the 
antibiotic and byproduct species at 275 nm and 3D field from 200-400nm199.  A mass to charge 
(m/z) scan range of 50-500 m/z with resolution of 140,000 was performed using positive mode 
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electrospray ionization and data was analyzed to determine masses of both the parent compounds 
and the degradation/transformation byproducts199-201.  
TOC was analyzed using a Shimadzu TOC-L analyzer with an ASI-L autosampler.  
Samples were diluted 1:4 with acidified DI water (pH 3.0 with HCl).  Statistical parameters for the 
method were described in Chapter 3191.  
Hydrogen peroxide concentrations were determined by reacting equal volumes of sample 
with ammonium metavanadate.  The metavanadate solution was prepared with 1-part ammonium 
metavanadate in 9.5 parts 1N sulfuric acid at 50˚C, then diluted with DI water to a final 
concentration of 12 mM and 114 mM, respectively.  Absorbance was measured using the 
Evolution 600 UV-Vis (wavelength 450 nm) 42, 202.  Absorbance was compared to solutions of 
known hydrogen peroxide concentrations.  
Ion chromatography used to analyze fluoride (F-) concentrations using a Dionex 2100/1100 
dual column system with background suppression.  pH of all samples was raised to 6, dissociating 
any potential hydrofluoric acid.  Fluoride detection limit was less than 5.2 µmol L-1 F- ions as 
described in Chapter 3. 
4.3 Results and Discussion 
4.3.1 Electrochemical persulfate decomposition and regeneration  
Persulfate behavior was investigated without an analyte using a single-cell RDE system for three 
anode/cathode combinations: Pt/Gr, BDD/Gr and BDD/Pt.  The persulfate removal rate was 
measured to demonstrate the maximum potential persulfate activation rate based on equation 1.3.  
For persulfate formation at the anode, this removal rate becomes the net rate of persulfate reduction 
(or activation) at the cathode and persulfate generation at the anode (Equation 4.3).  Similar results 
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were obtained for all electrode combinations with R2>0.95 linear relationship of persulfate 
decomposition with time. Plots for BDD/Gr (Figure 4.2a) illustrate these findings.  The zero-order 
mechanism indicates a surface-dominated reaction with the net persulfate reaction rate a function 
of current density (Figure 4.3a and 4.3b).  Persulfate reaction rates were independent of anode 
material but were higher using a Gr-cathode compared to a Pt-cathode, as shown in Figures 4.3a 
and b.  Additional experiments investigating the effects of cathode material for ciprofloxacin 
removal using EAP are described in Ciprofloxacin Degradation section. 
To further explore the role of sulfate radicals in EAOP, electrochemical persulfate removal 
and generation were examined using split-cell RDE experiments with a BDD/Gr anode/cathode 
combination.  Anodic persulfate generation from sulfate, shown to be a zero-order mechanism in 
Figure 4.2c, was used to demonstrate the presence of sulfate radicals, as sulfate-radical based 
reactions (Equation 4.3) have been shown to be the dominant mechanism of persulfate production 
at BDD anodes.203  
(4.3)  SO4
∙− +  SO4
∙−  →  S2O8
2− 
 
 During this process, persulfate becomes available in sulfate solution to initiate non-radical 
degradation or degradation through persulfate activation at the cathode42, 133, 203.  As expected, no 
persulfate was formed in the sulfate solution from cathodic reactions (Figure 4.2c) and no 
hydrogen peroxide was detected in any of the solutions.  Further evaluation of H2O2 suggests that 
reaction potentials used were outside the ideal range for H2O2 formation
204.  As the solution was 
not oxygenated, which aids H2O2 production (Equation 4.4)
204, this species was determined to have 
no significant influence in the current EAP system204.  
(4.4)  O2 +   2H
+ + 2e− →  H2O2 
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Figure 4.2b shows the persulfate concentration remained constant at the anode, thus 
persulfate activation by anodically generated hydroxyl radicals was ruled out.  Persulfate 
decomposition at the cathode followed a zero-order mechanism.  The zero-order persulfate 
reaction rate constant of 1.85 x 10-7 mol L-1 s-1 at a cathodic current density of 1.2 mA cm-2 
corresponds to the potential sulfate radical formation rate.  When the anodic persulfate formation 
rate of 3.40 x 10-9 mol L-1 s-1 was subtracted from the cathodic persulfate decomposition rate, the 
net reaction rate change in the divided cell was 1.82 x 10-7 mol L-1 s-1, higher than the 1.5 x 10-7 
mol L-1 s-1 predicted by the single-cell curve in Figures 4.3a and b at the same current densities 
(28.5/1.2 mA cm-2 anode/cathode, respectively).  Differences in single-cell and split-cell reaction 
rate constants imply the persulfate activation and generation processes may be dependent on one 
another and are influenced by reactions occurring at the opposite electrode.  Experiments 
determining whether cathodic persulfate decomposition corresponds to sulfate radical formation 
at the cathode are discussed in Cyclic voltammetry and Using ciprofloxacin to evaluate persulfate 
activation sections. 
4.3.2 Ciprofloxacin Degradation  
Removal of ciprofloxacin (extracted and separated by HPLC), ciprofloxacin-matrix (measured by 
UV-Vis; see Analytical Methods) and TOC was compared for BDD/Pt and BDD/Gr electrode pairs 
in a single-cell RDE system to establish how cathode materials affect EAP during analyte removal. 
The pseudo-first order rate constants (and relevant statistics) for the ciprofloxacin, ciprofloxacin-
matrix and TOC removal (with respect to these variables) by cathode type are shown in Tables 
4.3a, b and c. 
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Figure 4.2. Persulfate concentration with time in an electrochemical reactor 
(a) Zero-order persulfate removal over time in a single-cell reactor with [Persulfate]0= 22 mmol 
L-1. Legend values denote anodic / cathodic current densities. (b) Persulfate concentration versus 
time with [Persulfate]0= 22 mmol L
-1 in a split cell reactor. Anodic current density =28.5 mA cm-
2 and cathodic current density = 1.2 mA cm-2. (c) Persulfate concentration versus time with 
[Sulfate]0 =22 mmol L
-1 in a split cell reactor. Anodic current density =28.5 mA cm-2 and cathodic 
current density = 1.2 mA cm-2.  (a-c) BDD/Gr anode/cathode pairs. No organic analyte. Error bars 
represent the 95% interval. 
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Figure 4.3. Persulfate reaction rate as a function of current density 
(a) Persulfate zero-order reaction rate constant as a function of anodic current density.  (b) 
Persulfate zero-order reaction rate constant as a function of cathodic current density.  Error bars 
represent the 95% interval. 
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Table 4.3b. Effects of Cathodes on Removal Rates of Ciprofloxacin-Matrix 
 
Electrolyte Cathode Ciprofloxacin 
pseudo-first 
order rate 
constant 
(s-1 x 10-5) 
Pseudo-first 
order fit 
(r2) 
Difference 
(%) 
Statistical 
significance of 
difference 
 
Persulfate Pt 4.52 ± 0.22 0.9954 5% 0.5769  
 
Gr 4.28 ± 0.18 0.9907 
 
(not significant)  
      
 
Sulfate Pt 2.28 ± 0.22 0.9849 4% 0.6663  
 
Gr 2.31  ± 0.09 0.9892 
 
(not significant)  
      
 
Nitrate Pt 0.54 ± 0.16 0.7624 19% 0.3029  
 
Gr 0.44 ± 0.12 0.7691 
 
(not significant)  
      
 
 
 
Table 4.3c. Effects of Cathodes on Removal Rates of TOC 
Electrolyte Cathode TOC 
pseudo-first 
order rate 
constant 
(s-1 x 10-5) 
Pseudo-first 
order fit 
(r2) 
Difference 
(%) 
Statistical 
significance of 
difference 
Persulfate Pt 0.86 ± 0.21 0.9465 6% 0.6735 
 
Gr 0.81 ± 0.24 0.9270 
 
(not significant) 
      
Sulfate Pt 0.42 ± 0.13 0.8723 -5% 0.7871 
 
Gr 0.44 ± 0.17 0.9047 
 
(not significant) 
      
Nitrate Pt 0.099 ± 0.34 0.0787 75% 0.6930  
Gr 0.025 ± 0.28 0.0059 
 
(not significant) 
 
Table 4.3a. Effects of Cathodes on Removal Rates of Ciprofloxacin 
Electrolyte Cathode Ciprofloxacin 
pseudo-first 
order rate 
constant 
(s-1 x 10-5) 
Pseudo-first 
order fit 
(r2) 
Difference 
(%) 
Statistical 
significance of 
difference 
Persulfate Pt 1.92 ± 0.21 0.9907 8% 0.5902 
 
Gr 2.08 ± 0.58 0.9112 
 
(not significant)             
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Differences in ciprofloxacin, ciprofloxacin-matrix and TOC degradation rates were 
statistically insignificant with Pt- and Gr-cathodes.  It was concluded that graphite is a suitable 
substitute for platinum for ciprofloxacin removal using EAP. 
Electrolyte effects on ciprofloxacin, ciprofloxacin-matrix and TOC removal were 
compared using the single-cell RDE with nitrate, sulfate or persulfate.  The ciprofloxacin decay 
mechanism was pseudo-first order with respect to ciprofloxacin in all electrolytes, as shown in 
Figures 4.4 and 4.5a.  The pseudo-first order rate constants (and relevant statistics) for are shown 
in Table 4.4.  Ciprofloxacin degraded rapidly upon electrolysis in persulfate (Figures 4.4), reaching 
84% of the initial concentration after 120 minutes and plateauing at 90% after 240 minutes.  The 
removal rate in sulfate was 33% slower, although similar degrees of removal were achieved within 
240 minutes.  Much slower removal was observed in nitrate, reaching 90% in 24 hours (Figure 
4.5a).  A sixfold increase in the overall reaction rate constant was observed using sulfate in place 
of nitrate electrolyte.  This is similar to Radjenovic et al. (2016) findings where using sulfate 
instead of nitrate electrolyte resulted in a sevenfold increase in reaction rates for iopromide and 
diatrizoate removal.193  
Ciprofloxacin-matrix removal is shown in Figure 4.5b, with pseudo-first order modeling 
with respect to the matrix illustrated in Figure 4.6.  The initial stages of removal are shown in 
Figure 4.7.  The overall pseudo-first order rate constants (and relevant statistics) for are in Table 
4.5a.  Rate-constants for each electrode pairs (BDD/Pt and BDD/Gr) are also shown.  A fourfold 
increase in the overall reaction rate constant was observed using sulfate in place of nitrate 
electrolyte.  The current findings for ciprofloxacin and the ciprofloxacin-matrix, in conjunction 
with the previously described persulfate experiments, confirm that sulfate does not act as an inert  
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Figure 4.4. Removal of ciprofloxacin with time 
(a) Removal of ciprofloxacin versus time, as measured by HPLC-UV. [Persulfate]0 or [Sulfate]0 = 
22 mmol L-1. [Nitrate]0 = 66 mmol L
-1. [Ciprofloxacin]0  = 0.043 mmol L
-1.  Experiments 
completed in a single-cell RDE reactor at 76 mA cm-2 anodic current density, 
  
Table 4.4. Effects of Electrolytes on Removal Rates of Ciprofloxacin 
 
Analyte Electrolyte Ciprofloxacin 
Pseudo-first 
order rate 
constant 
(s-1  x 10-4) 
Pseudo-
first 
order fit 
(R2) 
Rate 
Constant 
Difference 
from 
Persulfate 
(%) 
Statistical 
Significance of 
Difference from 
Persulfate 
 
Ciprofloxacin persulfate 2.08 ± 0.58 0.9112    
 sulfate 1.39 ± 0.14 0.9717 33% >99%(p<0.0039)  
 nitrate 0.24 ± 0.05 0.9517 88% >99%(p<0.0001)  
± denotes 95% confidence intervals      
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Figure 4.5. Removal of ciprofloxacin with time 
(a) Removal of ciprofloxacin versus time, as measured by HPLC-UV. (b) Removal of 
ciprofloxacin-matrix versus time, as measured on UV/Vis (c) Total organic carbon removal versus 
time (d) Total organic carbon removal from ciprofloxacin after 24 hours.  [Persulfate]0 or [Sulfate]0 
= 22 mmol L-1. [Nitrate]0 = 66 mmol L
-1. [Ciprofloxacin]0  = 0.043 mmol L
-1.  Experiments 
completed in a single-cell RDE reactor at 76 mA cm-2 anodic current density and 1.33 mA cm-2 
cathodic current density.  BDD anode, data included for Gr or Pt cathodes. 
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Figure 4.6. Pseudo-first order kinetics for degradation of ciprofloxacin-matrix 
Data from Figure 4.5b. Single-cell RDE, BDD anode with graphite or platinum cathode.  Anodic 
current density = 76 mA cm-2 and cathodic current density = 1.33 mA cm-2.  [Persulfate]0 = 22 
mmol L-1 OR [Sulfate]0 = 22 mmol L
-1 OR [Nitrate]0 = 66 mmol L
-1. 
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Figure 4.7. Initial stages of ciprofloxacin removal 
Data from Figure 4.5. (a) Removal of ciprofloxacin matrix versus time, as measured on UV/Vis 
(b) Total organic carbon removal versus time. [Persulfate]0 or [Sulfate]0 = 22 mmol L
-1. [Nitrate]0 
= 66 mmol L-1. [Ciprofloxacin]0 = 0.043 mmol L
-1.  Experiments completed in a single-cell RDE 
reactor at 76 mA cm-2 anodic current density and 1.33 mA cm-2 cathodic current density.  BDD 
anode, data included for Gr or Pt cathodes. 
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Table 4.5a. Effects of Electrolytes on Removal Rates of Ciprofloxacin Matrix 
Electrode 
Combination 
Electrolyte Ciprofloxacin 
pseudo-first 
order rate 
constant 
(s-1  x 10-5) 
Ciprofloxacin 
pseudo-first 
order fit 
(R2) 
Rate Constant 
Difference from 
Persulfate (%) 
Statistical 
Significance of 
Difference 
BDD-Pt persulfate 4.52 ± 0.22 0.9954   
 sulfate 2.31  ± 0.09 0.9892 49% >99% (p<0.0001) 
 nitrate 0.54 ± 0.16 0.7624 88% >99% (p<0.0001) 
      
BDD-Gr persulfate 4.28 ± 0.18 0.9907   
 sulfate 2.28 ± 0.22 0.9849 47% >99% (p<0.0001) 
 nitrate 0.44 ± 0.12 0.7691 90% >99% (p<0.0001) 
      
Overall persulfate 4.33 ± 0.14 0.9891   
 sulfate 2.29 ± 0.08 0.9823 47% >99%(p<0.0001) 
 nitrate 0.48 ± 0.09 0.7530 91% >99%(p<0.0001) 
      
Table 4.5b. Effects of Electrolytes on Removal Rates of TOC from Ciprofloxacin Matrix 
Electrode 
Combination 
Electrolyte TOC 
pseudo-first 
order rate 
constant 
(s-1 x 10-5) 
Pseudo-first 
order fit 
(R2) 
Rate Constant 
Difference from 
Persulfate (%) 
Statistical 
Significance of 
Difference 
BDD-Pt persulfate 0.86 ± 0.21 0.9465   
 sulfate 0.42 ± 0.13 0.8723 51% >99% (p=0.0008) 
 nitrate 0.099 ± 0.34 0.0787 88% >99% (p<0.0001) 
      
BDD-Gr persulfate 0.81 ± 0.24 0.9270   
 sulfate 0.44 ± 0.17 0.9047 46% > 99% (p=0.0091) 
 nitrate 0.025 ± 0.28 0.0059 97% >99% (p<0.0001) 
      
Overall persulfate 0.83 ± 0.13 0.9396   
 sulfate 0.43 ± 0.10 0.8582 48% >99% (p<0.0001) 
 nitrate 0.061 ± 0.18 0.317 93% >99% (p<0.0001) 
± denotes 95% confidence intervals     
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electrolyte when using BDD anodes, rather it participates in degradation reactions, likely through 
sulfate radical formation.  A significant increase of 47% was achieved for the ciprofloxacin-matrix 
reaction rate constant using persulfate instead of sulfate electrolyte, which may be attributed to 
cathodic persulfate activation, as described in Cyclic voltammetry and Using ciprofloxacin to 
evaluate persulfate activation sections.  While the matrix removal reached ~85% for both 
persulfate and sulfate, persulfate attained this removal in ~12 hours versus ~24 hours for sulfate.   
TOC removal followed pseudo-first order kinetics in sulfate and persulfate (Figure 4.5c, 
Table 4.5b), with respect to TOC concentration.  Results by cathode type are provided in Table 
4.3b.  Degradation was proportional to but less than ciprofloxacin-matrix removal.  Although the 
pseudo-first order fit for nitrate was poor, this model aided quantitative comparison.  Nitrate 
initially produced more rapid TOC degradation than sulfate or persulfate electrolytes, and similar 
removal was observed for sulfate and persulfate during this initial timeframe (Figure 4.7).  
However, TOC removal in nitrate quickly plateaued and little removal was observed after the two-
hour mark, while persulfate began to show better removal than sulfate.  The effect of sulfate over 
nitrate produced a sevenfold increase in TOC removal rate (p<0.0001).  For the time series, the 
additional TOC removal rate for persulfate versus sulfate was 48%, slightly larger than that 
observed for the ciprofloxacin relationship (Table 4.4) and similar to that for the ciprofloxacin-
matrix relationship (Table 4.5b).  Comparison of 24-hour removal rates is shown in Figure 4.5d.  
For both environmentally relevant parameters, ciprofloxacin and TOC removal, EAP offers an 
advantage for degradation and may be the best approach for some EAOP applications. 
Figure 4.8 shows the specific energy consumption for the data in Figure 4.5.  Energy 
consumption per unit mass of TOC removed was calculated using Equation 4.5 and presented in  
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Figure 4.8. Removal of ciprofloxacin versus specific electrical charge 
(a) Removal of ciprofloxacin versus specific electrical charge, as measured by HPLC-MS. (b) 
Removal of ciprofloxacin matrix versus specific electrical charge, as measured on UV/Vis. (c) 
Removal of TOC versus specific electrical charge. [Persulfate]0 or [Sulfate]0 = 22 mmol L
-1. 
[Nitrate]0 = 66 mmol L
-1. [Ciprofloxacin]0  = 0.043 mmol L
-1.  Experiments completed in a single-
cell RDE reactor at 76 mA cm-2 anodic current density and 1.33 mA cm-2 cathodic current density. 
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Table 4.6.  
(4.5)   Energy consumption (EC) per unit mass205 (kWh (g )-1)  =  
Ecell ∗ I ∗ t
𝑉∗([𝐴]−[𝐴]0)
  
 
For Equation 4.5, Ecell = average cell voltage, I = current, V = cell volume, t= time and A= TOC 
concentration, OR ciprofloxacin matrix concentration.  Energy consumption for persulfate and 
sulfate electrolytes was in line with that determined for electro-Fenton degradation of enrofloxacin 
using a BDD anode205.   
Faraday’s law was used to calculate the Coulombic efficiency for ciprofloxacin removal in 
all three electrolytes.  From Figure 4.4, 120 minutes was used as the timepoint to calculate 
coulombs based on a constant 15 mA current. Faraday’s law establishes that 1.12 mmoles of 
ciprofloxacin should be degraded under theoretical 100% current efficiency. In nitrate, 0.013 
mmoles were degraded, giving a 1.2% coulombic efficiency. In sulfate, 0.029 mmoles 
ciprofloxacin were degraded, giving a 2.6% efficiency. In persulfate, 0.034 mmoles were 
degraded, giving a 3.1% efficiency. 
 
 
Persulfate was measured during ciprofloxacin reactions in both sulfate and persulfate 
electrolytes (Figure 4.9).  Ultimately, persulfate reduced to sulfate (Figure 4.10), with 1.99 moles 
 
Table 4.6. Energy consumption during removal of TOC from Ciprofloxacin 
 
Analyte Electrolyte TOC  
Pseudo-first 
order rate 
constant 
(s-1  x 10-5) 
Pseudo-
first 
order fit 
(R2) 
Rate 
Constant 
Difference  
from Persulfate 
Energy 
Consumption per 
Unit Mass 
(kWh (g -1)) 
TOC persulfate 0.83 ± 0.13 0.9396  
0.428 
 sulfate 0.43 ± 0.10 0.8582 48% 
0.578 
 nitrate 0.061 ± 0.18 0.317 93% 1.60 
± denotes 95% confidence intervals      
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sulfate formed for every mole persulfate decomposed.  In ciprofloxacin-persulfate solutions, 
persulfate did not follow the same kinetics as in experiments without organic analyte. Persulfate 
decayed following a pseudo-first order mechanism with respect to persulfate with R2=0.99 (Figure 
4.9).  The pseudo-first order kinetics indicates that, in addition to surface-based persulfate 
decomposition and generation, there are bulk persulfate reactions that depend on the persulfate 
concentration, which include possible interactions between persulfate and ciprofloxacin or 
persulfate and organic radicals.  In fact, although both ciprofloxacin decay and persulfate 
decomposition model well as pseudo-first order mechanisms with respect to themselves, (the 
typical kinetic model used in environmental remediation studies48), there is a second-order 
relationship at play between the persulfate and ciprofloxacin-matrix, shown in Figure 4.11.  The 
second-order reaction rate constant, calculated by Equation 4.6, is 2.1 x 10-2 L mol-1 s-1 with 
R2=0.95206, indicating a slow reaction rate between persulfate and the ciprofloxacin206.   
(4.6)   Second-order kinetics model206 
 
ln
[𝐴]0  [𝐵]  
 [𝐴]  [𝐵]0  
= ([𝐵]0  −  [𝐴]0  ) 𝑘 𝑡 
 
In Equation 4.6, [A]= [Ciprofloxacin] and  [A]0  = 0.043 mmol L
-1, [B] = [Persulfate] and 
[B]0 = 22 mmol L
-1, t = time (seconds) and k = second order reaction rate constant.  The second-
order rate constant for persulfate and ciprofloxacin was determined by graphing the left-hand term 
versus time (Figure 4.11). The slope was then set equal to ([B]0  −  [A]0  ) k  and the reaction rate, 
k, calculated. In sulfate, persulfate level increased in a non-uniform fashion, likely due to the 
complex set of reactions including sulfate radicals degrading ciprofloxacin, persulfate activation, 
and interaction between ciprofloxacin and persulfate.  
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Figure 4.9. Persulfate behavior during ciprofloxacin degradation  
Single-cell RDE with anodic current density = 76 mA cm-2 and cathodic current density = 1.33 
mA cm-2. 
 
 
 
 84 
 
 
Figure 4.10. Persulfate reduction to sulfate 
[Persulfate]0 = 22 mmol L
-1 and [Ciprofloxacin]0 =0.043 mmol L
-1.  Single-cell RDE with anodic 
current density = 76 mA cm-2 and cathodic current density = 1.33 mA cm-2.  BDD anode, combined 
data for Gr and Pt cathodes. 
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4.3.3 Radical roles in ciprofloxacin degradation  
Quenching studies examined hydroxyl and sulfate radical roles in ciprofloxacin removal.  Rate 
constants for quenchers or ciprofloxacin with radicals are outlined in Table 4.7.   
 
Table 4.7. Reaction Rate Constants for Quenching Experiments 
Reactant 
Reaction Rate Constant 
with Hydroxyl Radicals  
(M-1 s-1)  
Reaction Rate Constant  
with Sulfate Radicals   
 (M-1 s-1)  
DMSO 6.7 x 10
9     207 3.0 x 109     208 
TBA 6.0 x 10
8    158,42 4.0 x 105   158,42 
Ciprofloxacin (4.1 - 5.0) x 109    38, 209 *est. 106 - 109   76, 210 
*estimate based on reaction rate of sulfate radical with many organic compounds 
 
 
  
During DMSO quenching, virtually all radicals were predicted to react with DMSO over 
ciprofloxacin (Equation 4.7a-b)211.   
(4.7)   Competition kinetics for ciprofloxacin in quenchers211 
(a) 𝑓𝑂𝐻−𝐷𝑀𝑆𝑂 =   
𝑘𝑂𝐻_𝑐𝑖𝑝 [𝐶𝑖𝑝] 
𝑘𝑂𝐻_𝑐𝑖𝑝 [𝐶𝑖𝑝]+𝑘𝑂𝐻_𝐷𝑀𝑆𝑂 [𝐷𝑀𝑆𝑂]
          = 1.3 x 10-5 
 
(b)  𝑓𝑆𝑂4−𝐷𝑆𝑀0 =   
𝑘𝑆𝑂4_𝑐𝑖𝑝 [𝐶𝑖𝑝]
𝑘𝑆𝑂4_𝑐𝑖𝑝 [𝐶𝑖𝑝]+𝑘𝑆𝑂4_𝐷𝑀𝑆𝑂[𝐷𝑀𝑆𝑂]
    = 6.5 x 10-7 
 
(c) 𝑓𝑂𝐻−𝑇𝐵𝐴 =   
𝑘𝑂𝐻_𝑐𝑖𝑝 [𝐶𝑖𝑝] 
𝑘𝑂𝐻_𝑐𝑖𝑝[𝐶𝑖𝑝]+𝑘𝑂𝐻_𝑇𝐵𝐴 [𝑇𝐵𝐴]
           = 1.5 x 10-4 
 
(d) 𝑓𝑆𝑂4−𝑇𝐵𝐴 =   
𝑘𝑆𝑂4_𝑐𝑖𝑝 [𝐶𝑖𝑝] 
𝑘𝑆𝑂4_𝑐𝑖𝑝 [𝐶𝑖𝑝]+𝑘𝑆𝑂4_𝑇𝐵𝐴 [𝑇𝐵𝐴]
           = 4.9 x 10-3 
 
For Equation 4.7: fOH−DMSO represents the fraction of hydroxyl radicals preferentially 
reacting with ciprofloxacin instead of reacting with (being quenched by) DMSO, 
fSO4−DSM0 represents the fraction of sulfate radicals preferentially reacting with ciprofloxacin 
instead of reacting with (being quenched by) DMSO, fOH−TBA  represents the fraction of hydroxyl 
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radicals preferentially reacting with ciprofloxacin instead of reacting with (being quenched by) 
TBA, fSO4−TBA  represents the fraction of hydroxyl radicals preferentially reacting with 
ciprofloxacin instead of reacting with (being quenched by) TBA, [Cip] = concentration of 
ciprofloxacin (0.043 mmol L-1), [TBA] = concentration of tert-butanol quencher (2200 mmol L-1), 
[DMSO] = concentration of dimethyl sulfoxide quencher (2200 mmol L-1), kOH_cip = hydroxyl 
radical-ciprofloxacin second order reaction rate constant listed in Table 4.7 (median value of 4.55 
x 109 used for calculations), kSO4_cip = sulfate radical-ciprofloxacin second order reaction rate 
constant listed in Table 4.7 (a value of 108 used for calculations based on those found for many 
aromatic compounds)76, kOH_DMSO hydroxyl radical-DMSO second order reaction rate constant 
listed in Table 4.7, kSO4_DMSO sulfate radical-DMSO second order reaction rate constant listed 
in Table 4.7, kOH_TBA  hydroxyl radical-TBA second order reaction rate constant listed in Table 
4.7 and kSO4_TBA   sulfate radical-TBA second order reaction rate constant listed in Table 4.7. 
With DMSO addition, only 12% removal was observed in the nitrate solution (Figure 4.12).  
Therefore, a portion of the removal in the nitrate solution, under non-quenched conditions, was 
attributed to hydroxyl radicals, with electrode surface reactions, such as direct oxidation, 
contributing the remaining portion.  In sulfate or persulfate, a substantial reduction in removal was 
also observed during DMSO quenching.  However, in these cases a significant portion of 
degradation under non-quenched conditions was attributed to both hydroxyl and sulfate radicals.  
While TBA is typically used to distinguish between sulfate and hydroxyl radicals, calculations 
(Equations 4.7a-d) did not predict a significant difference in its ability to preferentially quench 
sulfate radicals over hydroxyl radicals under current experimental conditions.  Differences in 
removal with the two quenchers may be attributable to actual differences in hydroxyl versus sulfate 
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Figure 4.11. Second-order reaction modeling of ciprofloxacin and persulfate 
Initial 0.043 mmol L-1 ciprofloxacin and 22 mmol L-1 persulfate. Single-cell RDE with anodic 
current density = 76 mA cm-2 and cathodic current density = 1.33 mA cm-2. 
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Figure 4.12. Quenching Experiments 
Quenching Experiments.  [Persulfate]0 or [Sulfate]0 = 22 mmol L
-1. [Nitrate]0 = 66 mmol L
-1. 
[Ciprofloxacin]0  = 0.043 mmol L
-1.  Experiments completed in a single-cell RDE reactor at 76 
mA cm-2 anodic current density with a BDD anode and Gr or Pt cathode (data is averaged for 
cathodes since no significant difference was found between cathodes). 2200 mmol L-1 TBA used 
to quench hydroxyl radicals. 2200 mmol L-1DMSO used to quench hydroxyl and sulfate radicals. 
Time point of 120 minutes used to compare all samples. 
 
 
radical reactivity, or may be due to differences in the ability of quenchers to suppress radicals, as 
established by the competition kinetics fractional calculations (Equations 4.7c-d).  Overall, the 
decreasing ciprofloxacin degradation under quenched conditions suggests that one or both radicals 
play a significant role in ciprofloxacin degradation using EAP.  Of note is the ~35% removal 
achieved in persulfate with primary radicals quenched.  Radicals such as persulfate (S2O8
2-·), R· 
(organic) and ROO· (organo-peroxide) may propagate from sulfate and hydroxyl radicals but have 
limited potential to form because their parent radical is quenched96, 135, 151, 212.  It is suggested that 
non-radical based persulfate activation at the BDD anode is partially responsible for enhanced 
ciprofloxacin removal in persulfate, which has recently been observed in other persulfate-based 
systems42, 84, 213.  
 
 89 
 
4.3.4 Cyclic voltammetry  
Cyclic voltammograms (C-V) were performed to clarify differences between electrolytes for 
persulfate activation and ciprofloxacin abatement.  Two distinct oxidation peaks for ciprofloxacin 
were observed at the BDD anode (Figure 4.13) in all electrolytes, demonstrating that surface-based 
oxidation of ciprofloxacin is likely partially responsible for the ciprofloxacin removal seen in 
Figure 4.4.  A third oxidation peak was marginally visible in sulfate and nitrate, but was more 
prominent in persulfate, revealing that persulfate electrolyte may drive oxidation at a lower 
voltage.  Full C-Vs are shown in Figure 4.14.  Multi-cycle C-Vs, displayed in Figure 4.15, 
demonstrate ciprofloxacin oxidation is quasi-irreversible process, as there are no symmetric 
reduction peaks and the oxidation peaks almost disappear after the first cycle. C-Vs were also 
completed for graphite and platinum material (Figure 4.16), with focus on the reductive reactions 
occurring at these cathodes (Figure 4.17).  For nitrate and sulfate electrolytes, there were no 
significant differences between cathode materials.  Direct reduction of ciprofloxacin was not 
observed in the potential range evaluated.  An irreversible reduction peak at both cathodes is 
observed when persulfate and ciprofloxacin are present in solution together.  This indicates a 
surface-based reaction between persulfate and ciprofloxacin, i.e., direct electrochemical persulfate 
activation. 
4.3.5 Using ciprofloxacin to evaluate persulfate activation  
Further verification of electrochemical persulfate activation was established with ciprofloxacin 
electrolysis in a split-cell RDE with BDD/Gr electrodes.  Figure 4.18 shows a well-defined 
difference in ciprofloxacin removal at the cathode in persulfate with pseudo-first order 
(R2=0.9215) degradation, with respect to ciprofloxacin, in persulfate and 55% removal within 300  
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Figure 4.13. Ciprofloxacin oxidation peaks during cyclic voltammetry using a BDD anode  
C-Vs were run with multiple cycles to determine reversibility but only the first cycle is pictured 
for clarity.  “electrolyte only” are controls; other C-Vs with the addition of 0.043 mmol L-1 
ciprofloxacin at 250, 500 and 750 mV s-1 scan rates.  All C-Vs with 22 mmol L-1 sulfate or 
persulfate, or 66 mmol L-1 nitrate. 
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Figure 4.14.  Complete cyclic voltammograms of ciprofloxacin using BDD anode 
0.043 mmol L-1 ciprofloxacin in (a) 66 mmol L-1 nitrate b) 22 mmol L-1 sulfate or (c) 22 mmol L-
1 persulfate using a BDD anode at different scan rates. Numerical legend values are scan rates in 
mV s-1.  Electrolyte only baselines are scanned at 750 mV s-1.  
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Figure 4.15. Multiple-cycle cyclic voltammograms of ciprofloxacin 
0.043 mmol L-1 ciprofloxacin in (a) 66 mmol L-1 nitrate b) 22 mmol L-1 sulfate or (c) 22 mmol L-
1 persulfate using a BDD anode at a scan rate of 750 mV s-1.  Prominent oxidation peaks are present 
in the first cycle in all electrolytes. No oxidation peaks are present in nitrate after the first cycle. 
In persulfate, a slight oxidation peak appears in subsequent cycles for sulfate and persulfate. These 
voltammograms were similar at lower scan rates as well and illustrate the irreversible nature of the 
ciprofloxacin oxidations.  
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Figure 4.16. Cyclic voltammograms of ciprofloxacin using Pt or Gr anodes 
All C-Vs with 22 mmol L-1 sulfate or persulfate, or 66 mmol L-1 nitrate.  0.043 mmol L-1 
ciprofloxacin where indicated in legend. 
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Figure 4.17. Reduction peak during cyclic voltammetry of cathode materials 
Figures 4.17a and c: C-Vs of (a) electrolyte control and (c) electrolyte with ciprofloxacin, both 
completed with graphite electrode. Figure 4.17 b and d: C-Vs of (b) electrolyte control and (d) 
electrolyte with ciprofloxacin, both completed with platinum electrode.  All C-Vs with 22 mmol 
L-1 sulfate or persulfate, or 66 mmol L-1 nitrate. C-Vs c. and d. include the addition of 0.043 mmol 
L-1 ciprofloxacin. 
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Figure 4.18. Ciprofloxacin removal in a split-cell reactor 
Ciprofloxacin removal and corresponding persulfate concentration in a split-cell RDE. Anodic 
current density = 28.5 mA cm-2. Cathodic current density = 1.33 mA cm-2. [Ciprofloxacin]0  = 
0.043 mol L-1.  (a-b) [Persulfate]0 22 mmol L
-1.  (c-d) [Sulfate]0 = 22 mmol L
-1. 
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minutes (Figure 4.18a) versus no removal in sulfate electrolyte (Figure 4.18c).  These results, 
combined with C-V analysis, provide strong experimental evidence of persulfate activation at the 
cathode, verifying what other studies have previously postulated59, 133.  While persulfate 
transformation at the anode did not occur (Figure 4.18b) and sulfate was not available to form 
sulfate radicals, some ciprofloxacin removal was still observed at the anode in persulfate, with 
reaction rates of 1.1x10-4 s-1 and 5.1x10-5 s-1 in sulfate and persulfate, respectively.  Quenching 
results suggested that non-radical persulfate activation at the BDD anode may account for 
ciprofloxacin removal in the anode cell. 
Persulfate activation and regeneration were observed with organic analyte in solution 
(Figures 4.18b and d) as without organic analyte (Figure 4.2b and c).  Persulfate decomposition at 
the cathode (Figure 4.18b) did not exhibit pseudo-first order decay with respect to persulfate as 
seen in the single-cell solution even though ciprofloxacin was present.  This pseudo-first order 
mechanism may result from a synergistic effect between reactions at the anode and cathode. 
4.3.6 Ciprofloxacin transformation  
Ciprofloxacin transformation pathways were examined in the three electrolytes, as shown in Figure 
4.19.  Mass spectra corresponding to by-products shown in Figure 4.19 are presented in Appendix 
Figures A13a-u.  In persulfate, rapid defluorination occurred within 15 minutes (Figure 4.20), 
corresponding to the rapid ciprofloxacin removal observed in Figure 4.4.  A multi-point 
hydroxylation with fluoride substitution (Figure 4.19), through m/z 362, was identified as a 
dominant route for ciprofloxacin breakdown in persulfate.  Similar mechanisms involving 
hydroxylation and/or defluorination were observed in multiple studies44,96,176,184,194.  Ciprofloxacin 
defluorination (Figure 4.20) reached >90% in both persulfate and sulfate, which is important  
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Figure 4.19. Ciprofloxacin Transformation Pathways 
Primary persulfate pathways through m/z 362 and 264. Primary sulfate pathway through m/z 264. 
Primary nitrate pathways through m/z 264 and 362. Secondary pathway in all three electrolytes 
through m/z 328. 
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Figure 4.20. Defluorination of ciprofloxacin 
Defluorination of 0.043 mmol L-1  ciprofloxacin with a BDD anode and graphite or platinum 
cathode. Single-cell RDE with anodic current density = 76 mA cm-2 and cathodic current density 
= 1.33 mA cm-2.  (a) [Persulfate]0 = 22 mmol L
-1  (b) [Sulfate]0 = 22 mmol L
-1 (c) [Nitrate]0 = 66 
mmol L-1.  
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because defluorination may lower toxic effects of fluorinated contaminants176.  Defluorination in 
nitrate only reached 36%.  Fluoride removal in sulfate and nitrate was almost linear, indicating a 
surface-dominated mechanism.  Hydroxylation without defluorination, through m/z 264, was a 
major degradation route in all electrolytes and the dominant pathway in nitrate and sulfate.  A third 
pathway, breakdown of the core quinolone structure through m/z 328, was comparable to results 
observed in other studies44, 96. 
Additional key mechanisms here and other ciprofloxacin studies include: 1) piperazine-
ring cleavage44, 96, 176, 184, 194, 214, 2) cyclo-propyl group breakdown 44, 3) loss of amines44, 184, and 
4) decarboxylation96, 184, 214.  No significant differences were noted between cathode materials.  
While no sulfate-adducts were observed, possible nitrate-adduct formation indicates potential 
nitrate radical evolution at the BDD anode in nitrate.  Overall, electrochemically generated sulfate 
radicals resulted in additional degradation pathways corresponding to the enhanced ciprofloxacin 
and TOC removal observed in sulfate and persulfate solutions. 
4.4 Conclusion 
Based on this study’s results, anodic sulfate radical formation, anodic non-radical persulfate 
activation and cathodic persulfate activation are expected to contribute to accelerated removal rates 
of organic analytes susceptible to activated persulfate reactions.  This study screened EAP as a 
viable candidate for point source treatment of wastewaters contaminated by fluoroquinilone 
antibiotics like ciprofloxacin.  Future work should include analysis of reactions in real-water 
matrices (including presence of inorganic ions and high TOC levels) and application to other 
analytes.  Reactor design must also be considered, including flow-through single-cell reactors, 
where mass transfer limitations to electrode surface might impact the system’s ability to effectively 
 100 
 
activate persulfate and subsequently degrade antibiotics.  Further investigation is warranted in 
determining the efficacy of EAP for real-world application. 
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CHAPTER FIVE:  CIPROFLOXACIN DEGRADATION IN SYNTHETIC HOSPITAL 
EFFLUENT 
 
5.1 Introduction 
For scale-up of EAP from laboratory to practical application, more must be understood about 
variables affecting EAP degradation results.  These include effects of persulfate concentration, 
reactor configuration, sizes of electrodes and how the system performs when applied to complex 
wastewaters.  
A significant concern with the use of electrochemical treatment of organic effluents is the 
formation of organic and inorganic disinfection by-products (DBPs), which can occur in reactive 
systems that contain both halogens and organic matter46, 215.  During electrochemical treatment of 
water using a BDD anode, hydroxyl radicals formed at the BDD surface reacted with halogens to 
create halogenated radical species135.  These halogenated radical species have the potential to react 
with organics in solution to create trihalomethanes and halo-acetic acids216.  Hydroxyl radicals 
also can oxidize chloride ions to progressively form hypochlorite, chlorite, chlorate and 
perchlorate ions135, 215, 217.  One study generated significant levels (1-2 mg L-1) of chlorate and 
perchlorate during the electrochemical post-treatment of chlorinated drinking water217.   Another 
study treating clofibric acid in synthetic secondary wastewater effluent generated over 100 mg L-
1 perchlorate using a BDD anode, well above the US EPA’s drinking water health advisory of 15 
µg L-1 218.  Finally, the inorganic DBP nitrite can form by oxidation of nitrate at the anode surface 
in slightly basic solutions219. 
In an activated persulfate system, the same hydroxyl-based radicals that are active in 
electrochemical systems can create organic and inorganic DBPs216, 220.  The accelerated organic 
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degradation found by combing electrochemical reactions with activated persulfate reactions in an 
EAP system may compound the effect.  It is imperative that DBP formation in EAP systems is 
understood to prove the feasibility of using persulfate addition as a means for treating complex 
wastewater matrices.  
Ciprofloxacin is a fluoroquinolone antibiotic that is known to degrade electrochemically in 
sulfate and persulfate solutions, as shown in Chapter 4194.  Because of its high environmental risk 
factor29, ciprofloxacin was chosen as a model compound for this study and will be used to explore 
parameters influencing EAP for environmental contaminant removal. 
The first objective of this study is to evaluate reactor configurations for use with EAP.  
Ciprofloxacin removal during the EAP process was studied in a rotating-disk electrode (RDE) 
reactor, a batch reactor, and a flow-through reactor (FTR).  The second objective of the study is to 
establish effects of variable persulfate concentration and cathode size on ciprofloxacin removal 
using EAP.  Third, ciprofloxacin degradation will be analyzed using EAP in a “real-world” matrix.  
To accomplish this objective, EAP was applied to ciprofloxacin removal from synthetic hospital 
effluent.  Kinetics of ciprofloxacin decay were compared to that in pure electrolyte.  Finally, this 
study aims to evaluate inorganic DBP formation during treatment of ciprofloxacin in synthetic 
hospital effluent.  This step was completed for FTR and RDE reactor configurations. 
5.2 Materials and Methods 
5.2.1 Chemicals   
Ciprofloxacin (98%), sodium persulfate (98%), potassium sulfate, sodium nitrate, potassium 
iodide (99+%), urea, uric acid, DL-tyrosine (98%), creatinine (99+%), sodium bicarbonate (Acros 
Organic), Optima formic acid, Optima Methanol (MeOH), magnesium perchlorate, RICCA 
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sodium chlorite (80%), sodium chloride, ammonia chloride, potassium phosphate monobasic, and 
fluoride standard were purchased from Fisher Scientific (Pittsburg, PA) and 1N sulfuric acid  was 
from J.T. Baker.  Deionized water (DI) (18.2 MΩ-cm) was produced by a Millipore Milli-Q 
system. 
5.2.2 Experimental Setup  
Initial ciprofloxacin concentrations were 0.043 mmol L-1 for all experiments (after addition of 
electrolyte and effluent as noted below), with ciprofloxacin preparation as described in Chapter 4.  
All experiments were spiked with concentrated electrolyte to the desired concentration just before 
applying current, as described in Chapter 4. 
For hospital effluent experiments, concentrated hospital effluent was prepared in advance, 
with components shown in Table 5.1.  The synthetic effluent was mixed with ciprofloxacin before 
electrolyte was added.  Synthetic hospital effluent composition for all experiments is shown in 
Table 5.1 and is based on values determined experimentally in other publications28, 221.  Total 
organic carbon, at a level of 221 mg/L, consisted of ciprofloxacin plus a mixture of urea, uric acid, 
creatinine and tyrosine as outlined in Table 5.1.  Tyrosine has been shown to react with chlorine 
to form various organic chlorinated by-products222.  Urea and creatinine are major constituents of 
human urine, and uric acid is a minor constituent; all three are expected to be present in hospital 
wastewater223.   
FTR experiments were conducted using apparatus depicted in Figure 5.1.  A boron-doped 
diamond (BDD) anode and graphite cathode were used (both surface areas 18 cm2).  Recirculation 
was maintained at 16mL min-1.  The effective treatment time was calculated by equation 5.1132:  
(5.1) 𝑡𝑒𝑓𝑓 = 𝑡𝑎𝑐𝑡𝑢𝑎𝑙 ∗  
𝑟𝑒𝑎𝑐𝑡𝑜𝑟 𝑣𝑜𝑙𝑢𝑚𝑒
𝑡𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒
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Table 5.1. Synthetic Hospital Effluent Composition for EAP Degradation of 
Ciprofloxacin 
Compound Ion/Molecule Formula  
Ion Concentration  
(mg L -1) 
Potassium Sulfate Sulfate SO42- 34.6 
Potassium Nitrate Nitrate NO3- 18.0 
Ammonium Chloride Ammonium NH4+ 30.7 
Potassium Phosphate Monobasic Phosphate HPO4- 81.5 
(Ammonium-, Sodium- ) Chloride Chloride Cl- 150.2 
Sodium (-Chloride, -Bicarbonate) Sodium Na+ 85.5 
Potassium (-Phosphate Monobasic, -
Sulfate, -Nitrate) 
Potassium K+ 74.4 
Sodium Bicarbonate Bicarbonate HCO3- 73.0 
Total Organic Carbon  TOC 221 
Urea Urea CH4N2O 800 (160 mg L-1 TOC) 
Uric Acid Uric Acid C5H4N4O3 2.0 (0.71 mg L-1 TOC) 
Tyrosine Tyrosine C9H11NO34 2.0 (1.2 mg L-1 TOC) 
Creatinine Creatinine C4H7N3O 118 (50 mg L-1 TOC) 
Ciprofloxacin Ciprofloxacin C17H18FN3O3 14 (8.6 mg L-1 TOC) 
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Figure 5.1. Schematic of the flow-through cell   
Valves are used to allow for sampling. 
 
The reactor volume was 36.5 mL and initial solution volume was 1000 mL.  A BK 
Precision 1761 DC power supply purchased from Cole Parmer was used to maintain a current of 
125 mA (current density = 6.9 mA cm-2) for all FTR experiments. 
Batch reactor experiments were conducted using the apparatus depicted in Figure 5.2.  A 
BDD anode and graphite cathode were used (both surface areas 18 cm2).  Stirring was maintained 
with a magnetic stir bar. Initial solution volume was 500 mL.  The same BK Precision power 
supply was used to maintain a current of 125 mA (current density 6.9 mA cm-2) for all batch 
experiments.  An SP-150 potentiostat (Bio-Logic Science Instruments, Knoxville, TN) with a 
mercury-mercury sulfate reference electrode was used to perform rotating disk electrode (RDE) 
experiments with schematic provided in Chapter 4 (Figure 4.1a).  A multi-speed rotator (Pine  
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Figure 5.2. Schematic of batch reactor 
 
Research Instrumentation, PRI, Durham, NC) set to 2000 rpm was used for the RDE experiments 
and bulk mixing was maintained using a magnetic stir-bar.  The anode was a change-disk RDE tip 
(PRI) with BDD electrode insert of 0.196 cm-2 surface area (Fraunhofer Center for Coatings and 
Diamond Technologies, East Lansing, MI).  The cathodes were Electron Microscopy Science 
graphite (Gr) rods (Fisher Scientific, Pittsburg, PA) with 4.8 cm2 exposed to solution except as 
noted.  Experiments were conducted with 200-mL solution volumes with a constant current of 15 
mA  (76 mA cm-2 current density). 
Experiments were completed at 20˚C with an initial pH of 4.0 for experiments in the pure 
electrolyte and 7.05 for experiments in the synthetic hospital effluent.  pH was not buffered in 
these experiments to prevent impacts due to buffering ions141.  Average final pHs were consistently 
2.15-2.5 in persulfate electrolyte, with or without effluent.  In sulfate electrolyte, pH did not change 
during the reactions in the batch reactor.  In the FTR and RDE reactors, pH increased during 
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reactions in pure sulfate electrolyte, ending at 8.0 in the FTR and 6.5 in the RDE reactor. With 
sulfate in the effluent, average final pHs were 2.5-3.0 for both reactor configurations.  
5.2.3 Analytical Methods   
Persulfate and ciprofloxacin-matrix concentrations were analyzed using a ThermoScientific 
Evolution 600 UV/Vis spectrometer (ThermoFisher, Pittsburg, PA) at 272 and 352 nm, 
respectively, with methodology described in Chapter 3180, 181, 191. 
HPLC-UV was used for direct ciprofloxacin analysis. Samples were prepared by extraction 
with Waters Sep-Pak tC2 cartridges as follows: conditioning with 1-mL methanol/1-mL DI water; 
loading 1-mL sample; extracting with 2x1-mL quantities of methanol/0.1% formic acid191.  
Extraction efficiency was 80%.  Detailed methodology and statistical parameters were described 
in Chapter 4 and applied in this study. 
 A Shimadzu HPLC with Hypersil Gold column (100 mm long, 4.6 I.D., 5-micron particles) 
and detection by a SPD-M20A diode array detector at 278 nm was used to quantify ciprofloxacin, 
as described in Chapter 4. 
A Shimadzu TOC-L analyzer with an ASI-L autosampler was used to analyze TOC.  
Statistical parameters for the method were described in Chapter 3191. 
A ThermoFisher fluoride ion selective probe was used to analyze fluoride (F-) concentrations.  
TISAB II was added in equal amounts to samples and standards, to act as an ionic strength buffer 
and dissociate potential hydrofluoric acid.  Statistical parameters for the calibration curve are 
found in Table 5.2. The method detection limit was 0.012 mmol L-1.  
Ion chromatography was used to analyze the inorganic disinfection by-products chlorite, 
chlorate, perchlorate and nitrite.  A Dionex 2100/1100 dual column system with background 
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suppression was used.  Statistical parameters for the calibration curves for these ions are found in 
Tables 5.3-5.6.  The method detection limit for chlorite was 4.7 x 10-3, chlorate was 1.7 x 10-4mmol 
L-1, perchlorate was 1.7 x 10-2  mmol L-1 and nitrite was 3.8 x 10-4 mmol L-1. 
 
Table 5.2. Statistical Parameters for Fluoride Calibration Curve 
 Slope 
(mV per LN (mmol L-1 F-)) 
Intercept 
(mV) 
Value -22.0 28.0 
Standard error 0.50 1.86 
R2 0.9979  
 
 
 
Table 5.3. Statistical Parameters for Chlorite Calibration Curve 
 Slope 
(peak area per mmol L-1) 
Intercept 
(peak area) 
Value 8.32 0.017 
Standard error 0.22 0.034 
R2 0.9971  
 
 
Table 5.4. Statistical Parameters for Chlorate Calibration Curve 
 Slope 
(peak area per mmol L-1) 
Intercept 
(peak area) 
Value 9.44 -0.065 
Standard error 0.01 0.029 
R2 0.9996  
 
 
Table 5.5. Statistical Parameters for Perchlorate Calibration Curve 
 Slope 
(peak area per mol L-1) 
Intercept 
(peak area) 
Value 7.23 -0.040 
Standard error 0.13 0.016 
R2 0.9989  
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Table 5.6. Statistical Parameters for Nitrite Calibration Curve 
 Slope 
(peak area per mol L-1) 
Intercept 
(peak area) 
Value 8.40 -0.031 
Standard error 0.11 0.011 
R2 0.9992  
 
5.3 Results 
5.3.1 FTR experiments 
In Chapter 4, persulfate addition was shown to enhance removal of ciprofloxacin in a RDE reactor. 
To better assess reactor configuration for practical application, experiments to electrochemically 
degrade ciprofloxacin in a FTR and batch reactor were performed in sulfate and persulfate 
electrolytes.  At the same time, different levels of persulfate electrolyte were evaluated to optimize 
the amount of persulfate recommended for these systems. 
FTR results are shown in Figure 5.3.  Based on Chapter 4 results, it was expected that 
persulfate would offer an advantage over sulfate for electrochemical ciprofloxacin removal, due 
to persulfate activation at the cathode.  In 11 mmol L-1 persulfate, 95% of ciprofloxacin and 66% 
of TOC were removed in teff = 60 minutes.  Degradation followed pseudo-first-order kinetics, with 
ciprofloxacin-matrix keff = 9.53 +/- 1.03 x 10
-4 s-1 and TOC keff =  3.16 +/- 0.45 x 10
-4 s-1.  The fit 
for pseudo-first order was R2 = 0.9549 for ciprofloxacin-matrix and R2 = 0.9276 for TOC.  Similar 
results were found in 11 mmol L-1 sulfate electrolyte with 92% removal of ciprofloxacin-matrix 
and 61% removal of TOC in teff = 60 minutes.  Removal in sulfate also followed first-order kinetics 
with ciprofloxacin-matrix  keff =  7.68 +/-  0.57 10
-4 s-1 (R2=0.9768) and TOC keff =  2.64 +/- 0.65 
x 10-4 s-1  (R2=0.8259).  Removal of the ciprofloxacin-matrix was a statistically significant 19% 
faster in persulfate than sulfate (p=0.0016).  TOC removal was not statistically different 
(p=0.1631).   
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Figure 5.3. Degradation of ciprofloxacin-matrix and TOC in a flow-through reactor 
Sulfate0 = Persulfate0 = 11 mmol L
-1. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 6.9 mA 
cm-2. 
 
 
Defluorination, shown in Figure 5.4, reached 100% and was similar in both electrolytes.  
After an initial spike of defluorination with the addition of electrolyte, the ciprofloxacin 
defluorinated linearly with the square root of time (Figure 5.4b).  Because fluoride removal may 
lower the toxicity of fluorinated pharmaceuticals, defluorination is a significant outcome in the 
treatment of such compounds 189.  
Persulfate reduction, determined in Chapter 4 to indicate persulfate activation in an RDE 
system, was confirmed to occur in the FTR (Figure 5.5a) via a pseudo-first order (Figure5.5b) 
mechanism with respect to persulfate.  Persulfate generation from sulfate, previously established 
in an RDE system, was also confirmed in the FTR (Figure 5.5a).  Because of the small difference 
in ciprofloxacin removal and lack of difference in TOC removal between no persulfate (sulfate 
only) and a high level of persulfate (11 mmol L-1), intermediate levels were not tested.  
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Figure 5.4. Defluorination of ciprofloxacin in a FTR 
(a) Defluorination of ciprofloxacin in persulfate and sulfate electrolytes in an electrochemical FTR.  
(b) Modeling for Figure 5.4a.  (a-b) Sulfate0 = Persulfate0 = 11 mmol L
-1. Ciprofloxacin0 = 0.043 
mmol L-1. Current density 6.9 mA cm-2. 
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5.3.2 Batch Reactor Experiments 
Batch reactor results for electrochemical ciprofloxacin degradation are shown in Figure 5.6.  
Several levels of persulfate concentration were employed to better understand the limited 
difference in ciprofloxacin removal between persulfate levels on the FTR.  Ciprofloxacin-matrix 
and TOC removal both followed pseudo-first order kinetics with respect to themselves, as 
illustrated in Figures 5.6a and 5.6b respectively.  Reaction rate constants and statistics for the 
curves in Figure 5.6 are shown in Table 5.7.  Ciprofloxacin-matrix removal ranged from 92.5% 
without persulfate to 94% at 3.1 mmol L-1 persulfate to 96.5% in 11 mmol L-1 persulfate, all in 
300 minutes.  The removal rate with the high level of persulfate (k =  1.83 +/-  0.13 10
-4 s-1 ) was a 
statistically significant 25% greater than with sulfate alone (k =  1.37 +/-  0.12 10
-4 s-1 ), at 
p<0.0001.  With less persulfate (3.1 mmol L-1) the 11% increase in rate was also significant 
(p=0.0325).  TOC removal in the same timeframe averaged 78% and was not statistically 
significant without or with persulfate.  As shown in Figure 5.6c, the ciprofloxacin-matrix reaction 
rate constant increased linearly (R2=0.9360) with increasing persulfate concentration (Figure 
5.6c).  The pseudo-first order reaction rate constant (r) vs. persulfate concentration was modeled 
as r=(3.94x10-6) x c + (1.36x10-4), where c is mmol L-1 persulfate. 
Defluorination (Figure 5.7) was similar without persulfate and with high persulfate (11 
mmol L-1) and reached ~85%, so intermediate levels were not evaluated.  Defluorination increases 
linearly with the square root of time, as shown in Figure 5.7b, so the provided equations on Figure 
5.7b can be used to predict defluorination in this system. 
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Figure 5.5. Persulfate behavior during ciprofloxacin removal in a FTR 
(a) Persulfate concentration over time during ciprofloxacin removal in an electrochemical FTR.  
(b) Modeling for Figure 5.5a. (a-b) Sulfate0 = Persulfate0 = 11 mmol L
-1. Ciprofloxacin0 = 0.043 
mmol L-1. Current density 6.9 mA cm-2. 
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Figure 5.6.  Degradation of ciprofloxacin-matrix and TOC in in a batch reactor 
Sulfate0 or Persulfate0 shown on legend. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 6.9 mA 
cm-2. 
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Table 5.7. Reaction rate constants and statistics for batch reactor with varying persulfate 
levels 
Persulfate  
(mmol L-1) 
Pseudo-first order reaction 
rate constant 
X 10-4 (s-1) 
+/- R2 
first-order 
fit 
% difference 
from sulfate 
Statistical significance of 
difference from sulfate 
Ciprofloxacin-matrix     
11* 1.83 0.13 .9790 25% p < 0.0001 
5.5* 1.58 0.16 .9722 13% p=0.0325 
3.1 1.54 0.12 .9843 11% p=0.037 
0 1.37 0.12 .9794 n/a n/a 
TOC      
11 0.70 0.08 .9519 3% p=0.8305 (not sig.) 
5.5 0.72 0.06 .9771 0% p=0.9041 (not sig.) 
3.1 0.70 0.40 .9855 3% p=0.7471 (not sig.) 
0 0.72 0.07 .9755 n/a n/a 
*Difference between 11 and 3.1 was also a statistically significant 16% with p=0.0032; difference between 11 and 
5.5 was also a statistically significant 14% with p=0.0217. 
 
Persulfate reduction and persulfate generation from sulfate is shown in Figure 5.8. 
Persulfate reduction occurred via a first-order mechanism as shown in Figure 5.8b.   
It was suspected that the 1:1 anode:cathode ratio utilized in the batch and flow-through reactor 
make these anode dominant processes, so that persulfate activation at the cathode is not a 
significant contributor to degradation, especially for TOC removal.  Chapter 4, in which cathodic 
persulfate activation influenced degradation, had an anode:cathode size ratio of 1:24 with an RDE 
setup, much different than the 1:1 ratio for experiments described thus far in the current study. It 
was also hypothesized that mass transfer limitations, minimized in the previous study through use 
of an RDE, inhibited the ability of radicals formed at the anode or cathode to be effective in 
solution.  Mass transfer limitations would increase going from an RDE configuration with anode 
rotation at 2000 rpm, to a batch reactor with stirring maintained in the vessel, to a flow-through 
reactor with flow parallel to the reactor plate.  This expectation follows the observed decrease in 
persulfate effectiveness from RDE (Chapter 4) to batch to FTR. 
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Figure 5.7.  Defluorination of ciprofloxacin in a batch reactor 
(a) Defluorination of ciprofloxacin in persulfate and sulfate electrolytes in an electrochemical 
batch reactor.  (b) Modeling for Figure 5.7a. (a-b)  Sulfate0 or Persulfate0 = 11 mmol L
-1. 
Ciprofloxacin0 = 0.043 mmol L
-1. Current density 6.9 mA cm-2. 
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Figure 5.8. Persulfate behavior during ciprofloxacin removal in a batch reactor 
(a) Persulfate concentration over time for ciprofloxacin removal in a batch reactor.  (b) Modeling 
for Figure 5.8a. (a-b) Persulfate0 indicated on legend. Sulfate0 =11 mmol L
-1 (Figure 5.8a inset). 
Ciprofloxacin0 = 0.043 mmol L
-1. Current density 6.9 mA cm-2. 
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5.3.3 RDE reactor experiments 
To understand fundamental effects of cathode size, experiments were completed with an RDE 
while varying anode:cathode ratios (Figure 5.9).  Pseudo-first order reaction rate constants and 
related statistics are provided in Table 5.8.  Ciprofloxacin-matrix removal rate was significantly 
inhibited with an anode:cathode ratio of 1:1.  There was a statistically significant 32% increase in 
reaction rate going from a ratio of 1:1 to 1:10, with further increases in cathode size having 
negligible effect on the ciprofloxacin-matrix.  For TOC, reaction rates had a statistically significant 
26% increase when cathode size increased to a ratio of 1:20 and continued to increase slightly up 
at a 1:40 ratio.  In comparison, changing the anode:cathode from 1:1 to 1:30 for removal in nitrate 
electrolyte (an anode dominant process) did not change removal rates.  It is clear that 
anode:cathode ratio must be considered when designing an EAP process, and that a smaller, more 
expensive and brittle BDD can be used relative to a larger, less expensive graphite material.  To 
optimize removal time for both ciprofloxacin-matrix and TOC, a minimum of 1:20 anode: cathode 
size is recommended for use with a BDD/Gr pair. 
Persulfate activation, measured by net persulfate reduction, was also evaluated.  Increasing 
persulfate activation was observed for increasing cathode size (Figure 5.10).  Persulfate increased 
with the square root of increasing cathode:anode ratio, as shown on Figure 5.10d. 
 Ciprofloxacin removal versus varying persulfate concentration was next evaluated on the 
RDE to understand the fundamentals effects of increasing persulfate levels when mass transfer 
limitations are minimized.  Ciprofloxacin-matrix and TOC removal are shown in Figure 5.11.  
Both degraded via pseudo-first order mechanisms with respect to themselves, with reaction rates 
and related statistics shown in Table 5.9.  The maximum degradation rate occurred in 11 mmol L-  
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Figure 5.9. Ciprofloxacin-matrix and TOC removal with varying anode:cathode ratios 
(a-b) Degradation of ciprofloxacin-matrix and TOC in an RDE over time in persulfate electrolyte 
with various anode:cathode ratios as noted in legend.  (c-d) Reaction rate constants versus relative 
cathode size for curves shown in (a-b). Persulfate0 = 22 mmol L
-1. Ciprofloxacin0 = 0.043 mmol 
L-1. Current density mA cm-2.  Also shown, reaction rate constants for degradation of 
ciprofloxacin-matrix and TOC in an RDE over time in nitrate electrolyte under same conditions 
and nitrate0 = 22 mmol L
-1. 
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Table 5.8. Reaction rate constants and statistics for RDE with varying anode:cathode size 
Ratio of size 
(anode:cathode) 
 
Pseudo-first order 
reaction rate 
constant  
X 10-5 (s-1) 
+/- R2 
for first-
order fit 
% difference 
from 1:1 
Statistical significance 
of difference from 1:1 
Ciprofloxacin-matrix/persulfate*     
1:40 3.93 0.29 .9850 36% p<0.0001 
1:30 3.57 0.38 .9635 32% p<0.0001 
1:20 3.67 0.25 .9843 32% p<0.0001 
1:10 3.65 0.33 .9774 32% p<0.0001 
1:1 2.51 0.20 .9782 n/a n/a 
TOC from Ciprofloxacin/persulfate*   
1:40 0.88 0.14 .9211 40% p<0.0001 
1:30 0.82 0.21 .8424 35% p=0.0109 
1:20 0.72 0.11 .9303 26% p=0.0136 
1:10 0.63 0.21 .7291 16% p=0.3861 (not sig.) 
1:1 0.53 0.11 .8623 n/a n/a 
Ciprofloxacin-matrix/nitrate*     
1:30 0.40 0.10 0.8094 -22% p=0.9753 (not sig.) 
1:1 0.49 0.23 0.5996 n/a n/a 
TOC from Ciprofloxacin/nitrate*     
1:30 0.036 0.036 0.1260** 67% p=0.3297 (not sig.) 
1:1 0.012 
 
0.12 0.0795** n/a n/a 
*Experiments conducted in 22 mmol L-1 electrolyte  
**Poor statistics due to almost no removal in 24-hours for either case 
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Figure 5.10. Persulfate behavior with different cathode sizes during ciprofloxacin removal 
in a RDE reactor 
(a) Persulfate versus cathode size cathode sizes (b) Persulfate pseudo-first order reaction rate 
constant versus cathode size (relative to anode size) (c) Modeling for Figure 5.10a. (a-b) 
Persulfate0 = 11 mmol L
-1. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 15 mA cm-2. 
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 persulfate electrolyte, with 80% ciprofloxacin-matrix removal achieved in 10 hours, and 65% 
TOC removal achieved in 24 hours.  The ciprofloxacin removal rate constant of k = 4.5 +/-  0.28 
10-5 s-1 in 11 mmol L-1 persulfate was 44% greater than the rate without persulfate, at p<0.0001.  
The TOC removal rate constant of k = 1.20 +/-  0.13 in 11 mmol L
-1 persulfate showed even greater 
gains, with a statistically significant 53% increase versus no persulfate.  The removal rate declined 
when doubling the persulfate from 11 to 22 mmol L-1.  A maximum persulfate level beyond which 
degradation plateaus or decreases has been shown in other studies and is likely due to sulfate 
radicals scavenging themselves 48.  At a lower 3.1 mmol L-1 persulfate, 30% faster removal rates 
for both ciprofloxacin-matrix (k = 3.67 +/-  0.13) and TOC (k = 0.82 +/-  0.13) were achieved, 
resulting in statistically significant great improvements over no persulfate for the ciprofloxacin-
matrix degradation rate (p<0.0001) and the TOC degradation rate (at p=0.0410). Using 3.1 mmol 
L-1 persulfate offers the benefits of enhanced analyte removal while limiting the addition of sulfate 
to the system to 6.2 mmol L-1 (600 mg L-1) from persulfate reduction (as demonstrated in Figure 
4.10) and may be considered an optimum level for this system.  The fundamental relationship of 
ciprofloxacin-matrix removal versus varying persulfate concentration was elucidated in Figure 
5.11c.  The reaction rate constants of ciprofloxacin-matrix and TOC both increased with the square 
root of persulfate concentration up to 11 mmol L-1, with R2 values of 0.8933 and 0.9325 
respectively.    
The smaller, or in some cases lack of, difference between ciprofloxacin-matrix and TOC 
removal rates at higher and lower persulfate levels in the batch and flow-through reactors are 
attributed to the use of a 1:1 anode:cathode ratio as well as mass transfer limitations.  For EAP,  
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Figure 5.11. Ciprofloxacin-matrix and TOC removal with varying persulfate levels   
(a-b) Degradation of ciprofloxacin-matrix and TOC in an RDE over time in varying levels of 
persulfate electrolyte. (c) Reaction rate constants versus square root of persulfate concentration 
(*1.1 mmol L-1 persulfate level not shown in a-b for clarity but included in trend on c). Persulfate0 
= 22 mmol L-1. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 15 mA cm-2. 
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Table 5.9. Reaction rate constants and statistics for RDE reactor with varying persulfate 
levels 
Persulfate  
(mmol L-1) 
Pseudo-first 
order reaction 
rate constant 
X 10-5 (s-1) 
+/- R2 
for first-
order fit 
% 
difference 
from sulfate 
Statistical 
significance of 
difference from 
sulfate 
Statistical significance 
from previous increment 
(i.e. 3.1 vs 1.1)  
Ciprofloxacin-matrix      
22* 3.58 0.17 .9626 29% p < 0.0001  
11 4.50 0.28 .9801 44% p < 0.0001 p=0.0184 
5.5 3.90 0.30 .9808 35% p < 0.0001 p=0.2958 
3.1 3.67 0.35 .9724 31% p < 0.0001 p=0.8838 
1.1* 2.82 0.18 .9868 10% p=0.0588 p=0.0588 
0 2.53 0.22 .9635 n/a n/a n/a 
TOC       
22* 0.96 0.19 .9648 41% p=0.0138  
11 1.20 0.13 .9686 53% p < 0.0001 p=0.0001 
5.5 0.93 0.18 .8725 39% p=0.0206 p=0.2844 
3.1 0.82 0.13 .9377 30% p=0.0410 p=0.0001 
1.1* 0.83 0.13 .9361 30% p=0.0344 p=0.0344 
0 0.57 0.25 .7764 n/a n/a n/a 
*Not shown on Figure 5.11 
 
reactor design plays a critical role in the effectiveness of the system, as mass transfer must be 
maximized and anode:cathode ratio must be optimized. As in the flow-through and batch reactors, 
defluorination was not statistically different between 0 and 11 mmol L-1 (Figure 5.12).  There was 
also no effect by cathode size. Defluorination increased linearly with time, demonstrative of a 
surface-based reaction.  It was concluded that defluorination is dominated by an anodic 
electrochemical mechanism versus an EAP or cathodic mechanism. 
Persulfate activation, demonstrated by persulfate reduction, occurred through a first-order 
mechanism, as shown in Figure 5.13a-b.  Persulfate generation from sulfate is demonstrated in the 
inset.  The persulfate curves in Figures 5.5b, 5.8b and 5.13b for FTR, batch and RDE respectively, 
all show a linear relationship between LN (C/C0) with time, so it was concluded that persulfate 
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activates by a pseudo-first order mechanism, with respect to persulfate, across reactor 
configurations. 
 
 
Figure 5.12. Defluorination of ciprofloxacin in a RDE reactor  
(a) Defluorination of ciprofloxacin in persulfate and sulfate electrolytes in a RDE reactor. Sulfate0 
or Persulfate0 = 11 mmol L
-1. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 15 mA cm-2. 
 
5.3.4 Second-order mechanisms 
Although environmental contaminant degradation research relies almost solely on establishing 
pseudo-first order rate constants with respect to the analyte being degraded, evaluating second- 
order relationships may be useful for truly understanding fundamental mechanisms of decay.  The 
second-order relationships between persulfate and pure ciprofloxacin (extracted by SPE and 
evaluated on HPLC/UV) was evaluated for the RDE configurations using equation 4.6.  Results 
are shown in Figure 5.14 and indicate a second-order mechanism between ciprofloxacin decay and 
persulfate removal.  Second-order rate constants calculated from the 11 and 3.1 mmol L-1 
persulfate curves were 1.67 and 4.09 x10-2 L mol-1 s-1, respectively.  These values are the same 
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Figure 5.13. Persulfate behavior during ciprofloxacin removal in a RDE reactor 
(a) Persulfate concentration with time. (b) Modeling for Figure 5.13a. (a-b) Persulfate0 indicated 
on legend. Sulfate0 =11 mmol L
-1 (Figure S9a inset). Ciprofloxacin0 = 0.043 mmol L
-1. Current 
density 15 mA cm-2. 
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magnitude as the  rate constant (2.10 x10-2 L mol-1 s-1) calculated for the 22 mmol L-1 persulfate 
curve in Chapter 4.  Combining the three curves gives a ciprofloxacin-persulfate second-order rate 
constant of 2.62 +/- 1.46 x 10-2 L mol-1 s-1 in the RDE reactor. 
 
 
Figure 5.14. Second-order modeling for the reaction of Ciprofloxacin and Persulfate 
Persulfate0 = 3.1 and 11 mmol L
-1 indicated on legend. Ciprofloxacin0 = 0.043 mmol L
-1. Current 
density 15 mA cm-2.  
 
5.3.5 Ciprofloxacin degradation in synthetic hospital effluent 
An important consideration when evaluating EAP for practical application is the system’s 
performance for analyte removal in a “real-world” matrix. EAP was applied to ciprofloxacin 
removal from synthetic hospital effluent using the FTR and RDE reactor configurations.  The FTR 
was utilized to demonstrate a reactor configuration that might be used in the field, while the RDE 
was employed to elucidate fundamentals of EAP in a complex matrix.  Results for ciprofloxacin 
degradation in synthetic effluent in the FTR were compared to results obtained in pure electrolyte, 
as shown in Figure 5.15.  A pseudo-first order mechanism (with respect to listed analytes) for 
decay of ciprofloxacin-matrix and TOC was found in the effluent as in pure electrolyte, with rate 
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constants and related statistics shown in Table 5.10.  Removal rates for ciprofloxacin-matric 
decreased by 41% in the persulfate-effluent system and by 32% in the sulfate-effluent system.  The 
difference in removal rates previously seen between sulfate and persulfate was not found in the 
effluent, so that persulfate did not offer an advantage for ciprofloxacin-matrix removal in the 
synthetic effluent.  While TOC removal rates in both electrolyte/effluent systems declined by just 
over 50% versus pure electrolyte, of note is the 25x increase in TOC added by the effluent matrix.  
The decrease in performance was much less than the TOC added and it was concluded that the 
electrochemical FTR is capable of removing relatively high levels of TOC.  This experiment was 
unable to discern differences in TOC removal from ciprofloxacin versus the other organics in 
solution.  Persulfate provided a statistically significant (p=0.0010) 24% faster rate than sulfate for 
TOC removal from effluent. EAP in an FTR may offer an advantage over sulfate for TOC removal 
in complex matrices such as hospital effluent.   
 Defluorination in the effluent solution using the FTR followed the same pattern as in pure 
electrolyte, with defluorination increasing with the square root of effective time, as seen in Figure 
5.16. Less defluorination was achieved in effluent, in keeping with the lower rate of ciprofloxacin-
matrix removal achieved.  Defluorination in the sulfate-effluent system was higher than that in the 
persulfate-effluent system, with 80% removal versus 62% in 60 minutes of effective time, 
respectively.  It may be the interactions of persulfate and effluent at the anode interfered with the 
anode-dominated defluorination mechanism previously described. 
 Persulfate reduction in the effluent (Figure 5.17) followed the same trend as reduction in 
pure persulfate (Figure 5.5).  On the other hand, persulfate generation from sulfate was much less 
in the effluent, with only 0.10 mmol L-1 detected over the 60-minute effective treatment time in  
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Figure 5.15.  Degradation of ciprofloxacin-matrix and TOC in synthetic hospital effluent in 
a FTR.   
Sulfate0 = Persulfate0 = 11 mmol L
-1. TOC0=221 mg L
-1 in effluent and 8.6 mg L-1 in pure 
electrolyte. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 6.9 mA cm-2.  
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Figure 5.16.  Defluorination of ciprofloxacin in synthetic hospital effluent in a FTR 
(a) Defluorination with time. (b) Modeling for Figure 5.16a. (a-b) Sulfate0 or Persulfate0 = 11 
mmol L-1. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 6.9 mA cm-2. 
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Table 5.10. Reaction rate constants and statistics for FTR experiments in hospital effluent  
Persulfate  
(mmol L-1) 
Pseudo-first 
order reaction 
rate constant 
X 10-4 (s-1) 
+/- R2 
for first-
order fit 
% difference in 
effluent versus 
electrolyte 
Statistical significance of 
difference in electrolyte 
versus effluent 
Ciprofloxacin-matrix/persulfate     
Synthetic Effluent 5.65 0.42 .9791 -41% p < 0.0001 
Pure electrolyte 9.53 1.03 .9549   
*TOC/persulfate      
Synthetic Effluent 1.54 0.10 .9847 -51% p < 0.0001 
Pure electrolyte 3.16 0.45 .9276   
Ciprofloxacin-matrix/sulfate     
Synthetic Effluent 5.25 0.47 .9681 -32% p < 0.0001 
Pure electrolyte 7.68 0.57 .9768   
*TOC/sulfate      
Synthetic Effluent 1.17 0.19 .9058 -56% p < 0.0001 
Pure electrolyte 2.64 0.65 .8259   
*Note that starting TOC was significantly higher in the effluent, going from 8.6 mg L-1 in pure electrolyte to 221 mg 
L-1 in effluent 
      
      
      
      
      
 
  
 132 
 
 
Figure 5.17. Persulfate behavior during ciprofloxacin removal in synthetic hospital effluent 
in a FTR 
Sulfate0 or Persulfate0 =11 mmol L
-1. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 6.9 mA 
cm-2. 
 
effluent versus the accumulation of 1.0 mmol L-1 in the same time in pure sulfate electrolyte.  
Similar to defluorination, the interaction of the effluent at the anode may interfere with formation 
of persulfate from sulfate at the anode. 
 During experiments using the RDE, extracted ciprofloxacin (separated by SPE and 
measured by HPLC) was measured in addition to ciprofloxacin-matrix to study differences that 
may occur in molecular ciprofloxacin removal versus the ciprofloxacin-matrix.  Extracted 
ciprofloxacin was analyzed in pure electrolyte and effluent.  The pure ciprofloxacin degraded via 
pseudo-first order mechanisms, with respect to ciprofloxacin concentration, in all solutions, with 
reaction rate constants and statistics provided in Table 5.11.  In pure electrolyte, differences in 
removal between persulfate levels was similar for molecular ciprofloxacin as for the ciprofloxacin-
matrix, although molecular ciprofloxacin removal rates were an order of magnitude higher than 
those for the ciprofloxacin-matrix.  It is clear from comparing Figure 5.18a and b that pure 
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ciprofloxacin removal slowed dramatically in synthetic hospital effluent, unlike ciprofloxacin 
matrix or TOC in the effluent.  For pure ciprofloxacin and TOC, differences in removal rates by 
persulfate level, observed in pure electrolyte, did not translate to differences in removal in effluent.  
In fact, the ciprofloxacin removal rate from effluent with 3.1 mmol L-1 persulfate was actually 
slower than with no persulfate.  The only variable that was positively influenced by persulfate 
addition to the effluent system was the ciprofloxacin-matrix, in which 80% and 88% faster removal 
was obtained with the addition of 3.1 and 11 mmol L-1 persulfate, respectively.  As with the FTR, 
TOC rates between pure electrolyte and effluent only dropped between 21% and 43%, despite a 
25 times increase in the initial amount of TOC.  This confirms findings from the FTR that this 
electrochemical process is capable of removing relatively high levels of organics from a complex 
matrix such as hospital effluent.  
Defluorination of ciprofloxacin in the effluent followed a similar linear trend to that in pure 
electrolyte, although lower amounts of defluorination were achieved (Figure 5.19).  There was also 
a greater difference in the defluorination rate between 11 mmol L-1 persulfate and sulfate only 
solutions when the effluent was present.  This was correlated with the greater difference in 
ciprofloxacin-matrix removal, where the ciprofloxacin-matrix was found in Chapter 4 to be 
partially comprised of large fluorinated chromophores.   
Persulfate behavior in the synthetic effluent was also evaluated, as shown in Figure 5.20. 
While persulfate reduction was similar to that in pure electrolyte, persulfate generation from 
sulfate was not observed.  This matches findings in the FTR and further indicates an interfering 
effect at the anode from the effluent. 
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Figure 5.18.  Ciprofloxacin degradation over time in pure electrolyte and synthetic hospital 
effluent in a RDE reactor 
Persulfate0 indicated on legend. Sulfate0  = 11 mmol L
-1. TOC0=221 mg L
-1 in effluent and 8.6 mg 
L-1 in pure electrolyte. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 15 mA cm-2. 
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Table 5.11. Reaction rate constants and statistics for RDE experiments in hospital effluent  
Persulfate  
(mmol L-1) 
Pseudo-first order 
reaction rate constant 
X 10-5 (s-1) 
+/- R2 
for first-
order fit 
% difference 
from sulfate 
Statistical significance of 
difference from sulfate 
Ciprofloxacin in pure electrolyte     
11 23.3 6.5 .9251 41% p=0.0013 
3.1 21.7 6.5 .9742 37% p=0.0039 
0 13.7 1.8 .9622 n/a n/a 
Ciprofloxacin in effluent     
11 5.00 1.0 .9134 -10% p=0.6220 (not sig.) 
3.1 4.00 0.67 .9308 -38% p=0.0747 
0 5.50 1.8 .8446 n/a n/a 
Ciprofloxacin-matrix in pure electrolyte: see Table 5.8 
Ciprofloxacin-matrix in effluent   
11 2.33 0.25 .9389 88% p < 0.0001 
3.1 1.38 0.12 .9775 80% p < 0.0001 
0 0.28 0.28 .2288 n/a n/a 
TOC in pure electrolyte: see Table 5.8   
TOC in effluent     
11 0.68 0.06 .9535 6% p=0.3127 (not sig.) 
3.1 0.68 0.07 .9638 6% p=0.4917 (not sig.) 
0 0.72 0.06 .9834 n/a n/a 
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Figure 5.19.  Defluorination of ciprofloxacin in synthetic hospital effluent in a RDE reactor 
Sulfate0 or Persulfate0 = 11 mmol L
-1. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 15 mA 
cm-2. 
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Figure 5.20. Persulfate behavior during ciprofloxacin removal in synthetic hospital effluent 
in a RDE reactor  
(a) Persulfate concentration with time. (b) Modeling for Figure 5.20. (a-b) Persulfate0 indicated on 
legend. Ciprofloxacin0 = 0.043 mmol L
-1. Current density 15 mA cm-2. Persulfate generation from 
sulfate did not occur and is not pictured. 
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5.3.6 Inorganic disinfection by-products  
The inorganic DBPs chlorite, chlorate, perchlorate and nitrite were evaluated to screen EAP for 
practical application.  This study was conducted on both the FTR and RDE reactor, and formation 
amounts were compared between sulfate and persulfate electrolytes.  The variable mg L-1 DBP 
formed per mg L-1 TOC removed was utilized. Figure 5.21 shows that the formation of inorganic 
DBPs in the FTR is mostly independent of the presence of persulfate.  Slightly more chlorate was 
formed in the FTR in the presence of persulfate.  
Figure 5.22 shows that, like the FTR, formation of inorganic DBPs in the RDE is mostly 
independent of the presence of persulfate.  Slightly more nitrite was formed in the RDE 
experiments with persulfate than without persulfate. 
While the persulfate independence shows that use of EAP does not provide additional 
potential for inorganic DBP formation, the overall level of inorganic DBPS formed during the time 
to achieve significant TOC removal is of concern for both electrochemical setups, as shown in 
Table 5.12.  The FTR generated over 200 mg L-1 perchlorate during the 60-minute effective 
treatment time and the RDE generate over 29 mg L-1 perchlorate in a 24-hour treatment time. 
Perchlorate is chemically stable because of its high activation energy (120 kJ mol-1) and is 
not removed or destroyed by most traditional wastewater treatment processes224.  With use of EAP 
as a pre-treatment for release of hospital effluent to a WWTP, perchlorate may pass through the 
system unchanged and enter the environment.  The FTR-EAP system is not recommended in its 
current design as a stand-alone treatment system.  It may be best coupled with a successful 
perchlorate removal technique, such as ion-exchange, which would serve to remove organic 
components in the EAP phase and inorganic DBP through ion-exchange resin224. 
 139 
 
 
Figure 5.21.  Formation of inorganic disinfection by-products in synthetic hospital effluent 
in a FTR 
Persulfate0 indicated on legend. Sulfate0  = 11 mmol L
-1. TOC0=221 mg L
-1.  Current density = 6.9 
mA cm-2 on FTR. 
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Figure 5.22.  Formation of inorganic disinfection by-products in synthetic hospital effluent 
in a RDE reactor 
Persulfate0 indicated on legend. Sulfate0  = 11 mmol L
-1. TOC0=221 mg L
-1.  Current density = 15 
mA cm-2. 
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5.4 Conclusion 
Overall, this study demonstrated successful electrochemical degradation of ciprofloxacin using 
flow-through, batch and RDE reactors.  Electrochemically activated persulfate demonstrated 
improvement over sulfate in some cases in pure electrolyte, but showed limited benefit when 
applied to a more complex matrix such as synthetic hospital effluent.  Relative cathode size and 
mass transfer effects were both suggested to influence the effectiveness of the systems, with at 
least a 1:20 anode to cathode size ratio recommended to optimize contaminant removal.  The 
electrochemical systems showed efficacy for TOC removal even when TOC content was greatly 
increased by addition of synthetic hospital effluent components; however, these systems also 
generated high levels of perchlorate during TOC removal.  Further work is recommended to study 
multi-step treatment trains.  Such systems might consist of electrochemical treatment with sulfate 
or persulfate electrolyte, and a stage such as ion exchange to remove the generated inorganic DBPs. 
 
Table 5.12. Inorganic Disinfection By-product Formation During 
Electrochemical Treatment of Ciprofloxacin 
Disinfection  
By-product 
Persulfate 
(mmol L-1) 
mg L-1 
in RDE* 
mg L-1 
 in FTR** 
Nitrite 11 0.33 0.35 
 3.1 0.32  
 0 0.24 0.30 
Chlorite 11 11.8 9.8 
 3.1 12.9  
 0 10.2 10.8 
Chlorate 11 26.3 39.0 
 3.1 26.3  
 0 23.1 29.0 
Perchlorate 11 39.0 203.0 
 3.1 48.4  
 0 42.8 245.8 
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CHAPTER SIX: CONCLUSIONS  
 
The research described in Chapters 3 and 4 provides fundamentals of electrochemical persulfate 
activation, while Chapters 3, 4 and 5 examine application of EAP to ciprofloxacin degradation.  
Throughout these studies, ciprofloxacin removal is analyzed in detail, while ciprofloxacin is also 
used as a model compound to better understand EAP.   
Chapters 3 and 4 assessed electrochemical persulfate activation without analyte in solution, 
an important step to understand the fundamentals of EAP systems.  In chapter 3, persulfate 
activation by solid iron was proposed to be a surface dominated mechanism.  The relationships 
between iron surface area, applied current, iron production and persulfate activation were 
elucidated. Sustained persulfate activation was accomplished with the use of solid iron, with 1.14 
moles of persulfate activated for 1 mole of iron used.  It was found that the surface area of the solid 
iron could be adjusted to control the persulfate activation rate.  Applied current enhanced persulfate 
activation until diffusion limitations were reached.  In Chapter 4, anodic sulfate radical formation, 
anodic non-radical persulfate activation and cathodic persulfate activation were discovered to be 
persulfate activation mechanisms.  Cathodic activation was found to be the same for graphite and 
platinum materials.  Persulfate generation from sulfate at a BDD anode was also confirmed.  Net 
persulfate activation increased linearly with increased current density, within the range tested. 
Chapters 3, 4 and 5 examined parameters affecting ciprofloxacin removal using EAP. In 
Chapter 3, EAP using an iron anode and graphite cathode was evaluated without current and at 
three levels of applied current.  Although applied current did not enhance ciprofloxacin removal, 
significant defluorination and ciprofloxacin-matrix removal was attained from the chemical 
activation of persulafte by the solid iron rod.  Sustained persulfate activation and minimal iron 
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usage was achieved.  In Chapter 4, ciprofloxacin degradation was accomplished with applied 
current using a BDD/Gr anode/cathode pair without the addition of iron.  Significant 
improvements in removal rates were achieved by using sulfate instead of nitrate electrolyte, and 
even more benefit was gained through the use of persulfate electrolyte, in other words, EAP.  
Pathways of ciprofloxacin transformation were elucidated.  Chapter 5 evaluated effects of 
persulfate concentration, anode:cathode size ratio, and reactor configuration.  It was found that at 
least a 1:20 anode:cathode size ratio was needed to benefit from EAP.  In the flow-through reator 
configuration, increasing persulfate concentration only offered moderate improvements for 
ciprofloxacin removal, likely due to mass-transfer limitations and the sub-optimal anode:cathode 
size ratio used.  EAP was slightly more effective in a batch reactor.  The RDE reactor provided the 
most effective use of activated persulfate with increasing removal rates seen as persulfate 
concentration was increased.  This was attributed to the larger relative cathode size (at least 1:20 
anode:cathode was found to be optimal) and minimization of mass-transfer limitations. 
Chapter 5 evaluted the use of EAP for ciprofloxacin removal from synthetic hospital 
effluent.  Removal slowed down significantly in the effluent solution versus using pure electrolyte.  
There were no differences in removal of ciprofloxacin or TOC when using EAP or sulfate 
electrolyte for effluent treatment in the FTR.  Overall, the system was successful in removing high 
amounts of TOC from the effluent.  On the RDE, EAP increased removal rates of the ciprofloxacin-
matrix but did not increase the removal of the ciprofloxacin itself or TOC.  Again, high levels of 
TOC removal from the effluent was achieved.  During ciprofloxacin treatment in effluent in the 
FTR and RDE reactors, high levels of disinfection by-products were formed.  It was recommended 
that future studies incude pairing EAP with another treatment step, such as ion exchange, to 
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remove combine TOC removal with DBP removal.  It is also recommended to assess EAP with 
other organic analytes, where enhancements seen with ciprofloxacin in the pure electrolyte on the 
RDE may better translate to a flow-through reactor design in a complex matrix. 
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Table A1. Iron, Heat and Ultraviolet Light Activated Persulfate Degradation of Various Organics 
Iron-Activated 
Degradation 
Analyte  
(mmol L-1) 
Persulfate 
(mmol L-1) 
Maximum 
Analyte 
Removal 
Rxn 
Time 
(min) 
Optimal Molar Ratio Form of Iron 
Aniline100 0.05 2.5 100% 10 1:50:100 Fe0  
Aniline106 0.05 2.5 73% 240 1:125:25 Fe2+ 
Bisphenol A99 80 2 100% 45 1:5:4 Fe0 
Bisphenol A99 80 2 100% 30 1:5:4 Fe2+ Continuous addition 
Bisphenol A99 80 2 97% 30 1:5:4 Fe2+ Sequential addition 
-Nitroaniline109 0.2 8 100% 270 1:40:115 nano-Fe3O4 
2,4-Dichlorophenol121 0.184 12 93% 60 1:65:197 nano-Fe0 
Orange G225 0.1 1 100% 30 1:10:10 Fe2+ or Fe3+ 
Trichloroethene225 0.1 1 100% 120 1:10:10 Fe0 
Trichloroethene167 0.15 4.5 >99% 5 1:30:30:150 Fe0, biochar support 
Trichloroethane173 0.15 2.25 >99% 30 1:15:2:10 Fe2+, hydroxylamine 
Heat-Activated Degradation    Optimal Temp. (C) Synergistic Effects  
Aniline100 0.05 2.5 100% 60 80 +5mM Fe0  
Atrazine148 0.05 1 100% 90 60 none  
2,4-Dichlorophenol121 0.184 12 100% 60 50 +36mM Fe0  
Dimethyl Phthalate116 0.0515 10.8 100% 1080 40 none  
1,4-Dioxane49 1.135 26 100% 180 60 none  
1,4-Dioxane49 1.136 26 100% 240 60 +18mM Fe2+  
Monochlorobenzene226 0.00179 179 100% 120 60 none         
UV Light-Activated Degradation   Fluence Rate (mW cm-2) Synergistic Effects 
Wavelength/Power 
(nm/W) 
Acid Blue 113126 0.073 6.3 97.70% 120 - no pH effect 254 / 14 
Atrazine227 0.00464 1 50% - - pH=7.4 254 / - 
2-Methylisoborneol160 0.238 0.01 86% 10 1.29 no pH effect 254 / 60 
Phenol129 0.1 0.5 95% 900 0.18 +0.2 g/L Fe3O4 295-400 / 20 
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Table A2. Degradation of BTEX and Phenols by Iron-Activated Persulfate 
Analyte Analyte 
(mmol L-1) 
Persulfate  
(mmol L-1) 
*Form of  
Iron 
**Optimal Molar 
Ratio 
Maximum 
Analyte 
Removal 
Rxn  
Time  
(min) 
Benzene 228 1 20 Chelated (Citric Acid) Fe2+ 1:20:5:5 100% 70 
 
1 100 Fe2+ 1:100:4 60% 5 
Ethylbenzene228 1 100 Fe2+ 1:100:5 63% 5 
Toluene229 1 27.3 Fe2+ 1:27:08 84% 60 
Toluene228 1 100 Fe
2+ 1:100:5 50% 5 
Xylene228 1 100 Fe2+ 1:100:5 60% 5 
4-Chlorophenol153 0.156 0.78 Fe0  1:5:23 88% 60 
 
0.156 0.78 Fe2+ 1:5:20 31% 240 
 
0.156 0.78 Fe3+ 1:5:20 17% 240 
p-Nitrophenol61 0.72 30 Fe2+ 1:42:42 20% 180 
 
0.72 30 Cu2+ 1:42:42 15% 180 
*granular batch addition unless otherwise noted  **Molar Ratio of Organic: Persulfate: Fe  or Organic: Persulfate: Fe:Other Component 
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Table A3. Degradation of Various Organics by Iron-Activated Persulfate 
Analyte Analyte 
Conc. 
(mmol L-1) 
Persulfate 
Conc. 
(mmol L-1) 
*Form of  
Iron 
**Optimal 
Molar Ratio 
Maximum 
Analyte 
Removal 
Rxn  
Time  
(min) 
Chlorobenzene98 2.665 53 nano-Fe0 1:20:20 97% 1200 
 2.665 53 Fe
2+ 1:20:20 97% 1200 
 2.665 53 Fe
0 1:20:20 71% 1200 
Cyclohexanoic acid120 0.039 10.4 nano-Fe0 1:266:4590 82% 8640 
2,4-Dinitrotoluene79 0.275 1.3 Fe0 1:5:623 100% 120 
 0.275 1.3 Fe
2+ 1:5:623 22% 240 
Methyl tert-Butyl 
Ether98 3.523 70.5 nano-Fe0 1:20:20 40% 960 
 3.523 70.5 Fe
2+ 1:20:20 28% 960 
 3.523 70.5 Fe
0 1:20:20 28% 960 
Napthalene179 0.078 42 Fe0, sequential addition 1:538:231 >99% 7 
Napthalene98 0.101 2.02 nano-Fe0 1:20:20 >99% 1080 
 0.101 2.02 Fe
2+ 1:20:20 >99% 1140 
 0.101 2.02 Fe
0 1:20:20 >99% 1200 
Polyvinyl Alcohol92 0.581 1.3 Fe2+ 1:2:2 100% 240 
 0.581 1.3 Fe
0 1:2:2 70% 240 
Trichloroethene98 2.854 57 nano-Fe0 1:20:20 94% 1440 
 2.854 57 Fe
0 1:20:20 80% 1440 
 2.854 57 Fe
2+ 1:20:20 78% 1440 
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Table A4. Degradation of Pharmaceuticals by Iron-Activated Persulfate 
Analyte Analyte 
(mmol L-1) 
Persulfate 
(mmol L-1) 
*Form of  
Iron 
**Optimal 
Molar Ratio 
Maximum  
Analyte 
 Removal 
Rxn 
Time  
(min) 
Acetaminophen230 0.060 4.8 Fe0 1:80:80 60% 240 
Caffeine97 0.0258 7.36 Fe2+ Continuous addition 1:285:285 100% 15 
 0.0258 7.36 Fe
2+ 1:285:285 90% 15 
Carbemazepine149 0.150 6 Fe2+, Cl- addition 1:40:5 100% 10 
 0.150 6 Fe
2+ 1:40:5 50% 40 
 0.050 0.2 Fe
2+ 1:4:2 30% 60 
Ciprofloxacin96 0.030 2.4 Fe2+ 1:80:80 96% 30 
 0.030 0.3 
Fe2+ or Chelated (Citric Acid) 
Fe2+ 1:10:10:10 70% 30 
Ibuprofen97 0.0236 7.36 Fe2+ or Fe2+ Continuous addition 1:312:312 100% 15 
Nicotine97 0.0309 7.36 Fe2+ or Fe2+ Continuous addition 1:238:238 100% 15 
Phenacetin97 0.0279 7.36 Fe2+ Continuous addition 1:264:264 100% 30 
 0.0279 7.36  Fe
2+ 1:264:264 47% 30 
Sulfadiazine 144 0.008 1.8 Fe0 1:225:225 46% 60 
Sulfamethoxazole95 0.039 1.0 Fe0 1:25:56 95% 20 
 0.039 1.0 CoAgFe 1:25:56 95% 30 
 0.039 1.0 CoFe, AgFe, AgCoFe 1:25:56  95% 50 
 0.039 1.0 Fe
2+ Sequential addition 1:25:56 80% 120 
 0.030 2.4  Fe
2+ 1:80:80 75% 30 
 0.036 2.9 Fe
0 1:80:80 60% 5 
 0.030 0.3 Chelated (EDTA) Fe
2+ 1:10:10:10 50% 30 
 0.039 1.0  Fe
2+ 1:25:56 40% 120 
 0.030 0.3 Chelated (Citric Acid) Fe
2+ 1:10:10:10 35% 30 
 0.030 0.3  Fe
2+ 1:10:10 30% 30 
Triclosan230 0.031 2.5 Fe0 1:80:80 60% 5 
*granular batch addition unless otherwise noted  **Molar Ratio of Organic: Persulfate: Fe  or Organic: Persulfate: Fe:Other Component 
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Table A5. Degradation of Phenyls and Dyes by Iron-Activated Persulfate 
Analyte Analyte  
(mmol L-1) 
Persulfate  
(mmol L-1) 
*Form of  
Iron 
**Optimal 
Molar Ratio 
Maximum 
Analyte 
Removal 
Rxn  
Time  
(min) 
Aniline106 0.050 2.5 Chelated (Citric Acid) Fe2+ 1:50:25:25 60% 240 
Aniline155 0.10 2.5 Fe2+ 1:25:0.5 55% 10 
Aniline106 0.050 2.5 Chelated (EDTA) Fe2+ 1:50:25:25 50% 240 
 0.050 2.5 Fe
2+ 1:50:25 45% 240 
 0.050 2.5 Chelated (Oxalic) Fe
2+ 1:50:25:25 45% 240 
Diuron94 0.0215 7.36 Fe2+ Continuous addition 1:340:340 100% 15 
Diuron94 0.0858 3.1 Fe2+ Continuous addition 1:36:36 100% 30 
 0.0858 3.1 Fe
2+ 1:36:36 100% 30 
Diuron 0.0215 7.36 Fe2+ 1:340:340 90% 15 
Diuron231 0.010 0.2 Chelated (Citric Acid) Fe2+ 1:20:20 90% 240 
PCB28108 0.025 2 nano-Fe3O4, air purge 1:80:720 100% 200 
 0.025 2 nano-Fe3O4-Fe
2+ 1:80:720 95% 120 
 0.025 2 nano-Fe3O4 1:80:720 90% 240 
p-Chloroaniline232 0.050 2.5 Fe0 1:50:1700 100% 12 
Reactive Blue 1980 0.1 10 Fe0 1:100:143 100% 45 
Congo Red178 0.287 0.4 Zerovalent zinc 20mM 60% 180 
*granular batch addition unless otherwise noted  **Molar Ratio of Organic: Persulfate: Fe  or Organic: Persulfate: Fe:OtherComponent 
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Table A6. Degradation of Ethenes, Phenols and Phenyls by Thermally Activated Persulfate 
Analyte Analyte 
(mmol L-1) 
Persulfate  
(mmol L-1) 
Heating 
Method 
Optimal 
Temp. 
(C) 
Synergistic 
Effects 
Reaction 
pH 
Maximum 
Analyte 
Removal 
Rxn 
Time 
(min) 
Reaction Rate 
Constant (min-
1) 
Aniline154 0.030 100 conventional 50 none 7 75% 180 - 
Diuron94, 233 0.0858 3.1 conventional 50 +0.90 mM 
Fe2+  
3-9 100% 30 - 
 0.09 2.1 conventional 50 +0.72 mM 
Fe2+ 
2.5 100% 180 0.00451 
p-Chloroaniline232 0.050 2.5 conventional 50 +12.5 mM 
Fe0 
7 85% 300 - 
 
0.050 2.5 conventional 50 none 7 58% 300 - 
Pentachlorophenol11
5 
0.0375 0.75 microwave 90 none - 100% 40 0.1526 
 
0.0375 0.75 conventional 90 none - 94% 40 0.0707 
 
0.0375 0.112 microwave 130 none - 90% 1 rapid 
p-Nitroaniline109 0.200 8 conventional 55 +23mM 
nano-Fe3O4 
7 98% 20 0.19 
p-Nitrophenol61 0.720 30 conventional 70 Fe2+,Cu2+ did 
not increase 
degradation 
- 100% 180 0.0276 
 
0.720 30 conventional 90 - 100% 20 0.2942 
Tetrachloroethene63 0.045 0.45 conventional 60 none - 94% 60 0.0332 
Trichloroethene234 0.150 300 conventional 50 none - 100% 9 - 
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Table A7. Degradation of Pharmaceuticals by Thermally Activated Persulfate 
Analyte Analyte 
 (mmol L-1) 
Persulfate 
(mmol L-1) 
Heating Method Optimal 
Temp. 
(C) 
Synergistic 
Effects 
Reaction  
pH 
Maximum 
Analyte 
Removal 
Rxn 
Time 
(min) 
Reaction Rate 
Constant 
 (min-1) 
Antipyrine114 0.0265 1.855 conventional 70 none 7.1 94.0% 40 0.0854 
 0.0265 2.65 conventional 60 none 4 71.4% 120 0.0092 
Chloramphenicol235 0.200 4 conventional 80 none 5.4 >99% 40 0.0593 
 0.200 4 conventional 50 none 5.4 31% 160 0.0024 
Diclofenac172 0.047 0.47 Conventional 70 None 7 >90% 120 0.0162 
Ibuprofen165 0.0204 1 conventional 70 none 7 100% 20 0.183 
 0.0204 1 conventional 60 none 4 85% 60 0.0161 
Sulfamethoxazole118 0.050 2.5 conventional 90 none 4.7 80% 60 0.0271 
 0.050 2.5 microwave 90 none 4.7 100% 16 0.291 
 0.050 2.5 microwave 130 none 4.7 100% 1 rapid 
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Table A8. Degradation of Various Organics by Thermally Activated Persulfate 
Analyte Analyte  
(mmol L-1 ) 
Persulfate  
(mmol L-1 ) 
Heating 
Method 
Optimal 
Temp. 
(C) 
Synergistic 
Effects 
Maximum 
Analyte 
Removal 
Rxn 
Time 
(min) 
Reaction Rate 
Constant 
(min-1) 
         
Cyclohexanoic acid120 0.039 10.4 microwave 80 Fe0 did not 
increase 
degradation 
100% 120 - 
Dimethyl Phthalate116 0.0515   10.8 conventional 40 none 100% 1080 0.00172 
Methyl tert-Butyl Ether57 0.060 31.5 conventional 50 none 100% 150 0.0348 
Perfluorooctanoic Acid 0.2415 200 conventional 40 none 100% 4320 0.00086 
81, 92, 93, 236-238 0.254 50 microwave  90 none 99.3% 240 0.01633  
0.254 10 microwave  90 none 77% 120 0.00122  
0.254 5 microwave 90 +3.6 mM Fe0 67.60% 120 0.0417  
0.254 5 microwave 90 none 62.60% 240 0.0008 
 
0.0005 10 conventional 85 none 93.50% 3060 0.00158 
Polyvinyl Alcohol92 0.581 1.00 conventional 80 Fe2+,Fe0 did not 
increase 
degradation 
100% 10 0.4238 
 
0.581 1.00 conventional 60 Fe2+,Fe0 did not 
increase 
degradation 
 
100% 30 0.0846 
Landfill Leachate163 2090mg/L 
TOC 
22 microwave 85 none 
 
Fe2+,Fe0 did not 
increase 
degradation 
+9mM Fe0 
79.4 30 0.0099 
        
Spent Caustic239 2090mg/L 
TOC 
45 conventional 80 95% 120 0.0134 
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Table A9. Degradation of Pharmaceuticals by Ultraviolet Light Activated Persulfate 
Analyte Analyte 
(mmol L-1) 
Persulfate  
(mmol L-1) 
UV 
Wavelength/Power 
(nm/W) 
Fluence 
Rate 
(mW/cm2) 
Synergistic 
Effects 
Maximum 
Analyte 
Removal 
Rxn 
Time 
(min) 
Reaction Rate 
Constant  
(min-1) 
 
Ciprofloxacin185 
 
0.0302 
 
8 
 
254 / 8  
 
1 
 
 
 
95% 
 
30 
 
0.2988 
Acetaminophen158 0.017 0.132 253.7 / 75 0.114 - 100% 60 0.0453 
Ampicillin53 0.050 1 254 / 50  
(two lamps) 
0.1 - 75%   
Carbemazepine128 0.050 0.2 290 max / 1800 - +0.1mMol/L Fe2+  100% 30 0.109 
 0.050 0.2 290 max / 1800 - - 60% 60 0.0051 
Cephalothin53 0.050 1 254 / 50  
(two lamps) 
0.1 - 91%   
Florfenicol161 0.02 2 254 / - - - 100% 60 0.0325 
Sulfadiazine240 0.080 0.5 254 / 8  0.112 - 93% 180 0.0245 
Sulfamethizole240 0.074 0.5 254 / 8  0.112 - 97% 180 0.0096 
Sulfamethoxazole240 0.079 0.5 254 / 8  0.112 - 98% 180 0.0283 
Sulfathiazole240 0.078 0.5 254 / 8  0.112 - 99% 180 0.0141 
Tylosin150 0.0055 2 - / 30W - +93uM nano-Ag 90.90% 35 - 
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Table A10. Degradation of Various Organics by Ultraviolet Light Activated Persulfate 
Analyte Analyte 
\(mmol L-1) 
Persulfate  
(mmol L-1) 
UV 
Wavelength/
Power 
 (nm / W) 
Fluence 
Rate 
(mW cm-2) 
Synergistic 
Effects 
Maximum 
Analyte 
Removal 
Rxn 
Time 
(min) 
Reaction 
Rate 
Constant 
(min-1) 
2,2,3,3-tetrafluoro-1-
propanol82 
1.390 20 254 / - 2.04 pH=3.0 100% 60 - 
Acid Red 14241 0.040 5.0 200-280 / 30 - Nano-TiO2 on 
glass beads 
75% 15  
Anthracene242 0.004 0.08 300 / - - - 90% 6 0.35 
Geosmin160 0.219 0.01 254 / 60 1.29 no pH effect 94.50% 10 7.6*108  
L(mol-s)-1 
Imazalil243 0.084 42.2 365 / 125 31 pH=6.5 100% 120 0.596 
 
0.084 21.1 365 / 125  31 pH=3.0; +2.5 
g/L TiO2 
100% 240 0.501 
Nitrobenzene53 0.050 1 254 / 50  0.1 pH=2.0 75% 
 
- 
Perfluorononanoic Acid244 0.0148 1.1 220-460 / 200 - 0.48 MPa O2 100% 720 - 
Perfluorooctanoic Acid 0.0296 1.1 220-460 / 200 - 0.48 MPa O2 100% 240 - 
Phenol129 0.100 50 295-400 / 20 0.18 - 95% 300 - 
Polyvinyl Alcohol125, 245 20 mg L-1 0.325 254 / 8  - pH=3.0 100% <5 min 1.5509 
 
20 mg L-1 0.5 254 / 8  - - 100% <5 min 2.3438 
 
20 mg L-1 0.5 365 / 8  - - 93% 30 0.0275 
Tetrabromobisphenol A127 0.100 20 365 max / 100 - pH=13.0 99% 180 - 
 172 
 
 
 
 
Table A11. Degradation of Various Organics by Electrochemically Activated Persulfate 
Analyte Analyte  
(mmol L-1) 
Persulfate 
(mmol L-1) 
Anode Cathode Synergistic Effects Electrical 
Properties 
pH Max 
Analyte 
Removal 
Reaction 
duration 
(min) 
Acid Orange 7246 0.1 12 Ti/RuO2/Ir
O2 
stainless 
steel 
1 mM Fe2+ 16.8 mA cm-2 3 95.7% 60 
 0.1 12 Ti/RuO2/Ir
O2 
stainless 
steel 
none 16.8 mA cm-2 3 65.8% 60 
 
 
 
 
 
 
        
 Aniline50 
64 3% by wt. Pt Pt 150mL/min N2 6 V 3.7 100% 420 
Bisphenol A143 220 10  Ti/RuO2/Ir
O2 
stainless 
steel 
2mM Fe3+ 16.8 mA cm-2 3 >99% 120 
Dinitrotoluene59 25 mg L-1 
TOC 
1% by wt. Pt Pt 150mL/min N2 6 V 0.5 98% 480 
Orange II169 100 mg L-1 8.4 Ti/RuO2/Ir
O2 
stainless 
steel 
1g/L Fe-Co/SBA-
15 catalyst 
16.8 mA cm-2 6 95.6% 60 
 100 mg L-1 8.4 Ti/RuO2/Ir
O2 
stainless 
steel 
1g/L Fe-Co/SBA-
15 catalyst 
8.4 mA  
cm-2 
6 90.5% 60 
 100mg/L 8.4 Ti/RuO2/Ir
O2 
stainless 
steel 
none 8.4 mA cm2 6 89.4% 60 
Pentachlorophenol14
2 
50 0.115 Fe Fe Fe from electrodes 90 mA cm2 4.5 38% 20 
Trichloroethene141 400 5 Fe Mixed 
Metal 
Oxide 
up to 1.8mM Fe 
from Fe anode 
100 mA 5.6 100% 90 
Landfill leachate164 1900 mg L-1 
COD 
62.5 Ti/IrO2-
RuO2-TiO2 
Ti 15.6 mM  Fe2+ 13.9 mA cm-2 3 62.2% 60 
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Table A12. Degradation of Various Organics Using Unique Methods of Persulfate Activation 
Analyte 
Analyte 
Conc. 
(mmol L-1) 
Persulfate 
Conc. 
(mmol L-1) 
Activator Activator Properties 
Maximum 
Analyte 
Removal 
Optimization 
Reaction Rate 
Constant 
(min-1) 
Benzotriazole86 0.02 0.5 
Weak magnetic 
field with Fe0 
+0.5mM Fe0; pH=7.0 >90% 
WMF resulted in 
increase in removal 
0.0126 
Caffeine86 0.02 0.5 Same as above Same as above 100% Same as above 0.0175 
Diuron86 0.02 0.5 Same as above Same as above 100% Same as above 0.0291 
4-nitrophenol86 0.02 0.5 Same as above Same as above >95% Same as above 0.0189 
Ammonia 
Perfluorooctanoate56 
0.0464 10 Ultrasonication  300W, 20kHz 51.20% 
persulfate increased 
removal 15% 
 
Acid Orange 758  1.3 
Ultrasonication 
plus Fe0 
60W; +2.1mM Fe0; 96.40% 
Increased removal 
35% with US; 
pH=5.8 
 
Sulfadiazine144 0.008 1.84 Ultrasonication 90 Watts; +0.2mM Fe0 99.10% 
  
Perfluorooctanoic-
sulphonic Acid247 
0.0185 18.5 
Heat, UV , Fe2+ 
or 
Utrasonication 
UV=254nm,15W;   
US=2W/cm2 ,40kHz; 
Fe2=3mM 
22.5% with 
temp 
pH = 3.0 
heat>UV>Fe2+> 
US 
Ibuprofen60 1 20 
gamma 
irradiation 
80 kGy dose 97% 
Addition of 
persulfate required 
less dose  
 
PCB2851 0.002 5 
1,4-
benzoquinone 
0.1mM 88% pH = 7.4 0.0097 
Phenol68 0.213 6.2 
carbon 
nanotubes 
0.2g/L catalyst 100% 
 
0.0439 
p-Hydroxybenzoic 
Acid66 
0.1 2 electron beam  
3MeV vertical scan 
beam; 600 Gy dose 
80% 
Persulfate did not 
affect removal 
 
Acid Orange 7146 0.057 5.7 activated carbon 
5g/L (adsorbent and 
catalyst) 
>97% 
Rate constant 
reported for 1g/L AC 
(82% rem.) 
0.000347 
Perfluorooctanoic 
Acid67 
0.1206 6.3 activated carbon 
10g/L (adsorbent and 
catalyst) 
68.20% 
persulfate increased 
reaction rate 50% 
0.00437 
Trichloroethene145 0.076 8.4 activated carbon adsorbent and catalyst 97% 
Addition of 
persulfate increased 
TCE degradation 
0.0329 
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Figure A1. Mass spectra for byproducts are shown for a-h) nitrate, i) sulfate, and j-u) persulfate at 
various time points during the degradation of ciprofloxacin. 
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Figure A1. Continued   
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Figure A1. Continued 
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Figure A1. Continued 
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Figure A1. Continued 
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Figure A1. Continued 
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Figure A1. Continued 
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Figure A1. Continued 
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Figure A1. Continued 
 183 
 
 
 
 
 
Figure A1. Continued 
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Figure A1. Continued 
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